Octamer	B-protein
binding	I-protein
factors	I-protein
and	O
their	O
coactivator	B-protein
can	O
activate	O
the	O
murine	B-DNA
PU.1	I-DNA
(	I-DNA
spi-1	I-DNA
)	I-DNA
promoter	I-DNA
.	O

PU.1	B-protein
(	O
spi-1	B-protein
)	O
,	O
a	O
member	O
of	O
the	O
Ets	B-protein
transcription	I-protein
factor	I-protein
family	I-protein
,	O
is	O
predominantly	O
expressed	O
in	O
myeloid	B-cell_type
and	I-cell_type
B	I-cell_type
cells	I-cell_type
,	O
activates	O
many	O
B	B-DNA
cell	I-DNA
and	I-DNA
myeloid	I-DNA
genes	I-DNA
,	O
and	O
is	O
critical	O
for	O
development	O
of	O
both	O
of	O
these	O
lineages	O
.	O

Our	O
previous	O
studies	O
(	O
Chen	O
,	O
H.M.	O
,	O
Ray-Gallet	O
,	O
D.	O
,	O
Zhang	O
,	O
P.	O
,	O
Hetherington	O
,	O
C.J.	O
,	O
Gonzalez	O
,	O
D.A.	O
,	O
Zhang	O
,	O
D.-E.	O
,	O
Moreau-Gachelin	O
,	O
F.	O
,	O
and	O
Tenen	O
,	O
D.G.	O
(	O
1995	O
)	O
Oncogene	O
11	O
,	O
1549-1560	O
)	O
demonstrate	O
that	O
the	O
PU.1	B-DNA
promoter	I-DNA
directs	O
cell	B-DNA
type-specific	I-DNA
reporter	I-DNA
gene	I-DNA
expression	O
in	O
myeloid	O
cell	O
lines	O
,	O
and	O
that	O
PU.1	B-protein
activates	O
its	O
own	O
promoter	O
in	O
an	O
autoregulatory	O
loop	O
.	O

Here	O
we	O
show	O
that	O
the	O
murine	B-DNA
PU.1	I-DNA
promoter	I-DNA
is	O
also	O
specifically	O
and	O
highly	O
functional	O
in	O
B	B-cell_line
cell	I-cell_line
lines	I-cell_line
as	O
well	O
.	O

Oct-1	B-protein
and	O
Oct-2	B-protein
can	O
bind	O
specifically	O
to	O
a	O
site	O
at	O
base	O
pair	O
-55	O
in	O
vitro	O
,	O
and	O
this	O
site	O
is	O
specifically	O
protected	O
in	O
B	B-cell_type
cells	I-cell_type
in	O
vivo	O
.	O

We	O
also	O
demonstrate	O
that	O
two	O
other	O
sites	O
contribute	O
to	O
promoter	O
activity	O
in	O
B	B-cell_type
cells	I-cell_type
;	O
an	O
Sp1	B-DNA
binding	I-DNA
site	I-DNA
adjacent	O
to	O
the	O
octamer	B-DNA
site	I-DNA
,	O
and	O
the	O
PU.1	B-DNA
autoregulatory	I-DNA
site	I-DNA
.	O

Finally	O
,	O
we	O
show	O
that	O
the	O
B	O
cell	O
coactivator	B-protein
OBF-1/Bob1/OCA-B	B-protein
is	O
only	O
expressed	O
in	O
B	B-cell_type
cells	I-cell_type
and	O
not	O
in	O
myeloid	B-cell_type
cells	I-cell_type
,	O
and	O
that	O
OBF-1/Bob1/OCA-B	B-protein
can	O
transactivate	O
the	O
PU.1	B-DNA
promoter	I-DNA
in	O
HeLa	B-cell_line
and	O
myeloid	B-cell_type
cells	I-cell_type
.	O

This	O
B	B-protein
cell	I-protein
restricted	I-protein
coactivator	I-protein
may	O
be	O
responsible	O
for	O
the	O
B	O
cell	O
specific	O
expression	O
of	O
PU.1	B-protein
mediated	O
by	O
the	O
octamer	B-DNA
site	I-DNA
.	O

THs	NULL
JourNaL	NULL
or	NULL
BroLocicaL	NULL
CHEMISTRY	NULL
©	NULL
1996	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
for	NULL
Biochemistry	NULL
and	NULL
Molecular	NULL
Biology	NULL
,	NULL
Inc.	NULL
Vol	NULL
.	NULL

271	NULL
,	NULL
No	NULL
.	NULL

26	NULL
,	NULL
Issue	NULL
of	NULL
June	NULL
28	NULL
,	NULL
pp	NULL
.	NULL

15743-15752	NULL
,	NULL
1996	NULL
Printed	NULL
in	NULL
U.S.A.	NULL
Octamer	NULL
Binding	NULL
Factors	NULL
and	NULL
Their	NULL
Coactivator	NULL
Can	NULL
Activate	NULL
the	NULL
Murine	NULL
PU.1	NULL
(	NULL
spit-1	NULL
)	NULL
Promoter*	NULL
(	NULL
Received	NULL
for	NULL
publication	NULL
,	NULL
November	NULL
7	NULL
,	NULL
1995	NULL
,	NULL
and	NULL
in	NULL
revised	NULL
form	NULL
,	NULL
February	NULL
21	NULL
,	NULL
1996	NULL
)	NULL
Hui-min	NULL
Chen	NULL
}	NULL
,	NULL
Pu	NULL
Zhang	NULL
,	NULL
Hanna	NULL
S.	NULL
Radomska	NULL
,	NULL
Christopher	NULL
J.	NULL
Hetherington	NULL
,	NULL
Dong-Er	NULL
Zhang	NULL
,	NULL
and	NULL
Daniel	NULL
G.	NULL
Tenen	NULL
{	NULL
Hematology	NULL
/Oncology	NULL
Division	NULL
,	NULL
Department	NULL
of	NULL
Medicine	NULL
,	NULL
Beth	NULL
Israel	NULL
Hospital	NULL
,	NULL
Harvard	NULL
Medical	NULL
School	NULL
,	NULL
Boston	NULL
,	NULL
Massachusetts	NULL
02215	NULL
PU.1	NULL
(	NULL
spi-1	NULL
)	NULL
,	NULL
a	NULL
member	NULL
of	NULL
the	NULL
Ets	NULL
transcription	NULL
factor	NULL
family	NULL
,	NULL
is	NULL
predominantly	NULL
expressed	NULL
in	NULL
myeloid	NULL
and	NULL
B	NULL
cells	NULL
,	NULL
activates	NULL
many	NULL
B	NULL
cell	NULL
and	NULL
myeloid	NULL
genes	NULL
,	NULL
and	NULL
is	NULL
critical	NULL
for	NULL
development	NULL
of	NULL
both	NULL
of	NULL
these	NULL
lineages	NULL
.	NULL

Our	NULL
previous	NULL
studies	NULL
(	NULL
Chen	NULL
,	NULL
H.	NULL
M.	NULL
,	NULL
Ray-Gallet	NULL
,	NULL
D.	NULL
,	NULL
Zhang	NULL
,	NULL
P.	NULL
,	NULL
Hetherington	NULL
,	NULL
C.	NULL
J.	NULL
,	NULL
Gonzalez	NULL
,	NULL
D.	NULL
A.	NULL
,	NULL
Zhang	NULL
,	NULL
D.-E.	NULL
,	NULL
Moreau-Gachelin	NULL
,	NULL
F.	NULL
,	NULL
and	NULL
Tenen	NULL
,	NULL
D.	NULL
G.	NULL
(	NULL
1995	NULL
)	NULL
Oncogene	NULL
11	NULL
,	NULL
1549-1560	NULL
)	NULL
demonstrate	NULL
that	NULL
the	NULL
PU.1	NULL
promoter	NULL
directs	NULL
cell	NULL
type-specific	NULL
reporter	NULL
gene	NULL
expression	NULL
in	NULL
myeloid	NULL
cell	NULL
lines	NULL
,	NULL
and	NULL
that	NULL
PU.1	NULL
activates	NULL
its	NULL
own	NULL
promoter	NULL
in	NULL
an	NULL
autoregulatory	NULL
loop	NULL
.	NULL

Here	NULL
we	NULL
show	NULL
that	NULL
the	NULL
murine	NULL
PU.1	NULL
promoter	NULL
is	NULL
also	NULL
specifically	NULL
and	NULL
highly	NULL
functional	NULL
in	NULL
B	NULL
cell	NULL
lines	NULL
as	NULL
well	NULL
.	NULL

Oct-1	NULL
and	NULL
Oct-2	NULL
can	NULL
bind	NULL
specifically	NULL
to	NULL
a	NULL
site	NULL
at	NULL
base	NULL
pair	NULL
-55	NULL
in	NULL
vitro	NULL
,	NULL
and	NULL
this	NULL
site	NULL
is	NULL
specifically	NULL
protected	NULL
in	NULL
B	NULL
cells	NULL
in	NULL
vivo	NULL
.	NULL

We	NULL
also	NULL
demonstrate	NULL
that	NULL
two	NULL
other	NULL
sites	NULL
contribute	NULL
to	NULL
promoter	NULL
activity	NULL
in	NULL
B	NULL
cells	NULL
;	NULL
an	NULL
Spl	NULL
binding	NULL
site	NULL
adjacent	NULL
to	NULL
the	NULL
octamer	NULL
site	NULL
,	NULL
and	NULL
the	NULL
PU.1	NULL
autoregulatory	NULL
site	NULL
.	NULL

Finally	NULL
,	NULL
we	NULL
show	NULL
that	NULL
the	NULL
B	NULL
cell	NULL
coactivator	NULL
OBF-1/Bobl/OCA-B	NULL
is	NULL
only	NULL
expressed	NULL
in	NULL
B	NULL
cells	NULL
and	NULL
not	NULL
in	NULL
myeloid	NULL
cells	NULL
,	NULL
and	NULL
that	NULL
OBF-1/Bob1/0CA-B	NULL
can	NULL
transactivate	NULL
the	NULL
PU.1	NULL
promoter	NULL
in	NULL
HeLa	NULL
and	NULL
myeloid	NULL
cells	NULL
.	NULL

This	NULL
B	NULL
cell	NULL
restricted	NULL
coactivator	NULL
may	NULL
be	NULL
responsible	NULL
for	NULL
the	NULL
B	NULL
cell	NULL
specific	NULL
expression	NULL
of	NULL
PU.1	NULL
mediated	NULL
by	NULL
the	NULL
octamer	NULL
site	NULL
.	NULL

PU.1	NULL
is	NULL
the	NULL
product	NULL
of	NULL
the	NULL
spi-1	NULL
oncogene	NULL
identified	NULL
as	NULL
a	NULL
consequence	NULL
of	NULL
its	NULL
transcriptional	NULL
activation	NULL
in	NULL
Friend	NULL
virus	NULL
induced	NULL
erythroleukemias	NULL
(	NULL
1-4	NULL
)	NULL
.	NULL

The	NULL
overexpression	NULL
of	NULL
the	NULL
PU.1	NULL
gene	NULL
from	NULL
a	NULL
retroviral	NULL
construct	NULL
in	NULL
long	NULL
term	NULL
bone	NULL
marrow	NULL
cultures	NULL
is	NULL
able	NULL
to	NULL
provoke	NULL
the	NULL
proliferation	NULL
of	NULL
proerythro-blast-like	NULL
cells	NULL
that	NULL
differentiate	NULL
at	NULL
a	NULL
low	NULL
frequency	NULL
into	NULL
hemo-globinized	NULL
cells	NULL
(	NULL
5	NULL
)	NULL
.	NULL

PU.1	NULL
antisense	NULL
oligonucleotides	NULL
reduce	NULL
the	NULL
capacity	NULL
of	NULL
Friend	NULL
tumor	NULL
cells	NULL
to	NULL
proliferate	NULL
,	NULL
and	NULL
competitor	NULL
oligonucleotides	NULL
block	NULL
myeloid	NULL
colony	NULL
formation	NULL
in	NULL
human	NULL
CD34*	NULL
cells	NULL
(	NULL
6	NULL
,	NULL
7	NULL
)	NULL
.	NULL

Moreover	NULL
,	NULL
disruption	NULL
of	NULL
the	NULL
PU.1	NULL
gene	NULL
by	NULL
homologous	NULL
recombination	NULL
in	NULL
murine	NULL
embryonic	NULL
stem	NULL
cells	NULL
is	NULL
lethal	NULL
for	NULL
homozygous	NULL
PU	NULL
.	NULL

1	NULL
mutant	NULL
progeny	NULL
(	NULL
8	NULL
)	NULL
.	NULL

Embryos	NULL
present	NULL
with	NULL
multilineage	NULL
defects	NULL
in	NULL
white	NULL
cell	NULL
development	NULL
,	NULL
including	NULL
B	NULL
cells	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
these	NULL
data	NULL
demonstrate	NULL
the	NULL
importance	NULL
of	NULL
proper	NULL
regulation	NULL
of	NULL
PU.1	NULL
in	NULL
the	NULL
hematopoietic	NULL
system	NULL
in	NULL
general	NULL
,	NULL
and	NULL
particularly	NULL
in	NULL
B	NULL
cells	NULL
.	NULL

PU.1	NULL
is	NULL
a	NULL
member	NULL
of	NULL
the	NULL
Ets	NULL
family	NULL
of	NULL
transcriptional	NULL
acti-	NULL
*	NULL
This	NULL
work	NULL
was	NULL
supported	NULL
in	NULL
part	NULL
by	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
Grants	NULL
CA41456	NULL
and	NULL
CA59589	NULL
.	NULL

The	NULL
costs	NULL
of	NULL
publication	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
the	NULL
payment	NULL
of	NULL
page	NULL
charges	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
advertisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

Section	NULL
17834	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL
}	NULL

Recipient	NULL
of	NULL
a	NULL
fellowship	NULL
from	NULL
The	NULL
Medical	NULL
Foundation	NULL
,	NULL
Boston	NULL
.	NULL

§	NULL
To	NULL
whom	NULL
correspondence	NULL
should	NULL
be	NULL
addressed	NULL
:	NULL
Harvard	NULL
Institutes	NULL
of	NULL
Medicine	NULL
,	NULL
Rm	NULL
.	NULL

954	NULL
,	NULL
77	NULL
Avenue	NULL
Louis	NULL
Pasteur	NULL
,	NULL
Boston	NULL
,	NULL
MA	NULL
02215	NULL
.	NULL

Tel	NULL
.	NULL

:	NULL
617-667-5561	NULL
;	NULL
Fax	NULL
:	NULL
617-667-3299	NULL
;	NULL
E-mail	NULL
:	NULL
tenen	NULL
@	NULL
mberr	NULL
.	NULL

harvard.edu	NULL
.	NULL

vators	NULL
and	NULL
is	NULL
involved	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
expression	NULL
of	NULL
multiple	NULL
genes	NULL
specific	NULL
for	NULL
different	NULL
lineages	NULL
.	NULL

PU.1	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
bind	NULL
to	NULL
the	NULL
promoters	NULL
of	NULL
many	NULL
myeloid	NULL
genes	NULL
and	NULL
is	NULL
critical	NULL
for	NULL
their	NULL
myeloid	NULL
specific	NULL
expression	NULL
(	NULL
listed	NULL
in	NULL
Ref	NULL
.	NULL

9	NULL
and	NULL
reviewed	NULL
in	NULL
Ref	NULL
.	NULL

10	NULL
)	NULL
.	NULL

In	NULL
B	NULL
cells	NULL
,	NULL
PU.1	NULL
regulates	NULL
the	NULL
J	NULL
chain	NULL
promoter	NULL
and	NULL
immunoglobulin	NULL
promoters	NULL
,	NULL
the	NULL
immunoglobulin	NULL
A	NULL
2-4	NULL
and	NULL
k	NULL
3'-enhancers	NULL
,	NULL
the	NULL
u	NULL
heavy	NULL
chain	NULL
gene	NULL
enhancer	NULL
,	NULL
the	NULL
B29	NULL
gene	NULL
promoter	NULL
,	NULL
and	NULL
Epstein-Barr	NULL
viral	NULL
promoters	NULL
(	NULL
11-18	NULL
)	NULL
.	NULL

Since	NULL
PU.1	NULL
is	NULL
such	NULL
an	NULL
important	NULL
transcription	NULL
factor	NULL
in	NULL
hematopoietic	NULL
development	NULL
,	NULL
and	NULL
abnormalities	NULL
of	NULL
PU.1	NULL
expression	NULL
can	NULL
lead	NULL
to	NULL
experimental	NULL
erythroleukemia	NULL
,	NULL
we	NULL
investigated	NULL
the	NULL
PU.1	NULL
promoter	NULL
in	NULL
order	NULL
to	NULL
understand	NULL
its	NULL
regulation	NULL
.	NULL

Our	NULL
previous	NULL
investigation	NULL
of	NULL
the	NULL
murine	NULL
PU	NULL
.	NULL

1	NULL
promoter	NULL
in	NULL
myeloid	NULL
cells	NULL
demonstrate	NULL
that	NULL
as	NULL
little	NULL
as	NULL
334	NULL
bp	NULL
``	NULL
of	NULL
upstream	NULL
promoter	NULL
sequence	NULL
directs	NULL
cell-type	NULL
specific	NULL
transcription	NULL
.	NULL

This	NULL
promoter	NULL
includes	NULL
a	NULL
binding	NULL
site	NULL
for	NULL
PU.1	NULL
itself	NULL
in	NULL
this	NULL
region	NULL
,	NULL
which	NULL
may	NULL
play	NULL
an	NULL
important	NULL
role	NULL
in	NULL
positive	NULL
autoregulation	NULL
of	NULL
PU.1	NULL
(	NULL
9	NULL
)	NULL
.	NULL

As	NULL
discussed	NULL
above	NULL
,	NULL
in	NULL
addition	NULL
to	NULL
myeloid	NULL
cells	NULL
,	NULL
PU.1	NULL
is	NULL
also	NULL
strongly	NULL
expressed	NULL
in	NULL
B	NULL
lymphocytes	NULL
and	NULL
regulates	NULL
many	NULL
B	NULL
cell-specific	NULL
genes	NULL
.	NULL

The	NULL
functional	NULL
region	NULL
of	NULL
the	NULL
PU.1	NULL
promoter	NULL
has	NULL
octamer	NULL
and	NULL
Spl	NULL
sites	NULL
which	NULL
are	NULL
conserved	NULL
in	NULL
both	NULL
the	NULL
murine	NULL
and	NULL
human	NULL
PU	NULL
.	NULL
]	NULL

promoters	NULL
(	NULL
9	NULL
)	NULL
.	NULL

The	NULL
octamer	NULL
sequence	NULL
ATGCAAAT	NULL
was	NULL
originally	NULL
found	NULL
in	NULL
all	NULL
immunoglobulin	NULL
heavy	NULL
and	NULL
light	NULL
chain	NULL
promoters	NULL
,	NULL
as	NULL
well	NULL
as	NULL
the	NULL
intronic	NULL
heavy	NULL
chain	NULL
enhancer	NULL
(	NULL
reviewed	NULL
in	NULL
Refs	NULL
.	NULL

19	NULL
and	NULL
20	NULL
)	NULL
.	NULL

Octamer	NULL
binding	NULL
proteins	NULL
belong	NULL
to	NULL
the	NULL
POU	NULL
homeodomain	NULL
transcription	NULL
factor	NULL
family	NULL
(	NULL
21	NULL
)	NULL
.	NULL

Two	NULL
of	NULL
the	NULL
best	NULL
characterized	NULL
octamer	NULL
binding	NULL
proteins	NULL
are	NULL
Oct-1	NULL
and	NULL
Oct-2	NULL
.	NULL

The	NULL
Oct-1	NULL
protein	NULL
is	NULL
ubiquitously	NULL
expressed	NULL
,	NULL
whereas	NULL
Oct-2	NULL
is	NULL
expressed	NULL
mainly	NULL
in	NULL
B	NULL
lymphocytes	NULL
(	NULL
22-27	NULL
)	NULL
.	NULL

Constitutively	NULL
expressed	NULL
Oct-2	NULL
can	NULL
preserve	NULL
expression	NULL
of	NULL
B	NULL
cell-specific	NULL
genes	NULL
in	NULL
cell	NULL
hybrids	NULL
(	NULL
28	NULL
,	NULL
29	NULL
)	NULL
.	NULL

Oct-2	NULL
gene	NULL
disruption	NULL
shows	NULL
that	NULL
it	NULL
plays	NULL
an	NULL
important	NULL
role	NULL
in	NULL
B	NULL
cell	NULL
maturation	NULL
at	NULL
late	NULL
stages	NULL
,	NULL
but	NULL
not	NULL
in	NULL
early	NULL
B	NULL
cell	NULL
development	NULL
(	NULL
30	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
several	NULL
reports	NULL
suggested	NULL
the	NULL
existence	NULL
of	NULL
octamer	NULL
coactivators	NULL
,	NULL
proteins	NULL
which	NULL
augment	NULL
the	NULL
ability	NULL
of	NULL
octamer	NULL
factors	NULL
to	NULL
stimulate	NULL
promoters	NULL
in	NULL
a	NULL
factor	NULL
,	NULL
promoter	NULL
,	NULL
and	NULL
cell	NULL
type-specific	NULL
manner	NULL
(	NULL
31	NULL
,	NULL
32	NULL
)	NULL
.	NULL

Recently	NULL
,	NULL
both	NULL
Oct-1	NULL
and	NULL
Oct-2	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
interact	NULL
with	NULL
a	NULL
non-DNA	NULL
binding	NULL
octamer	NULL
coactivator	NULL
,	NULL
known	NULL
as	NULL
Bob1	NULL
(	NULL
83	NULL
)	NULL
,	NULL
OBF-1	NULL
(	NULL
34	NULL
)	NULL
,	NULL
or	NULL
OCA-B	NULL
(	NULL
35	NULL
)	NULL
,	NULL
and	NULL
that	NULL
this	NULL
interaction	NULL
is	NULL
critical	NULL
for	NULL
octamer	NULL
function	NULL
.	NULL

In	NULL
these	NULL
reports	NULL
,	NULL
the	NULL
Oct-1/Oct-2	NULL
coactivator	NULL
was	NULL
reported	NULL
to	NULL
be	NULL
expressed	NULL
in	NULL
B	NULL
cells	NULL
and	NULL
not	NULL
T	NULL
cells	NULL
,	NULL
but	NULL
its	NULL
expression	NULL
in	NULL
myeloid	NULL
cells	NULL
was	NULL
not	NULL
extensively	NULL
studied	NULL
.	NULL

In	NULL
this	NULL
study	NULL
,	NULL
we	NULL
show	NULL
that	NULL
the	NULL
murine	NULL
PU.1	NULL
promoter	NULL
is	NULL
highly	NULL
functional	NULL
in	NULL
B	NULL
lymphocytes	NULL
and	NULL
that	NULL
an	NULL
octamer	NULL
site	NULL
at	NULL
bp	NULL
-55	NULL
of	NULL
the	NULL
PU	NULL
.	NULL

1	NULL
promoter	NULL
is	NULL
an	NULL
important	NULL
determinant	NULL
of	NULL
its	NULL
B	NULL
cell	NULL
specificity	NULL
and	NULL
activity	NULL
.	NULL

We	NULL
also	NULL
show	NULL
that	NULL
the	NULL
octamer	NULL
*	NULL
The	NULL
abbreviations	NULL
used	NULL
are	NULL
:	NULL
bp	NULL
,	NULL
base	NULL
pair	NULL
(	NULL
s	NULL
)	NULL
;	NULL
CMV	NULL
,	NULL
cytomegalovirus	NULL
;	NULL
hGH	NULL
,	NULL
human	NULL
growth	NULL
hormone	NULL
;	NULL
EMSA	NULL
,	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
;	NULL
PCR	NULL
,	NULL
polymerase	NULL
chain	NULL
reaction	NULL
.	NULL

15743	NULL
610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
15744	NULL
coactivator	NULL
is	NULL
not	NULL
expressed	NULL
in	NULL
myeloid	NULL
cells	NULL
,	NULL
suggesting	NULL
why	NULL
the	NULL
octamer	NULL
site	NULL
is	NULL
relatively	NULL
more	NULL
important	NULL
for	NULL
PU.1	NULL
expression	NULL
in	NULL
B	NULL
cells	NULL
than	NULL
in	NULL
myeloid	NULL
cells	NULL
,	NULL
in	NULL
which	NULL
the	NULL
PU.1	NULL
site	NULL
itself	NULL
is	NULL
most	NULL
important	NULL
.	NULL

Interaction	NULL
between	NULL
Oct-1/O0ct-2	NULL
and	NULL
their	NULL
coactivator	NULL
may	NULL
contribute	NULL
significantly	NULL
to	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
PU.1	NULL
promoter	NULL
in	NULL
B	NULL
cell	NULL
lines	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Cell	NULL
Culture-Human	NULL
promonocytic	NULL
U937	NULL
cells	NULL
(	NULL
American	NULL
Type	NULL
Culture	NULL
Collection	NULL
(	NULL
ATCC	NULL
)	NULL
no	NULL
.	NULL

CRL	NULL
1593	NULL
,	NULL
Rockville	NULL
,	NULL
MD	NULL
)	NULL
,	NULL
human	NULL
promye-locyte	NULL
HL-60	NULL
cells	NULL
(	NULL
ATCC	NULL
no	NULL
.	NULL

CCL	NULL
240	NULL
)	NULL
,	NULL
human	NULL
monocytic	NULL
THP-1	NULL
cells	NULL
(	NULL
ATCC	NULL
no	NULL
.	NULL

TIB	NULL
202	NULL
)	NULL
,	NULL
human	NULL
myeloblastic	NULL
KG-1a	NULL
cells	NULL
(	NULL
ATCC	NULL
no	NULL
.	NULL

CCL	NULL
246.1	NULL
)	NULL
,	NULL
human	NULL
T-lymphoblastic	NULL
Jurkat	NULL
cells	NULL
(	NULL
ATCC	NULL
no	NULL
.	NULL

TIB	NULL
152	NULL
)	NULL
,	NULL
human	NULL
T-lymphoblastic	NULL
RPMI-8402	NULL
cells	NULL
(	NULL
86	NULL
)	NULL
,	NULL
murine	NULL
myeloblastic	NULL
M1	NULL
cells	NULL
(	NULL
ATCC	NULL
no	NULL
.	NULL

TIB	NULL
192	NULL
)	NULL
,	NULL
human	NULL
B	NULL
cell	NULL
BJA-B	NULL
(	NULL
37	NULL
)	NULL
,	NULL
murine	NULL
B	NULL
cell	NULL
K46	NULL
(	NULL
38	NULL
)	NULL
,	NULL
and	NULL
murine	NULL
B-lymphoma	NULL
cell	NULL
line	NULL
A20	NULL
cells	NULL
(	NULL
ATCC	NULL
no	NULL
.	NULL

TIB	NULL
208	NULL
)	NULL
were	NULL
maintained	NULL
in	NULL
RPMI	NULL
1640	NULL
medium	NULL
(	NULL
Life	NULL
Technologies	NULL
,	NULL
Inc.	NULL
)	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
(	NULL
Hyclone	NULL
,	NULL
Logan	NULL
,	NULL
UT	NULL
)	NULL
and	NULL
2	NULL
mM	NULL
L-glutamine	NULL
.	NULL

Human	NULL
epithelial	NULL
HeLa	NULL
cells	NULL
(	NULL
ATCC	NULL
no	NULL
.	NULL

CCL	NULL
2	NULL
)	NULL
were	NULL
maintained	NULL
in	NULL
Dulbecco	NULL
's	NULL
modified	NULL
Eagle	NULL
's	NULL
medium	NULL
(	NULL
Life	NULL
Technologies	NULL
,	NULL
Inc.	NULL
)	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
newborn	NULL
calf	NULL
serum	NULL
and	NULL
2	NULL
mM	NULL
L-glutamine	NULL
.	NULL

The	NULL
murine	NULL
myeloma	NULL
line	NULL
Sp2/0-Ag14	NULL
(	NULL
ATCC	NULL
no	NULL
.	NULL

CRL	NULL
1581	NULL
)	NULL
was	NULL
maintained	NULL
in	NULL
Dulbecco	NULL
's	NULL
modified	NULL
Eagle	NULL
's	NULL
medium	NULL
supplemented	NULL
with	NULL
4.5	NULL
g/liter	NULL
glucose	NULL
and	NULL
10	NULL
%	NULL
FCS	NULL
.	NULL

The	NULL
human	NULL
monocytic	NULL
cell	NULL
line	NULL
Mono	NULL
Mac	NULL
6	NULL
and	NULL
murine	NULL
pro-B	NULL
cell	NULL
line	NULL
LyD9	NULL
were	NULL
maintained	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
89	NULL
,	NULL
40	NULL
)	NULL
.	NULL

Plasmid	NULL
Constructions-The	NULL
murine	NULL
0.5-kb	NULL
BamHI	NULL
fragment	NULL
containing	NULL
the	NULL
PU.1	NULL
promoter	NULL
region	NULL
from	NULL
bp	NULL
-334	NULL
to	NULL
+147	NULL
was	NULL
subcloned	NULL
into	NULL
the	NULL
promoterless	NULL
vector	NULL
pXP2	NULL
just	NULL
upstream	NULL
of	NULL
the	NULL
luciferase	NULL
reporter	NULL
gene	NULL
to	NULL
generate	NULL
mPU-334/luc	NULL
(	NULL
9	NULL
)	NULL
.	NULL

Unidirectional	NULL
deletions	NULL
of	NULL
mPU-334/lue	NULL
were	NULL
prepared	NULL
using	NULL
exonuclease	NULL
III	NULL
as	NULL
described	NULL
(	NULL
9	NULL
)	NULL
to	NULL
create	NULL
5	NULL
'	NULL
deletions	NULL
starting	NULL
bp	NULL
-197	NULL
,	NULL
-86	NULL
,	NULL
-61	NULL
,	NULL
-48	NULL
,	NULL
-39	NULL
,	NULL
-7	NULL
,	NULL
+34	NULL
,	NULL
and	NULL
+107	NULL
,	NULL
to	NULL
the	NULL
end	NULL
of	NULL
bp	NULL
+147	NULL
,	NULL
to	NULL
generate	NULL
mPU-197/lue	NULL
,	NULL
mPU-86/lue	NULL
,	NULL
mPU-61/lue	NULL
,	NULL
mPU-48/luc	NULL
,	NULL
mPU-39/lue	NULL
,	NULL
mPU-7/ue	NULL
,	NULL
mPU+34/lue	NULL
,	NULL
and	NULL
mPU+107/lue	NULL
plasmids	NULL
,	NULL
respectively	NULL
(	NULL
see	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

Site-directed	NULL
mutagenesis	NULL
(	NULL
41	NULL
,	NULL
42	NULL
)	NULL
was	NULL
employed	NULL
to	NULL
create	NULL
single	NULL
mutations	NULL
of	NULL
the	NULL
murine	NULL
PU.1	NULL
-334	NULL
promoter	NULL
at	NULL
the	NULL
bp	NULL
+20	NULL
PU.1	NULL
site	NULL
,	NULL
the	NULL
bp	NULL
-40	NULL
Sp1	NULL
site	NULL
and	NULL
the	NULL
bp	NULL
-55	NULL
octamer	NULL
site	NULL
,	NULL
or	NULL
double	NULL
mutations	NULL
for	NULL
octamer	NULL
and	NULL
Sp1	NULL
sites	NULL
to	NULL
generate	NULL
mPU-334	NULL
(	NULL
PU.1	NULL
mut	NULL
)	NULL
/lue	NULL
,	NULL
mPU-334	NULL
(	NULL
Spl	NULL
mut	NULL
)	NULL
/lue	NULL
,	NULL
mPU-334	NULL
(	NULL
Oct	NULL
mut	NULL
)	NULL
/lue	NULL
,	NULL
and	NULL
mPU-834	NULL
(	NULL
Oct	NULL
and	NULL
Sp1	NULL
mut	NULL
)	NULL
constructs	NULL
.	NULL

The	NULL
oligonucleotides	NULL
used	NULL
to	NULL
generate	NULL
the	NULL
mutations	NULL
mentioned	NULL
above	NULL
are	NULL
(	NULL
wild	NULL
type	NULL
sequences	NULL
in	NULL
capitals	NULL
and	NULL
mutations	NULL
in	NULL
small	NULL
letters	NULL
)	NULL
:	NULL
PU.1	NULL
site	NULL
mutation	NULL
,	NULL
5'-CAaagetTTGTGCTGGCCCTGC-3	NULL
'	NULL
,	NULL
bp	NULL
+15	NULL
to	NULL
+86	NULL
;	NULL
Sp1	NULL
site	NULL
mutation	NULL
,	NULL
5'-CTGaGeteaTGATGTCACCCC-3	NULL
'	NULL
,	NULL
bp	NULL
-46	NULL
to	NULL
-26	NULL
;	NULL
octamer	NULL
site	NULL
mutation	NULL
,	NULL
5'-TTAgageteCGGGCTGG-GGCGG-3	NULL
'	NULL
,	NULL
bp	NULL
-59	NULL
to	NULL
-38	NULL
;	NULL
octamer	NULL
and	NULL
Sp1	NULL
site	NULL
mutation	NULL
,	NULL
5-TTA-gagetcCGGGCTGaGetcaTGATGTCACCCC-3	NULL
'	NULL
,	NULL
bp	NULL
-59	NULL
to	NULL
-26	NULL
.	NULL

Transient	NULL
Transfections-Electroporation	NULL
was	NULL
performed	NULL
at	NULL
960	NULL
uF	NULL
and	NULL
230	NULL
V	NULL
for	NULL
both	NULL
BJA-B	NULL
and	NULL
Hela	NULL
cells	NULL
,	NULL
and	NULL
at	NULL
300	NULL
V	NULL
for	NULL
U937	NULL
cells	NULL
.	NULL

Luciferase	NULL
assays	NULL
were	NULL
performed	NULL
following	NULL
transient	NULL
transfection	NULL
of	NULL
20	NULL
ug	NULL
of	NULL
the	NULL
promoter-luciferase	NULL
constructs	NULL
by	NULL
electroporation	NULL
as	NULL
described	NULL
elsewhere	NULL
(	NULL
43	NULL
)	NULL
.	NULL

Transfection	NULL
efficiency	NULL
was	NULL
normalized	NULL
by	NULL
cotransfecting	NULL
1	NULL
ug	NULL
of	NULL
a	NULL
plasmid	NULL
containing	NULL
the	NULL
CMV	NULL
promoter	NULL
driving	NULL
human	NULL
growth	NULL
hormone	NULL
(	NULL
CMV-hGH	NULL
)	NULL
,	NULL
and	NULL
measuring	NULL
growth	NULL
hormone	NULL
levels	NULL
in	NULL
the	NULL
supernatant	NULL
.	NULL

Cells	NULL
were	NULL
harvested	NULL
at	NULL
5	NULL
h.	NULL
Data	NULL
represent	NULL
the	NULL
mean	NULL
and	NULL
the	NULL
standard	NULL
error	NULL
of	NULL
the	NULL
mean	NULL
for	NULL
three	NULL
to	NULL
four	NULL
independent	NULL
experiments	NULL
,	NULL
and	NULL
all	NULL
transfections	NULL
were	NULL
performed	NULL
with	NULL
at	NULL
least	NULL
three	NULL
independent	NULL
DNA	NULL
preparations	NULL
for	NULL
each	NULL
construct	NULL
.	NULL

For	NULL
cotransfection	NULL
experiments	NULL
,	NULL
10	NULL
ug	NULL
of	NULL
PU.1	NULL
promoter	NULL
constructs	NULL
and	NULL
2	NULL
pg	NULL
of	NULL
either	NULL
the	NULL
Oct-1	NULL
(	NULL
pCGOct-1	NULL
)	NULL
or	NULL
Oct-2	NULL
(	NULL
pCGOct-2	NULL
)	NULL
expression	NULL
vectors	NULL
(	NULL
in	NULL
which	NULL
the	NULL
octamer	NULL
cDNAs	NULL
are	NULL
expressed	NULL
by	NULL
a	NULL
CMV	NULL
promoter	NULL
)	NULL
(	NULL
44	NULL
)	NULL
were	NULL
transfected	NULL
with	NULL
or	NULL
without	NULL
2	NULL
ug	NULL
of	NULL
the	NULL
Bob1	NULL
(	NULL
octamer	NULL
coactivator	NULL
expression	NULL
vector	NULL
pCATH	NULL
NLS-BOB1	NULL
,	NULL
in	NULL
which	NULL
the	NULL
Bobl	NULL
cDNA	NULL
is	NULL
expressed	NULL
by	NULL
a	NULL
CMV	NULL
promoter	NULL
)	NULL
(	NULL
33	NULL
)	NULL
into	NULL
Hela	NULL
cells	NULL
using	NULL
the	NULL
Ca	NULL
,	NULL
(	NULL
PO	NULL
,	NULL
)	NULL
,	NULL
coprecipitation	NULL
method	NULL
(	NULL
42	NULL
)	NULL
,	NULL
or	NULL
into	NULL
U937	NULL
cells	NULL
by	NULL
electroporation	NULL
(	NULL
48	NULL
)	NULL
.	NULL

Luciferase	NULL
assays	NULL
were	NULL
performed	NULL
48	NULL
h	NULL
after	NULL
transfection	NULL
for	NULL
HeLa	NULL
and	NULL
24	NULL
h	NULL
for	NULL
U937	NULL
cells	NULL
.	NULL

Transfection	NULL
efficiency	NULL
was	NULL
normalized	NULL
by	NULL
cotransfecting	NULL
0.2	NULL
pg	NULL
of	NULL
a	NULL
plasmid	NULL
containing	NULL
the	NULL
CMV-hGH	NULL
,	NULL
and	NULL
measuring	NULL
growth	NULL
hormone	NULL
levels	NULL
in	NULL
the	NULL
supernatant	NULL
.	NULL

Data	NULL
represent	NULL
the	NULL
mean	NULL
and	NULL
the	NULL
standard	NULL
error	NULL
of	NULL
the	NULL
mean	NULL
for	NULL
three	NULL
independent	NULL
experiments	NULL
,	NULL
and	NULL
all	NULL
transfections	NULL
were	NULL
performed	NULL
with	NULL
three	NULL
independent	NULL
DNA	NULL
preparations	NULL
for	NULL
each	NULL
construct	NULL
.	NULL

In	NULL
Vivo	NULL
Footprinting-1	NULL
X	NULL
10°	NULL
BJA-B	NULL
,	NULL
Hela	NULL
,	NULL
or	NULL
U937	NULL
cells	NULL
were	NULL
pelleted	NULL
by	NULL
centrifugation	NULL
at	NULL
500	NULL
x	NULL
g	NULL
for	NULL
5	NULL
min	NULL
and	NULL
resuspended	NULL
in	NULL
2	NULL
ml	NULL
of	NULL
RPMI	NULL
medium	NULL
.	NULL

Cells	NULL
were	NULL
exposed	NULL
to	NULL
0.5	NULL
%	NULL
(	NULL
v/v	NULL
)	NULL
dimethyl	NULL
sulfide	NULL
(	NULL
Sigma	NULL
)	NULL
for	NULL
2	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
and	NULL
DNA	NULL
extracted	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
9	NULL
,	NULL
42	NULL
,	NULL
45	NULL
)	NULL
.	NULL

In	NULL
vivo	NULL
footprinting	NULL
bands	NULL
were	NULL
visualized	NULL
using	NULL
PU.1	NULL
Regulation	NULL
by	NULL
Octamer	NULL
Factors	NULL
and	NULL
Coactivators	NULL
the	NULL
ligation-mediated-PCR	NULL
procedure	NULL
(	NULL
42	NULL
,	NULL
46	NULL
)	NULL
.	NULL

The	NULL
universal	NULL
linker	NULL
used	NULL
in	NULL
this	NULL
amplification	NULL
method	NULL
is	NULL
composed	NULL
of	NULL
two	NULL
oligonucleotides	NULL
,	NULL
linker	NULL
oligo	NULL
1	NULL
(	NULL
GAATTCAGATC	NULL
)	NULL
and	NULL
linker	NULL
oligo	NULL
2	NULL
(	NULL
GCGGTGACCCGG-GAGATCTGAATTC	NULL
)	NULL
.	NULL

The	NULL
specific	NULL
oligonucleotides	NULL
from	NULL
the	NULL
murine	NULL
PU.1	NULL
promoter	NULL
coding	NULL
strand	NULL
were	NULL
as	NULL
follows	NULL
:	NULL
oligo	NULL
1	NULL
,	NULL
used	NULL
for	NULL
first	NULL
strand	NULL
transcription	NULL
,	NULL
bp	NULL
-228	NULL
to	NULL
-206	NULL
of	NULL
the	NULL
human	NULL
PU.1	NULL
promoter	NULL
:	NULL
AGCTACACGTTCTCCCTCCCATC	NULL
;	NULL
oligo	NULL
2	NULL
,	NULL
used	NULL
for	NULL
PCR	NULL
amplifica-tion	NULL
,	NULL
bp	NULL
-189	NULL
to	NULL
bp	NULL
-167	NULL
TAGCCCCCAAAGTCATCCCTCTCAG	NULL
;	NULL
and	NULL
oligo	NULL
3	NULL
,	NULL
kinased	NULL
with	NULL
[	NULL
y-°°PJATP	NULL
and	NULL
used	NULL
in	NULL
primer	NULL
extension	NULL
for	NULL
visualization	NULL
of	NULL
PCR	NULL
products	NULL
,	NULL
bp	NULL
-187	NULL
to	NULL
bp	NULL
-160	NULL
:	NULL
CCCCAAAGT-CATCCCTCTCAGTCCCAGC	NULL
.	NULL

With	NULL
this	NULL
primer	NULL
set	NULL
,	NULL
we	NULL
analyzed	NULL
bp	NULL
-120	NULL
to	NULL
+102	NULL
of	NULL
the	NULL
noncoding	NULL
strand	NULL
.	NULL

Electrophoretic	NULL
Mobility	NULL
Shift	NULL
Assay	NULL
(	NULL
EMSA	NULL
)	NULL
-Oct-1/COS	NULL
and	NULL
Oct-2/	NULL
COS	NULL
nuclear	NULL
extracts	NULL
were	NULL
made	NULL
by	NULL
transiently	NULL
transfecting	NULL
COS	NULL
cells	NULL
separately	NULL
with	NULL
either	NULL
Oct-1	NULL
(	NULL
pCGOct-1	NULL
)	NULL
or	NULL
Oct-2	NULL
(	NULL
pCGOct-2	NULL
)	NULL
expression	NULL
vectors	NULL
(	NULL
44	NULL
)	NULL
.	NULL

The	NULL
cell	NULL
lines	NULL
were	NULL
grown	NULL
to	NULL
log	NULL
phase	NULL
and	NULL
harvested	NULL
for	NULL
nuclear	NULL
protein	NULL
extraction	NULL
.	NULL

Nuclear	NULL
extracts	NULL
for	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assays	NULL
were	NULL
prepared	NULL
from	NULL
cell	NULL
lines	NULL
and	NULL
transfected	NULL
Cos	NULL
cells	NULL
by	NULL
the	NULL
method	NULL
of	NULL
Dignam	NULL
et	NULL
al	NULL
.	NULL

(	NULL
47	NULL
)	NULL
with	NULL
1	NULL
mm	NULL
diisopropyl	NULL
fluorophosphate	NULL
in	NULL
all	NULL
three	NULL
extraction	NULL
buffers	NULL
(	NULL
48	NULL
,	NULL
49	NULL
)	NULL
.	NULL

For	NULL
production	NULL
of	NULL
in	NULL
vitro	NULL
translated	NULL
PU.1	NULL
protein	NULL
,	NULL
1	NULL
ug	NULL
of	NULL
PU	NULL
.	NULL

1	NULL
cDNA	NULL
was	NULL
transcribed	NULL
and	NULL
translated	NULL
using	NULL
the	NULL
TNT	NULL
``	NULL
T	NULL
;	NULL
coupled	NULL
reticulocyte	NULL
lysate	NULL
system	NULL
(	NULL
Promega	NULL
)	NULL
.	NULL

Probes	NULL
were	NULL
labeled	NULL
with	NULL
[	NULL
y-*	NULL
``	NULL
P	NULL
]	NULL
JATP	NULL
to	NULL
a	NULL
specific	NULL
activity	NULL
of	NULL
2	NULL
x	NULL
10°	NULL
cpm/ug	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
42	NULL
)	NULL
.	NULL

0.5	NULL
ng	NULL
of	NULL
probe	NULL
was	NULL
incubated	NULL
with	NULL
2-5	NULL
ug	NULL
of	NULL
nuclear	NULL
extract	NULL
in	NULL
20	NULL
pl	NULL
containing	NULL
a	NULL
final	NULL
concentration	NULL
of	NULL
10	NULL
mm	NULL
HEPES	NULL
,	NULL
pH	NULL
7.5	NULL
,	NULL
50	NULL
mm	NULL
KCl	NULL
,	NULL
5	NULL
mm	NULL
MgCl	NULL
,	NULL
,	NULL
1	NULL
mm	NULL
EDTA	NULL
,	NULL
1	NULL
mM	NULL
dithiothreitol	NULL
,	NULL
0.1	NULL
mg/ml	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
,	NULL
0.1	NULL
mg/ml	NULL
bovine	NULL
serum	NULL
albumin	NULL
,	NULL
and	NULL
5	NULL
%	NULL
glycerol	NULL
on	NULL
ice	NULL
for	NULL
15	NULL
min	NULL
.	NULL

For	NULL
competition	NULL
experiments	NULL
,	NULL
unlabeled	NULL
competitor	NULL
oligonucleotides	NULL
were	NULL
added	NULL
to	NULL
the	NULL
reaction	NULL
at	NULL
50-100-fold	NULL
molar	NULL
excess	NULL
immediately	NULL
prior	NULL
to	NULL
the	NULL
addition	NULL
of	NULL
the	NULL
radioactive	NULL
probe	NULL
.	NULL

For	NULL
supershift	NULL
experiments	NULL
,	NULL
1	NULL
pl	NULL
of	NULL
antisera	NULL
raised	NULL
against	NULL
a	NULL
peptide	NULL
representing	NULL
amino	NULL
acid	NULL
444-463	NULL
of	NULL
human	NULL
Oct-2	NULL
(	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
,	NULL
Santa	NULL
Cruz	NULL
,	NULL
CA	NULL
)	NULL
,	NULL
or	NULL
against	NULL
a	NULL
peptide	NULL
representing	NULL
amino	NULL
acids	NULL
7283-743	NULL
of	NULL
human	NULL
Oct-1	NULL
(	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
)	NULL
,	NULL
or	NULL
against	NULL
amino	NULL
acids	NULL
33-45	NULL
of	NULL
the	NULL
murine	NULL
PU.1	NULL
protein	NULL
(	NULL
gift	NULL
of	NULL
Richard	NULL
Maki	NULL
)	NULL
(	NULL
12	NULL
,	NULL
50	NULL
)	NULL
was	NULL
added	NULL
to	NULL
the	NULL
reaction	NULL
.	NULL

Binding	NULL
reactions	NULL
were	NULL
elec-trophoresed	NULL
at	NULL
10	NULL
V/em	NULL
on	NULL
a	NULL
6	NULL
%	NULL
polyacrylamide	NULL
gel	NULL
in	NULL
0.5	NULL
x	NULL
TBE	NULL
(	NULL
45	NULL
mm	NULL
Tris	NULL
borate	NULL
,	NULL
45	NULL
mM	NULL
borie	NULL
acid	NULL
,	NULL
1	NULL
mM	NULL
EDTA	NULL
)	NULL
at	NULL
4	NULL
°C	NULL
.	NULL

In	NULL
the	NULL
EMSA	NULL
shown	NULL
in	NULL
Figs	NULL
.	NULL

2C	NULL
and	NULL
6A	NULL
,	NULL
nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
as	NULL
described	NULL
elsewhere	NULL
(	NULL
47	NULL
)	NULL
with	NULL
some	NULL
modifications	NULL
.	NULL

Briefly	NULL
,	NULL
cells	NULL
were	NULL
washed	NULL
once	NULL
in	NULL
1	NULL
X	NULL
phosphate-buffered	NULL
saline	NULL
,	NULL
pelleted	NULL
,	NULL
and	NULL
allowed	NULL
to	NULL
swell	NULL
on	NULL
ice	NULL
for	NULL
15	NULL
min	NULL
in	NULL
an	NULL
equal	NULL
volume	NULL
of	NULL
10	NULL
mM	NULL
Hepes	NULL
(	NULL
pH	NULL
7.9	NULL
)	NULL
,	NULL
10	NULL
mm	NULL
KCI	NULL
,	NULL
1.5	NULL
mm	NULL
MgCl	NULL
,	NULL
,	NULL
0.5	NULL
mm	NULL
dithiothreitol	NULL
,	NULL
and	NULL
0.5	NULL
mM	NULL
phenyImethylsulfonyl	NULL
fluoride	NULL
.	NULL

Cell	NULL
membranes	NULL
were	NULL
disrupted	NULL
by	NULL
pushing	NULL
the	NULL
cell	NULL
suspension	NULL
5-10	NULL
times	NULL
through	NULL
a	NULL
25-gauge	NULL
needle	NULL
attached	NULL
to	NULL
a	NULL
1-ml	NULL
syringe	NULL
.	NULL

Nuclei	NULL
were	NULL
pelleted	NULL
at	NULL
top	NULL
speed	NULL
(	NULL
12,000	NULL
rpm	NULL
)	NULL
in	NULL
a	NULL
microcentrifuge	NULL
for	NULL
20	NULL
s	NULL
and	NULL
resuspended	NULL
in	NULL
0.67	NULL
volume	NULL
of	NULL
20	NULL
mM	NULL
Hepes	NULL
(	NULL
pH	NULL
7.9	NULL
)	NULL
,	NULL
25	NULL
%	NULL
glycerol	NULL
,	NULL
420	NULL
mM	NULL
NaCl	NULL
,	NULL
1.5	NULL
mm	NULL
MgCl	NULL
,	NULL
,	NULL
0.2	NULL
mm	NULL
EDTA	NULL
,	NULL
0.5	NULL
mM	NULL
dithiothreitol	NULL
,	NULL
and	NULL
0.5	NULL
mM	NULL
phenylmethylsulfonyl	NULL
fluoride	NULL
.	NULL

After	NULL
a	NULL
30-min	NULL
incubation	NULL
at	NULL
4	NULL
°C	NULL
,	NULL
the	NULL
extracts	NULL
were	NULL
centrifuged	NULL
5	NULL
min	NULL
in	NULL
a	NULL
microcentrifuge	NULL
at	NULL
12,000	NULL
x	NULL
g	NULL
,	NULL
and	NULL
the	NULL
supernatant	NULL
was	NULL
frozen	NULL
in	NULL
liquid	NULL
nitrogen	NULL
.	NULL

Binding	NULL
reactions	NULL
and	NULL
gel	NULL
retardation	NULL
assays	NULL
were	NULL
performed	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
51	NULL
)	NULL
.	NULL

Nuclear	NULL
extracts	NULL
(	NULL
10	NULL
pg	NULL
of	NULL
protein	NULL
)	NULL
were	NULL
incubated	NULL
for	NULL
20	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
with	NULL
10	NULL
``	NULL
dpm	NULL
of	NULL
a	NULL
51-bp	NULL
fragment	NULL
:	NULL
TCAGCAAAACACCACCTGGGTAATTTGCATT-TCTAAAATAAGTTGAGGATT	NULL
(	NULL
uE4	NULL
and	NULL
octamer	NULL
sites	NULL
underlined	NULL
,	NULL
re-spectively	NULL
)	NULL
.	NULL

The	NULL
fragment	NULL
was	NULL
end	NULL
labeled	NULL
with	NULL
[	NULL
°	NULL
``	NULL
P	NULL
]	NULL
dATP	NULL
and	NULL
Klenow	NULL
polymerase	NULL
.	NULL

The	NULL
binding	NULL
mixture	NULL
also	NULL
contained	NULL
2	NULL
pg	NULL
of	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
,	NULL
10	NULL
mM	NULL
Tris-HCl	NULL
(	NULL
pH	NULL
7.5	NULL
)	NULL
,	NULL
50	NULL
mm	NULL
NaCl	NULL
,	NULL
1	NULL
mM	NULL
dithiothreitol	NULL
,	NULL
1	NULL
mM	NULL
EDTA	NULL
,	NULL
and	NULL
5	NULL
%	NULL
glycerol	NULL
in	NULL
a	NULL
total	NULL
volume	NULL
of	NULL
25	NULL
pl	NULL
.	NULL

Unbound	NULL
fragment	NULL
and	NULL
protein-bound	NULL
fragments	NULL
were	NULL
separated	NULL
from	NULL
one	NULL
another	NULL
by	NULL
electrophoresis	NULL
through	NULL
4	NULL
%	NULL
polyacrylamide	NULL
gels	NULL
in	NULL
Tris/glycine	NULL
buffer	NULL
(	NULL
50	NULL
mM	NULL
Tris	NULL
base	NULL
,	NULL
380	NULL
mM	NULL
glycine	NULL
,	NULL
2	NULL
mM	NULL
EDTA	NULL
)	NULL
.	NULL

Transactivation	NULL
of	NULL
the	NULL
PU.1	NULL
Promoter	NULL
in	NULL
Drosophila	NULL
Schneider	NULL
Cells-The	NULL
Drosophila	NULL
Schneider	NULL
cell	NULL
line	NULL
S2	NULL
was	NULL
grown	NULL
in	NULL
Schneider	NULL
medium	NULL
(	NULL
Sigma	NULL
)	NULL
supplemented	NULL
with	NULL
penicillin	NULL
,	NULL
streptomycin	NULL
,	NULL
and	NULL
10	NULL
%	NULL
heat-inactivated	NULL
fetal	NULL
calf	NULL
serum	NULL
(	NULL
Sigma	NULL
)	NULL
.	NULL

For	NULL
transactivation	NULL
assays	NULL
,	NULL
S2	NULL
cells	NULL
were	NULL
transfected	NULL
using	NULL
calcium	NULL
phosphate	NULL
coprecipitation	NULL
as	NULL
described	NULL
elsewhere	NULL
(	NULL
42	NULL
)	NULL
with	NULL
10	NULL
ug	NULL
of	NULL
reporter	NULL
vector	NULL
(	NULL
either	NULL
the	NULL
wild	NULL
type	NULL
-8334	NULL
PU.1	NULL
promoter	NULL
or	NULL
the	NULL
promoter	NULL
containing	NULL
mutations	NULL
in	NULL
the	NULL
Sp1	NULL
site	NULL
or	NULL
in	NULL
the	NULL
octamer	NULL
site	NULL
as	NULL
described	NULL
above	NULL
)	NULL
;	NULL
1	NULL
ug	NULL
of	NULL
the	NULL
Spl	NULL
expression	NULL
vector	NULL
pPacSp1	NULL
,	NULL
containing	NULL
the	NULL
C-terminal	NULL
696	NULL
amino	NULL
acids	NULL
of	NULL
Spl	NULL
in	NULL
a	NULL
Drosophila	NULL
actin	NULL
promoter	NULL
expression	NULL
construct	NULL
(	NULL
52	NULL
)	NULL
;	NULL
or	NULL
1	NULL
ug	NULL
of	NULL
pUC18	NULL
.	NULL

Luciferase	NULL
assay	NULL
were	NULL
performed	NULL
48	NULL
h	NULL
after	NULL
transfection	NULL
as	NULL
described	NULL
elsewhere	NULL
(	NULL
43	NULL
)	NULL
.	NULL

RNA	NULL
Preparations	NULL
and	NULL
Northern	NULL
Blot	NULL
Analysis-Total	NULL
cellular	NULL
RNA	NULL
was	NULL
isolated	NULL
by	NULL
guanidium	NULL
isothiocyanate	NULL
extraction	NULL
followed	NULL
by	NULL
cesium	NULL
chloride	NULL
gradient	NULL
purification	NULL
(	NULL
53	NULL
)	NULL
.	NULL

RNA	NULL
(	NULL
10	NULL
ug/lane	NULL
)	NULL
was	NULL
denatured	NULL
in	NULL
610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
PU.1	NULL
Regulation	NULL
by	NULL
Octamer	NULL
Factors	NULL
and	NULL
Coactivators	NULL
Octamer	NULL
Spl	NULL
-30v	NULL
-20v	NULL
o	NULL
Gocev2	NULL
sor	NULL
-334	NULL
a	NULL
Luc	NULL
.	NULL

197	NULL
-86	NULL
-61	NULL
48	NULL
-39	NULL
7	NULL
(	NULL
Q-mz3	NULL
mpu-1	NULL
+34	NULL
mPU+34	NULL
+107	NULL
-ESSAmPU+107	NULL
pXP2	NULL
pXP2	NULL
15745	NULL
PU.1	NULL
-10v	NULL
Hr	NULL
,	NULL
+10v	NULL
ATGTCACCCCAAGGGGACTATCTCCCAGTGGCAGGCCCTTCGATAAAAT	NULL
CTACTGTGGGGTTCCCCTGATAGAGGGTCACCGTCCGGCAAGCTATTTTA	NULL
$	NULL
o	NULL
o	NULL
o	NULL
®	NULL
®	NULL
_®	NULL
RLU/mng	NULL
CY	NULL
¥	NULL
5	NULL
K	NULL
``	NULL
nGH/m	NULL
H	NULL
sJjA-cs	NULL
U937	NULL
[	NULL
]	NULL
HeLa	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

A	NULL
,	NULL
murine	NULL
PU.1	NULL
promoter	NULL
sequence	NULL
,	NULL
showing	NULL
the	NULL
location	NULL
of	NULL
the	NULL
functional	NULL
octamer	NULL
,	NULL
Sp1	NULL
,	NULL
and	NULL
PU.1	NULL
binding	NULL
sites	NULL
.	NULL

The	NULL
murine	NULL
PU.1	NULL
promoter	NULL
sequence	NULL
from	NULL
bp	NULL
-63	NULL
to	NULL
+37	NULL
is	NULL
shown	NULL
.	NULL

A	NULL
horizontal	NULL
arrow	NULL
shows	NULL
the	NULL
location	NULL
of	NULL
the	NULL
murine	NULL
transcriptional	NULL
start	NULL
site	NULL
labeled	NULL
+1	NULL
,	NULL
defined	NULL
by	NULL
primer	NULL
extension	NULL
,	NULL
S1	NULL
,	NULL
and	NULL
RNase	NULL
protection	NULL
analyses	NULL
(	NULL
9	NULL
)	NULL
.	NULL

The	NULL
ATG	NULL
translation	NULL
start	NULL
site	NULL
is	NULL
located	NULL
at	NULL
bp	NULL
+208	NULL
of	NULL
the	NULL
first	NULL
exon	NULL
.	NULL

Also	NULL
shown	NULL
are	NULL
the	NULL
octamer	NULL
,	NULL
Sp1	NULL
,	NULL
and	NULL
PU.1	NULL
binding	NULL
sites	NULL
.	NULL

B	NULL
,	NULL
deletion	NULL
analysis	NULL
of	NULL
the	NULL
murine	NULL
PU.1	NULL
promoter	NULL
in	NULL
BJA-B	NULL
and	NULL
HeLa	NULL
cell	NULL
lines	NULL
.	NULL

Left	NULL
,	NULL
schematic	NULL
representation	NULL
of	NULL
the	NULL
deletion	NULL
series	NULL
of	NULL
the	NULL
murine	NULL
PU.1	NULL
promoter-luciferase	NULL
constructs	NULL
.	NULL

Right	NULL
,	NULL
the	NULL
activity	NULL
observed	NULL
when	NULL
20	NULL
ug	NULL
of	NULL
these	NULL
constructs	NULL
as	NULL
well	NULL
as	NULL
the	NULL
promoterless	NULL
pXP2	NULL
vector	NULL
alone	NULL
were	NULL
transfected	NULL
into	NULL
the	NULL
BJA-B	NULL
B	NULL
cell	NULL
line	NULL
(	NULL
black	NULL
bars	NULL
)	NULL
and	NULL
the	NULL
HeLa	NULL
epithelial	NULL
cell	NULL
line	NULL
(	NULL
white	NULL
bars	NULL
)	NULL
.	NULL

Transfection	NULL
efficiency	NULL
was	NULL
corrected	NULL
by	NULL
cotransfecting	NULL
1	NULL
ug	NULL
of	NULL
CMV-hGH	NULL
.	NULL

Data	NULL
represent	NULL
the	NULL
mean	NULL
and	NULL
the	NULL
standard	NULL
error	NULL
of	NULL
the	NULL
mean	NULL
for	NULL
three	NULL
to	NULL
four	NULL
independent	NULL
experiments	NULL
.	NULL

For	NULL
comparison	NULL
,	NULL
we	NULL
have	NULL
also	NULL
shown	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
-334	NULL
promoter	NULL
in	NULL
the	NULL
myeloid	NULL
U937	NULL
cell	NULL
line	NULL
(	NULL
Rkatched	NULL
bar	NULL
)	NULL
.	NULL

formamide/formaldehyde	NULL
followed	NULL
by	NULL
electrophoresis	NULL
in	NULL
1	NULL
%	NULL
agarose/	NULL
formaldehyde	NULL
gels	NULL
.	NULL

RNA	NULL
was	NULL
then	NULL
transferred	NULL
to	NULL
Biotrans	NULL
nylon	NULL
membrane	NULL
(	NULL
ICN	NULL
,	NULL
Irvine	NULL
,	NULL
CA	NULL
)	NULL
,	NULL
and	NULL
hybridized	NULL
to	NULL
a	NULL
human	NULL
Bobl	NULL
probe	NULL
(	NULL
cor-responding	NULL
to	NULL
bp	NULL
49-866	NULL
of	NULL
the	NULL
human	NULL
Bobl	NULL
cDNA	NULL
)	NULL
(	NULL
83	NULL
)	NULL
and	NULL
a	NULL
18	NULL
S	NULL
oligonucleotide	NULL
probe	NULL
(	NULL
bp	NULL
938	NULL
to	NULL
921	NULL
of	NULL
the	NULL
human	NULL
18	NULL
S	NULL
ribosomal	NULL
RNA	NULL
gene	NULL
(	NULL
54	NULL
)	NULL
,	NULL
5-TCGGGCCTGCTTTGAACA-3	NULL
'	NULL
)	NULL
.	NULL

The	NULL
Bobl	NULL
probe	NULL
was	NULL
labeled	NULL
by	NULL
the	NULL
random	NULL
priming	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
55	NULL
)	NULL
.	NULL

Hybridization	NULL
was	NULL
performed	NULL
at	NULL
65	NULL
°C	NULL
in	NULL
0.5	NULL
M	NULL
sodium	NULL
phosphate	NULL
buffer	NULL
(	NULL
pH	NULL
7.2	NULL
)	NULL
,	NULL
7	NULL
%	NULL
SDS	NULL
,	NULL
and	NULL
1	NULL
%	NULL
BSA	NULL
for	NULL
15	NULL
h.	NULL
Membranes	NULL
were	NULL
washed	NULL
twice	NULL
in	NULL
2	NULL
X	NULL
SSC	NULL
and	NULL
0.2	NULL
%	NULL
SDS	NULL
at	NULL
room	NULL
temperature	NULL
for	NULL
5	NULL
min	NULL
and	NULL
once	NULL
in	NULL
0.2	NULL
%	NULL
SSC	NULL
and	NULL
0.2	NULL
%	NULL
SDS	NULL
at	NULL
65	NULL
°C	NULL
for	NULL
20	NULL
min	NULL
.	NULL

Autoradiography	NULL
was	NULL
performed	NULL
at	NULL
-80	NULL
°C	NULL
with	NULL
Kodak	NULL
XAR-5	NULL
film	NULL
using	NULL
an	NULL
intensifying	NULL
screen	NULL
for	NULL
4	NULL
days	NULL
.	NULL

Subsequently	NULL
,	NULL
the	NULL
Bob1	NULL
probe	NULL
was	NULL
removed	NULL
by	NULL
shaking	NULL
in	NULL
10	NULL
mM	NULL
sodium	NULL
phosphate	NULL
buffer	NULL
(	NULL
pH	NULL
6.5	NULL
)	NULL
and	NULL
50	NULL
%	NULL
deionized	NULL
formamide	NULL
for	NULL
1	NULL
h	NULL
at	NULL
65	NULL
°C	NULL
,	NULL
followed	NULL
by	NULL
washing	NULL
in	NULL
2	NULL
X	NULL
SSC	NULL
and	NULL
0.1	NULL
%	NULL
SDS	NULL
for	NULL
15	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
.	NULL

The	NULL
blot	NULL
was	NULL
then	NULL
hybridized	NULL
to	NULL
the	NULL
[	NULL
«	NULL
-	NULL
``	NULL
``	NULL
P	NULL
]	NULL
4CTP	NULL
3'-end-labeled	NULL
(	NULL
56	NULL
)	NULL
18	NULL
S	NULL
oligonucleotide	NULL
overnight	NULL
in	NULL
6	NULL
x	NULL
SSC	NULL
,	NULL
5	NULL
x	NULL
Denhardt	NULL
's	NULL
solution	NULL
and	NULL
0.5	NULL
%	NULL
SDS	NULL
at	NULL
48	NULL
°C	NULL
,	NULL
washed	NULL
twice	NULL
in	NULL
2	NULL
x	NULL
SSC	NULL
and	NULL
0.2	NULL
%	NULL
SDS	NULL
at	NULL
room	NULL
temperature	NULL
for	NULL
5	NULL
min	NULL
,	NULL
and	NULL
once	NULL
in	NULL
0.2	NULL
x	NULL
SSC	NULL
and	NULL
0.2	NULL
%	NULL
SDS	NULL
at	NULL
48	NULL
°C	NULL
for	NULL
30	NULL
min	NULL
.	NULL

Autoradiography	NULL
was	NULL
performed	NULL
at	NULL
room	NULL
temperature	NULL
for	NULL
3	NULL
min	NULL
.	NULL

RESULTS	NULL
The	NULL
Murine	NULL
PU.1	NULL
-334-bp	NULL
Promoter	NULL
Is	NULL
Functional	NULL
in	NULL
B	NULL
Cell	NULL
Lines	NULL
,	NULL
and	NULL
an	NULL
Octamer	NULL
Site	NULL
at	NULL
bp	NULL
-55	NULL
Contributes	NULL
to	NULL
This	NULL
Tissue	NULL
Specificity-Our	NULL
previous	NULL
studies	NULL
have	NULL
shown	NULL
that	NULL
the	NULL
murine	NULL
334-bp	NULL
PU.1	NULL
promoter	NULL
,	NULL
as	NULL
well	NULL
as	NULL
the	NULL
human	NULL
290-bp	NULL
promoter	NULL
,	NULL
demonstrate	NULL
tissue-specific	NULL
reporter	NULL
gene	NULL
expression	NULL
in	NULL
myeloid	NULL
cell	NULL
lines	NULL
but	NULL
not	NULL
in	NULL
T	NULL
cells	NULL
and	NULL
Hela	NULL
(	NULL
nonhemato-poietic	NULL
)	NULL
cells	NULL
(	NULL
9	NULL
)	NULL
.	NULL

To	NULL
determine	NULL
if	NULL
this	NULL
region	NULL
of	NULL
the	NULL
PU.1	NULL
promoter	NULL
was	NULL
functional	NULL
in	NULL
B	NULL
cells	NULL
,	NULL
which	NULL
also	NULL
express	NULL
high	NULL
levels	NULL
of	NULL
PU.1	NULL
(	NULL
8	NULL
,	NULL
50	NULL
)	NULL
,	NULL
the	NULL
-334	NULL
PU.1	NULL
promoter/luciferase	NULL
construct	NULL
was	NULL
transfected	NULL
into	NULL
the	NULL
B	NULL
cell	NULL
line	NULL
BJA-B	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

1B	NULL
,	NULL
the	NULL
murine	NULL
PU.1I	NULL
-334-bp	NULL
promoter	NULL
luciferase	NULL
construct	NULL
(	NULL
mPU.1-334/luc	NULL
)	NULL
is	NULL
highly	NULL
active	NULL
in	NULL
BJA-B	NULL
ells	NULL
,	NULL
with	NULL
luciferase	NULL
activities	NULL
47-fold	NULL
higher	NULL
than	NULL
in	NULL
Hela	NULL
cells	NULL
.	NULL

The	NULL
activity	NULL
in	NULL
BJA-B	NULL
is	NULL
5-fold	NULL
higher	NULL
than	NULL
that	NULL
in	NULL
the	NULL
myeloid	NULL
cell	NULL
line	NULL
U937	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
.	NULL

To	NULL
locate	NULL
the	NULL
important	NULL
regulatory	NULL
region	NULL
of	NULL
the	NULL
PU.1	NULL
promoter	NULL
in	NULL
B	NULL
cells	NULL
,	NULL
a	NULL
5	NULL
deletion	NULL
series	NULL
of	NULL
the	NULL
-334	NULL
PU	NULL
.	NULL

1	NULL
promoter	NULL
was	NULL
transfected	NULL
into	NULL
BJA-B	NULL
cells	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

1B	NULL
,	NULL
in	NULL
BJA-B	NULL
cells	NULL
,	NULL
deletion	NULL
from	NULL
bp	NULL
-334	NULL
to	NULL
bp	NULL
-61	NULL
did	NULL
not	NULL
significantly	NULL
change	NULL
promoter	NULL
function	NULL
,	NULL
but	NULL
deletion	NULL
from	NULL
bp	NULL
-61	NULL
to	NULL
-48	NULL
,	NULL
which	NULL
removes	NULL
an	NULL
octamer	NULL
binding	NULL
site	NULL
,	NULL
decreased	NULL
activity	NULL
to	NULL
20	NULL
%	NULL
of	NULL
the	NULL
bp	NULL
-334	NULL
promoter	NULL
.	NULL

Deletion	NULL
from	NULL
bp	NULL
-48	NULL
to	NULL
-39	NULL
,	NULL
which	NULL
contains	NULL
a	NULL
Spl	NULL
binding	NULL
site	NULL
,	NULL
did	NULL
not	NULL
result	NULL
in	NULL
a	NULL
significant	NULL
change	NULL
in	NULL
luciferase	NULL
activity	NULL
.	NULL

Deletion	NULL
from	NULL
bp	NULL
-7	NULL
to	NULL
+34	NULL
,	NULL
which	NULL
removes	NULL
a	NULL
PU.1	NULL
binding	NULL
site	NULL
,	NULL
decreased	NULL
activity	NULL
to	NULL
50	NULL
%	NULL
of	NULL
the	NULL
bp	NULL
-7	NULL
promoter	NULL
.	NULL

Similar	NULL
results	NULL
were	NULL
obtained	NULL
with	NULL
the	NULL
murine	NULL
B	NULL
cell	NULL
line	NULL
K46	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
Transcription	NULL
Factors	NULL
Oct-1	NULL
and	NULL
Oct-2	NULL
Bind	NULL
to	NULL
the	NULL
PU.1	NULL
Promoter	NULL
at	NULL
bp	NULL
-55-The	NULL
functional	NULL
analysis	NULL
of	NULL
the	NULL
PU.1	NULL
promotor	NULL
deletion	NULL
series	NULL
suggested	NULL
that	NULL
the	NULL
murine	NULL
PU	NULL
.	NULL

1	NULL
promoter	NULL
-55	NULL
octamer	NULL
site	NULL
was	NULL
important	NULL
for	NULL
its	NULL
function	NULL
in	NULL
B	NULL
cell	NULL
lines	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
the	NULL
octamer	NULL
binding	NULL
proteins	NULL
bind	NULL
the	NULL
PU.1	NULL
promoter	NULL
,	NULL
we	NULL
performed	NULL
gel	NULL
shift	NULL
assays	NULL
.	NULL

A	NULL
25-bp	NULL
(	NULL
bp	NULL
-66	NULL
to	NULL
-42	NULL
)	NULL
oligonucleotide	NULL
containing	NULL
a	NULL
central	NULL
octamer	NULL
site	NULL
was	NULL
used	NULL
as	NULL
a	NULL
probe	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

24	NULL
,	NULL
nuclear	NULL
extracts	NULL
from	NULL
the	NULL
Oct-1	NULL
or	NULL
Oct-2	NULL
transiently	NULL
transfected	NULL
COS	NULL
cells	NULL
,	NULL
which	NULL
express	NULL
undetectable	NULL
levels	NULL
of	NULL
Oct-2	NULL
``	NULL
were	NULL
used	NULL
as	NULL
sources	NULL
of	NULL
Oct-1	NULL
and	NULL
Oct-2	NULL
proteins	NULL
for	NULL
controls	NULL
.	NULL

Nuclear	NULL
extracts	NULL
from	NULL
transfected	NULL
*	NULL
H.-M.	NULL
Chen	NULL
,	NULL
P.	NULL
Zhang	NULL
,	NULL
H.	NULL
S.	NULL
Radomska	NULL
,	NULL
C.	NULL
J.	NULL
Hetherington	NULL
,	NULL
D.-E.	NULL
Zhang	NULL
,	NULL
and	NULL
D.	NULL
G.	NULL
Tenen	NULL
,	NULL
unpublished	NULL
data	NULL
.	NULL

610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
15746	NULL
PU.1	NULL
Regulation	NULL
by	NULL
Octamer	NULL
Factors	NULL
and	NULL
Coactivators	NULL
A	NULL
Octamer	NULL
-66	NULL
-42	NULL
Probe	NULL
and	NULL
wild	NULL
type	NULL
competitor	NULL
(	NULL
w	NULL
)	NULL
:	NULL
Mutant	NULL
octamer	NULL
competitor	NULL
(	NULL
mj	NULL
:	NULL
Wild	NULL
type	NULL
nctamer	NULL
and	NULL
mutant	NULL
Sp1	NULL
competitor	NULL
(	NULL
n	NULL
}	NULL
:	NULL
Wild	NULL
type	NULL
SpI	NULL
site	NULL
competitor	NULL
(	NULL
s	NULL
)	NULL
:	NULL
AAMCGGGCTGSSOCGOTGATOTCAC	NULL
TTTGCCCGAC	NULL
ACTACAGTG	NULL
+5	NULL
PU.1	NULL
+24	NULL
TCGATAAAATCA	NULL
AGCTATTTTAC	NULL
pGaAc	NULL
Bok	NULL
-	NULL
2	NULL
s	NULL
s	NULL
n	NULL
e	NULL
s	NULL
6	NULL
Ros	NULL
Oct-2C08	NULL
aoe	NULL
e	NULL
dge	NULL
nis	NULL
Wild	NULL
type	NULL
PU.1	NULL
site	NULL
competitor	NULL
(	NULL
p	NULL
)	NULL
:	NULL
U937	NULL
NE	NULL
200	NULL
0k	NULL
00	NULL
0	NULL
n	NULL
dob	NULL
A	NULL
b	NULL
b	NULL
oA	NULL
to	NULL
#	NULL
BJA-B	NULL
NE	NULL
oor	NULL
Competitor	NULL
sow	NULL
s	NULL
-	NULL
owo	NULL
-	NULL
~	NULL
women	NULL
s	NULL
pos	NULL
>	NULL
-	NULL
.	NULL

wom	NULL
nos	NULL
po	NULL
<	NULL
-o	NULL
>	NULL
Antibody	NULL
Lol	NULL
fol	NULL
l	NULL
go	NULL
l.	NULL
l	NULL
ll	NULL
l	NULL
}	NULL
p	NULL
2	NULL
Wo	NULL
-+	NULL
bd	NULL
b	NULL
|	NULL
-	NULL
5	NULL
!	NULL

*-	NULL
S2	NULL
Oct-1	NULL
-*	NULL
Muah	NULL
-	NULL
tat	NULL
.-	NULL
..	NULL
Quiet	NULL
-	NULL
mn	NULL
most	NULL
-	NULL
bad	NULL
Oct-2	NULL
-	NULL
n	NULL
1	NULL
2	NULL
3	NULL
4	NULL
506	NULL
7	NULL
$	NULL
9	NULL
10	NULL
LI	NULL
1213	NULL
14	NULL
1s	NULL
16	NULL
1718	NULL
10	NULL
20	NULL
21	NULL
22	NULL
C	NULL
Sp1	NULL
(	NULL
PU.1	NULL
promoter	NULL
)	NULL
+66	NULL
Spl	NULL
mutant	NULL
Sp1	NULL
(	NULL
CD11b	NULL
promoter	NULL
)	NULL
B	NULL
Probe	NULL
and	NULL
wild	NULL
type	NULL
competitor	NULL
(	NULL
wt	NULL
)	NULL
:	NULL
AGCTATTTTAGITCCTTEAAC	NULL
TCGATAAAATCAaagcLTTG	NULL
PU.1	NULL
mutant	NULL
competitor	NULL
(	NULL
m	NULL
)	NULL
:	NULL
-2	NULL
-31	NULL
CD11b	NULL
PU.1	NULL
site	NULL
competitor	NULL
(	NULL
CD	NULL
)	NULL
:	NULL
CAAAGAAGGGCAGAAAAGGAGAAGTAGGCT	NULL
GTTICTTCCCGTCTTTTOCTCTTCATCCGA	NULL
PU.1	NULL
protein	NULL
gogo	NULL
+	NULL
-	NULL
+	NULL
>	NULL
>	NULL
-	NULL
>	NULL
=	NULL
BJA-B	NULL
NE	NULL
soe	NULL
t	NULL
$	NULL
o	NULL
4	NULL
#	NULL
#	NULL
406	NULL
>	NULL
HeLa	NULL
NE	NULL
au	NULL
e	NULL
2	NULL
egos	NULL
Competitor	NULL
202	NULL
co	NULL
}	NULL
>	NULL
PU.1	NULL
Antibody	NULL
sop	NULL
k	NULL
k	NULL
+	NULL
k	NULL
gk	NULL
%	NULL
w	NULL
_-	NULL
ih	NULL
gig	NULL
nom	NULL
nn	NULL
n	NULL
tow	NULL
§§	NULL
-	NULL
dah	NULL
PUA	NULL
-	NULL
«	NULL
p	NULL
--	NULL
Uo	NULL
-	NULL
>	NULL
ue	NULL
F	NULL
1	NULL
%	NULL
3	NULL
4	NULL
506	NULL
7	NULL
8	NULL
9	NULL
Spl	NULL
~53	NULL
29	NULL
BJA-B	NULL
U937	NULL
.8	NULL
-=	NULL
B	NULL
w.	NULL
=	NULL
#	NULL
G.	NULL
32,43	NULL
A	NULL
1	NULL
3	NULL
&	NULL
fBig	NULL
d	NULL
102	NULL
3	NULL
4	NULL
§06	NULL
7	NULL
8	NULL
9	NULL
10	NULL
111	NULL
%	NULL
13	NULL
610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
PU.1	NULL
Regulation	NULL
by	NULL
Octamer	NULL
Factors	NULL
and	NULL
Coactivators	NULL
COS	NULL
cells	NULL
bound	NULL
to	NULL
an	NULL
oligonucleotide	NULL
probe	NULL
from	NULL
the	NULL
PU.1	NULL
promoter	NULL
bp	NULL
-66	NULL
to	NULL
-42	NULL
(	NULL
Fig	NULL
.	NULL

24	NULL
,	NULL
lanes	NULL
1	NULL
and	NULL
4	NULL
)	NULL
.	NULL

Binding	NULL
was	NULL
competed	NULL
by	NULL
self	NULL
oligonucleotide	NULL
(	NULL
Fig	NULL
.	NULL

24	NULL
,	NULL
lanes	NULL
2	NULL
and	NULL
5	NULL
)	NULL
,	NULL
demonstrating	NULL
specific	NULL
binding	NULL
activity	NULL
.	NULL

The	NULL
complexes	NULL
of	NULL
Oct-1	NULL
and	NULL
Oct-2	NULL
could	NULL
be	NULL
supershifted	NULL
by	NULL
anti-Oct-1	NULL
antibody	NULL
or	NULL
anti-Oct-2	NULL
antibody	NULL
,	NULL
respectively	NULL
(	NULL
shown	NULL
as	NULL
SI	NULL
or	NULL
S2	NULL
in	NULL
Fig	NULL
.	NULL

24	NULL
,	NULL
lanes	NULL
3	NULL
and	NULL
6	NULL
)	NULL
.	NULL

An	NULL
Oct-1	NULL
complex	NULL
was	NULL
formed	NULL
using	NULL
nuclear	NULL
extracts	NULL
from	NULL
U937	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

2A	NULL
,	NULL
lane	NULL
7	NULL
)	NULL
.	NULL

The	NULL
complex	NULL
was	NULL
specifically	NULL
competed	NULL
out	NULL
by	NULL
self	NULL
oligonucleotide	NULL
or	NULL
by	NULL
an	NULL
oligonucleotide	NULL
which	NULL
has	NULL
a	NULL
wild	NULL
type	NULL
octamer	NULL
site	NULL
and	NULL
mutant	NULL
Sp1	NULL
site	NULL
(	NULL
Fig	NULL
.	NULL

24	NULL
,	NULL
lanes	NULL
8	NULL
and	NULL
10	NULL
)	NULL
,	NULL
but	NULL
not	NULL
by	NULL
a	NULL
mutated	NULL
octamer	NULL
site	NULL
oligonucleotide	NULL
from	NULL
the	NULL
PU.1	NULL
promoter	NULL
,	NULL
a	NULL
wild	NULL
type	NULL
Spl	NULL
site	NULL
oligonucleotide	NULL
from	NULL
the	NULL
PU	NULL
.	NULL

1	NULL
promoter	NULL
,	NULL
or	NULL
wild	NULL
type	NULL
PU.1	NULL
site	NULL
oligonucleotide	NULL
from	NULL
the	NULL
PU.1	NULL
promoter	NULL
(	NULL
Fig	NULL
.	NULL

24	NULL
,	NULL
lanes	NULL
9	NULL
,	NULL
11	NULL
,	NULL
and	NULL
12	NULL
)	NULL
.	NULL

Only	NULL
anti-Oct-1	NULL
antibody	NULL
could	NULL
supershift	NULL
the	NULL
complex	NULL
in	NULL
U937	NULL
nuclear	NULL
extracts	NULL
,	NULL
but	NULL
not	NULL
anti-Oct-2	NULL
antibody	NULL
(	NULL
Fig	NULL
.	NULL

24	NULL
,	NULL
lanes	NULL
13	NULL
and	NULL
14	NULL
)	NULL
.	NULL

BJA-B	NULL
nuclear	NULL
extracts	NULL
demonstrated	NULL
a	NULL
similar	NULL
pattern	NULL
of	NULL
competition	NULL
and	NULL
supershifts	NULL
for	NULL
Oct-1	NULL
binding	NULL
,	NULL
and	NULL
in	NULL
addition	NULL
an	NULL
Oct-2	NULL
complex	NULL
was	NULL
observed	NULL
which	NULL
could	NULL
be	NULL
specifically	NULL
competed	NULL
by	NULL
unlabeled	NULL
oligonucleotides	NULL
and	NULL
supershifted	NULL
by	NULL
anti-Oct-2	NULL
antibody	NULL
(	NULL
Fig	NULL
.	NULL

2A	NULL
,	NULL
lanes	NULL
15-22	NULL
)	NULL
.	NULL

Nonim-mune	NULL
antibody	NULL
could	NULL
not	NULL
supershift	NULL
the	NULL
Oct-1	NULL
and	NULL
Oct-2	NULL
complexes	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

These	NULL
results	NULL
show	NULL
that	NULL
in	NULL
the	NULL
B	NULL
cell	NULL
line	NULL
BJA-B	NULL
,	NULL
both	NULL
Oct-1	NULL
and	NULL
Oct-2	NULL
bind	NULL
to	NULL
the	NULL
PU.1	NULL
promoter	NULL
octamer	NULL
site	NULL
,	NULL
but	NULL
in	NULL
the	NULL
myeloid	NULL
cell	NULL
line	NULL
U937	NULL
only	NULL
Oct-1	NULL
binding	NULL
is	NULL
observed	NULL
.	NULL

The	NULL
Transcription	NULL
Factors	NULL
PU.1	NULL
and	NULL
Sp1	NULL
Bind	NULL
to	NULL
the	NULL
PU.1	NULL
Promoter	NULL
at	NULL
bp	NULL
+20	NULL
and	NULL
-40	NULL
,	NULL
Respectively	NULL
,	NULL
in	NULL
B	NULL
Cells-We	NULL
have	NULL
previously	NULL
shown	NULL
that	NULL
in	NULL
myeloid	NULL
cells	NULL
,	NULL
PU.1	NULL
binds	NULL
to	NULL
a	NULL
site	NULL
in	NULL
the	NULL
5'-untranslated	NULL
region	NULL
of	NULL
the	NULL
PU.1	NULL
promoter	NULL
(	NULL
at	NULL
bp	NULL
+20	NULL
)	NULL
,	NULL
and	NULL
that	NULL
this	NULL
site	NULL
is	NULL
functionally	NULL
important	NULL
,	NULL
leading	NULL
to	NULL
an	NULL
autoregulatory	NULL
loop	NULL
in	NULL
myeloid	NULL
cells	NULL
(	NULL
9	NULL
)	NULL
.	NULL

Since	NULL
PU.1	NULL
is	NULL
also	NULL
expressed	NULL
at	NULL
high	NULL
levels	NULL
in	NULL
B	NULL
cells	NULL
,	NULL
we	NULL
asked	NULL
whether	NULL
PU.1	NULL
from	NULL
B	NULL
cell	NULL
extracts	NULL
also	NULL
binds	NULL
to	NULL
this	NULL
site	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

2B	NULL
,	NULL
PU.1	NULL
from	NULL
the	NULL
B	NULL
cell	NULL
line	NULL
BJA-B	NULL
binds	NULL
to	NULL
the	NULL
PU.1	NULL
site	NULL
to	NULL
form	NULL
a	NULL
complex	NULL
which	NULL
comigrates	NULL
with	NULL
that	NULL
formed	NULL
by	NULL
in	NULL
vitro	NULL
translated	NULL
PU.1	NULL
,	NULL
indicating	NULL
that	NULL
the	NULL
complex	NULL
does	NULL
not	NULL
contain	NULL
other	NULL
proteins	NULL
,	NULL
specifically	NULL
NF-EMS5	NULL
,	NULL
which	NULL
can	NULL
interact	NULL
with	NULL
PU.1	NULL
at	NULL
sites	NULL
found	NULL
in	NULL
B	NULL
cell	NULL
enhancers	NULL
(	NULL
12	NULL
)	NULL
.	NULL

This	NULL
complex	NULL
can	NULL
be	NULL
competed	NULL
efficiently	NULL
with	NULL
wild	NULL
type	NULL
but	NULL
not	NULL
mutant	NULL
PU.1	NULL
oligonucleotides	NULL
,	NULL
indicating	NULL
a	NULL
specific	NULL
interaction	NULL
.	NULL

Interestingly	NULL
,	NULL
al	NULL
15747	NULL
though	NULL
this	NULL
site	NULL
is	NULL
functionally	NULL
important	NULL
(	NULL
see	NULL
below	NULL
)	NULL
,	NULL
PU.1	NULL
appears	NULL
to	NULL
bind	NULL
with	NULL
slightly	NULL
lower	NULL
affinity	NULL
to	NULL
this	NULL
site	NULL
compared	NULL
to	NULL
the	NULL
CD11b	NULL
PU	NULL
.	NULL

1	NULL
promoter	NULL
site	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
,	NULL
lanes	NULL
4	NULL
and	NULL
6	NULL
)	NULL
.	NULL

This	NULL
was	NULL
also	NULL
observed	NULL
when	NULL
using	NULL
nuclear	NULL
extracts	NULL
from	NULL
myeloid	NULL
cells	NULL
(	NULL
9	NULL
)	NULL
.	NULL

Most	NULL
of	NULL
the	NULL
binding	NULL
activity	NULL
is	NULL
supershifted	NULL
with	NULL
an	NULL
antibody	NULL
specific	NULL
for	NULL
PU.1	NULL
,	NULL
which	NULL
does	NULL
not	NULL
react	NULL
with	NULL
the	NULL
related	NULL
ets	NULL
family	NULL
member	NULL
Spi-B	NULL
(	NULL
50	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
although	NULL
both	NULL
PU.1	NULL
and	NULL
Spi-B	NULL
bind	NULL
to	NULL
this	NULL
site	NULL
(	NULL
9	NULL
)	NULL
,	NULL
and	NULL
both	NULL
are	NULL
expressed	NULL
in	NULL
BJA-B	NULL
cells	NULL
(	NULL
50	NULL
)	NULL
,	NULL
it	NULL
appears	NULL
that	NULL
most	NULL
of	NULL
the	NULL
binding	NULL
activity	NULL
to	NULL
this	NULL
site	NULL
in	NULL
B	NULL
cells	NULL
represents	NULL
PU.1	NULL
and	NULL
not	NULL
Spi-B	NULL
.	NULL

Sp1	NULL
bound	NULL
to	NULL
bp	NULL
-40	NULL
of	NULL
the	NULL
PU	NULL
.	NULL

1	NULL
promoter	NULL
,	NULL
as	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

2C	NULL
.	NULL

The	NULL
binding	NULL
complex	NULL
could	NULL
be	NULL
formed	NULL
in	NULL
nuclear	NULL
extracts	NULL
from	NULL
both	NULL
B	NULL
cells	NULL
and	NULL
myeloid	NULL
cells	NULL
,	NULL
competed	NULL
out	NULL
specifically	NULL
(	NULL
Fig	NULL
.	NULL

2C	NULL
,	NULL
lanes	NULL
3	NULL
,	NULL
4	NULL
,	NULL
9	NULL
,	NULL
and	NULL
10	NULL
)	NULL
and	NULL
abolished	NULL
specifically	NULL
with	NULL
anti-Sp1	NULL
antibody	NULL
(	NULL
Fig	NULL
.	NULL

2C	NULL
,	NULL
lanes	NULL
6	NULL
and	NULL
12	NULL
)	NULL
.	NULL

The	NULL
Octamer	NULL
Site	NULL
Is	NULL
Protected	NULL
in	NULL
Vivo-Since	NULL
in	NULL
vitro	NULL
DNA-protein	NULL
binding	NULL
experiments	NULL
may	NULL
not	NULL
reflect	NULL
binding	NULL
occurring	NULL
on	NULL
promoters	NULL
embedded	NULL
in	NULL
chromosomal	NULL
structures	NULL
in	NULL
vivo	NULL
(	NULL
42	NULL
,	NULL
46	NULL
)	NULL
,	NULL
in	NULL
vivo	NULL
footprinting	NULL
analysis	NULL
was	NULL
performed	NULL
to	NULL
determine	NULL
whether	NULL
DNA-protein	NULL
interactions	NULL
occurred	NULL
in	NULL
a	NULL
B	NULL
cell	NULL
specific	NULL
matter	NULL
.	NULL

Fig	NULL
.	NULL

3	NULL
shows	NULL
in	NULL
vivo	NULL
footprinting	NULL
of	NULL
the	NULL
noncoding	NULL
strand	NULL
of	NULL
the	NULL
highly	NULL
conserved	NULL
region	NULL
of	NULL
the	NULL
bp	NULL
-120	NULL
to	NULL
+102	NULL
PU.1	NULL
promoter	NULL
.	NULL

The	NULL
human	NULL
B	NULL
cell	NULL
line	NULL
BJA-B	NULL
repeatedly	NULL
showed	NULL
a	NULL
protected	NULL
region	NULL
located	NULL
at	NULL
bp	NULL
-51	NULL
,	NULL
which	NULL
lies	NULL
in	NULL
the	NULL
center	NULL
of	NULL
the	NULL
octamer	NULL
binding	NULL
sequence	NULL
,	NULL
ATGCAAAC	NULL
(	NULL
57	NULL
,	NULL
58	NULL
)	NULL
.	NULL

This	NULL
protection	NULL
was	NULL
not	NULL
observed	NULL
in	NULL
the	NULL
myeloid	NULL
cell	NULL
line	NULL
U937	NULL
.	NULL

One	NULL
hypersensitive	NULL
band	NULL
is	NULL
located	NULL
at	NULL
bp	NULL
+21	NULL
,	NULL
which	NULL
is	NULL
located	NULL
just	NULL
3	NULL
'	NULL
of	NULL
the	NULL
PU.1	NULL
core	NULL
site	NULL
AGGAA	NULL
(	NULL
59	NULL
)	NULL
,	NULL
and	NULL
one	NULL
protected	NULL
band	NULL
at	NULL
bp	NULL
+28	NULL
is	NULL
noted	NULL
in	NULL
U937	NULL
cells	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
.	NULL

No	NULL
obvious	NULL
change	NULL
was	NULL
observed	NULL
at	NULL
the	NULL
-40	NULL
region	NULL
,	NULL
which	NULL
contains	NULL
a	NULL
Spl	NULL
site	NULL
.	NULL

The	NULL
epithelial	NULL
cell	NULL
HeLa	NULL
line	NULL
showed	NULL
neither	NULL
protected	NULL
nor	NULL
hypersensitive	NULL
bands	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
,	NULL
lane	NULL
4	NULL
)	NULL
compared	NULL
to	NULL
that	NULL
produced	NULL
by	NULL
deproteinized	NULL
genomic	NULL
DNA	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
,	NULL
lane	NULL
1	NULL
)	NULL
.	NULL

A	NULL
weakly	NULL
protected	NULL
band	NULL
was	NULL
also	NULL
observed	NULL
at	NULL
bp	NULL
-76	NULL
in	NULL
BJA-B	NULL
and	NULL
U937	NULL
cells	NULL
.	NULL

We	NULL
did	NULL
not	NULL
observe	NULL
any	NULL
protected	NULL
or	NULL
hypersensitive	NULL
bands	NULL
on	NULL
the	NULL
coding	NULL
strand	NULL
in	NULL
BJA-B	NULL
,	NULL
U937	NULL
,	NULL
or	NULL
Hela	NULL
cells	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

A	NULL
Mutation	NULL
in	NULL
the	NULL
Octamer	NULL
Site	NULL
Which	NULL
Abolishes	NULL
Oct-1	NULL
and	NULL
Oct-2	NULL
Binding	NULL
Reduces	NULL
PU.1	NULL
Promoter	NULL
Function-The	NULL
results	NULL
shown	NULL
above	NULL
indicate	NULL
that	NULL
the	NULL
octamer	NULL
site	NULL
in	NULL
the	NULL
PU.1	NULL
promoter	NULL
binds	NULL
Oct-1	NULL
and	NULL
Oct-2	NULL
in	NULL
vitro	NULL
,	NULL
and	NULL
is	NULL
protected	NULL
in	NULL
vivo	NULL
in	NULL
Fig	NULL
.	NULL

2	NULL
.	NULL

A	NULL
,	NULL
Oct-1	NULL
and	NULL
Oct-2	NULL
binding	NULL
to	NULL
the	NULL
PU	NULL
.	NULL

1	NULL
promoter	NULL
at	NULL
bp	NULL
-55	NULL
.	NULL

The	NULL
probe	NULL
used	NULL
in	NULL
the	NULL
gel	NULL
shift	NULL
is	NULL
the	NULL
murine	NULL
PU	NULL
.	NULL

1	NULL
promoter	NULL
bp	NULL
-66	NULL
to	NULL
-42	NULL
containing	NULL
a	NULL
centrally	NULL
located	NULL
octamer	NULL
binding	NULL
site	NULL
.	NULL

The	NULL
legend	NULL
above	NULL
the	NULL
autoradiograph	NULL
indicates	NULL
the	NULL
source	NULL
of	NULL
nuclear	NULL
extract	NULL
,	NULL
competitor	NULL
,	NULL
and	NULL
antibody	NULL
used	NULL
.	NULL

Oct-1/COS	NULL
represents	NULL
nuclear	NULL
extract	NULL
from	NULL
COS	NULL
cells	NULL
transiently	NULL
transfected	NULL
with	NULL
an	NULL
Oct-1	NULL
expression	NULL
vector	NULL
;	NULL
Oct-2/COS	NULL
represents	NULL
nuclear	NULL
extract	NULL
from	NULL
COS	NULL
cells	NULL
transiently	NULL
transfected	NULL
with	NULL
an	NULL
Oct-2	NULL
expression	NULL
vector	NULL
;	NULL
U937	NULL
NK	NULL
is	NULL
U937	NULL
nuclear	NULL
extract	NULL
;	NULL
BJA-B	NULL
NE	NULL
is	NULL
BJA-B	NULL
nuclear	NULL
extract	NULL
.	NULL

Competitors	NULL
are	NULL
wild	NULL
type	NULL
PU.1	NULL
promoter	NULL
octamer	NULL
site	NULL
oligonucleotide	NULL
(	NULL
w	NULL
)	NULL
;	NULL
octamer	NULL
mutant	NULL
(	NULL
m	NULL
)	NULL
,	NULL
containing	NULL
a	NULL
6-bp	NULL
mutation	NULL
changing	NULL
the	NULL
sequence	NULL
from	NULL
bp	NULL
-56	NULL
to	NULL
-51	NULL
from	NULL
5'-TGCAAA-3	NULL
'	NULL
to	NULL
5'-gagetc-3	NULL
'	NULL
,	NULL
as	NULL
described	NULL
under	NULL
``	NULL
Materials	NULL
and	NULL
Methods	NULL
``	NULL
;	NULL
and	NULL
a	NULL
longer	NULL
oligonucleotide	NULL
from	NULL
bp	NULL
-59	NULL
to	NULL
-26	NULL
which	NULL
contains	NULL
wild	NULL
type	NULL
octamer	NULL
site	NULL
and	NULL
mutant	NULL
Sp1	NULL
site	NULL
(	NULL
5'-AAGAGATTTATGCAAACGGGCTGagetcaTGA-3	NULL
'	NULL
)	NULL
(	NULL
n	NULL
)	NULL
;	NULL
Spl	NULL
binding	NULL
site	NULL
oligonucleotide	NULL
from	NULL
the	NULL
PU.1	NULL
promoter	NULL
(	NULL
bp	NULL
-53	NULL
to	NULL
-29	NULL
,	NULL
5-AAACGGGCTGGGGCGGTGATGTCAC-3	NULL
'	NULL
)	NULL
(	NULL
s	NULL
)	NULL
PU.1	NULL
oligonucleotide	NULL
from	NULL
the	NULL
PU.1	NULL
promoter	NULL
(	NULL
bp	NULL
+5	NULL
to	NULL
+24	NULL
,	NULL
5-TCGATAAAATCAGGAACTTG-3	NULL
'	NULL
)	NULL
(	NULL
p	NULL
)	NULL
.	NULL

In	NULL
lanes	NULL
3	NULL
,	NULL
13	NULL
,	NULL
and	NULL
21	NULL
,	NULL
an	NULL
antiserum	NULL
(	NULL
1	NULL
)	NULL
raised	NULL
against	NULL
amino	NULL
acids	NULL
7283-743	NULL
of	NULL
human	NULL
Oct-1	NULL
(	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
)	NULL
was	NULL
used	NULL
to	NULL
supershift	NULL
the	NULL
Oct-1	NULL
complex	NULL
;	NULL
in	NULL
lanes	NULL
6	NULL
,	NULL
14	NULL
,	NULL
and	NULL
22	NULL
,	NULL
an	NULL
antiserum	NULL
(	NULL
2	NULL
)	NULL
raised	NULL
against	NULL
amino	NULL
acids	NULL
444-463	NULL
of	NULL
human	NULL
Oct-2	NULL
(	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
)	NULL
,	NULL
was	NULL
used	NULL
to	NULL
supershift	NULL
the	NULL
Oct-2	NULL
complex	NULL
.	NULL

The	NULL
symbol	NULL
W	NULL
on	NULL
the	NULL
Zeft	NULL
refers	NULL
to	NULL
the	NULL
location	NULL
of	NULL
the	NULL
well	NULL
;	NULL
Oct-1	NULL
,	NULL
the	NULL
Oct-1	NULL
complex	NULL
;	NULL
Oct-2	NULL
,	NULL
the	NULL
Oct-2	NULL
complex	NULL
;	NULL
on	NULL
the	NULL
right	NULL
,	NULL
S1	NULL
,	NULL
the	NULL
supershifted	NULL
Oct-1	NULL
complex	NULL
;	NULL
S2	NULL
,	NULL
the	NULL
supershifted	NULL
Oct-2	NULL
complex	NULL
.	NULL

F	NULL
indicates	NULL
free	NULL
probe	NULL
.	NULL

B	NULL
,	NULL
PU.1	NULL
binds	NULL
to	NULL
the	NULL
PU	NULL
.	NULL

1	NULL
promoter	NULL
in	NULL
B	NULL
cells	NULL
.	NULL

The	NULL
probe	NULL
used	NULL
in	NULL
the	NULL
gel	NULL
shift	NULL
is	NULL
the	NULL
murine	NULL
PU	NULL
.	NULL

1	NULL
promoter	NULL
bp	NULL
+5	NULL
to	NULL
+24	NULL
,	NULL
5'-TCGATAAAATCAGGAACTTG-3	NULL
'	NULL
,	NULL
containing	NULL
a	NULL
centrally	NULL
located	NULL
PU.1	NULL
binding	NULL
site	NULL
.	NULL

The	NULL
legend	NULL
above	NULL
the	NULL
autoradiograph	NULL
indicates	NULL
the	NULL
source	NULL
of	NULL
protein	NULL
,	NULL
competitor	NULL
,	NULL
and	NULL
antibody	NULL
used	NULL
.	NULL

PU	NULL
.	NULL

1	NULL
protein	NULL
represents	NULL
in	NULL
vitro	NULL
translated	NULL
PU.1	NULL
protein	NULL
;	NULL
BJA-B	NULL
NE	NULL
is	NULL
BJA-B	NULL
nuclear	NULL
extract	NULL
;	NULL
HeLa	NULL
NE	NULL
is	NULL
HeLa	NULL
nuclear	NULL
extract	NULL
.	NULL

Competitors	NULL
are	NULL
wild	NULL
type	NULL
PU.1	NULL
promoter	NULL
oligonucleotide	NULL
(	NULL
w¢	NULL
)	NULL
;	NULL
PU.1	NULL
mutant	NULL
(	NULL
m	NULL
)	NULL
,	NULL
containing	NULL
a	NULL
5-bp	NULL
mutation	NULL
changing	NULL
the	NULL
sequence	NULL
from	NULL
bp	NULL
+17	NULL
to	NULL
+21	NULL
from	NULL
5-GGAAC-3	NULL
'	NULL
to	NULL
5'-AAGCT-3	NULL
'	NULL
,	NULL
as	NULL
described	NULL
under	NULL
``	NULL
Materials	NULL
and	NULL
Methods	NULL
``	NULL
;	NULL
and	NULL
the	NULL
wild	NULL
type	NULL
PU	NULL
.	NULL

1	NULL
oligonucleotide	NULL
from	NULL
the	NULL
CD11b	NULL
promoter	NULL
(	NULL
CD	NULL
)	NULL
(	NULL
72	NULL
)	NULL
,	NULL
In	NULL
Zanes	NULL
2	NULL
and	NULL
7	NULL
,	NULL
an	NULL
antiserum	NULL
raised	NULL
against	NULL
amino	NULL
acids	NULL
33-45	NULL
of	NULL
murine	NULL
PU.1	NULL
,	NULL
which	NULL
specifically	NULL
reacts	NULL
against	NULL
PU.1	NULL
and	NULL
not	NULL
Spi-B	NULL
(	NULL
3	NULL
,	NULL
50	NULL
)	NULL
,	NULL
was	NULL
used	NULL
to	NULL
supershift	NULL
the	NULL
PU.1	NULL
complex	NULL
.	NULL

The	NULL
symbol	NULL
W	NULL
at	NULL
the	NULL
left	NULL
refers	NULL
to	NULL
the	NULL
location	NULL
of	NULL
the	NULL
well	NULL
;	NULL
SS	NULL
,	NULL
the	NULL
supershifted	NULL
PU.1	NULL
complex	NULL
;	NULL
PU	NULL
.	NULL

1	NULL
,	NULL
PU.1	NULL
complex	NULL
;	NULL
F	NULL
,	NULL
free	NULL
probe	NULL
.	NULL

The	NULL
sequences	NULL
of	NULL
the	NULL
wild	NULL
type	NULL
PU.1	NULL
promoter	NULL
PU.1	NULL
site	NULL
probe	NULL
,	NULL
as	NULL
well	NULL
as	NULL
that	NULL
of	NULL
the	NULL
PU.1	NULL
promoter	NULL
PU.1	NULL
site	NULL
mutant	NULL
and	NULL
CD11b	NULL
PU.1	NULL
site	NULL
,	NULL
are	NULL
shown	NULL
at	NULL
the	NULL
top	NULL
with	NULL
the	NULL
PU.1	NULL
sites	NULL
vertically	NULL
aligned	NULL
and	NULL
boxed	NULL
.	NULL

C	NULL
,	NULL
Spl	NULL
binds	NULL
to	NULL
the	NULL
PU.1	NULL
promoter	NULL
in	NULL
B	NULL
and	NULL
myeloid	NULL
cells	NULL
.	NULL

The	NULL
probe	NULL
used	NULL
in	NULL
the	NULL
gel	NULL
shift	NULL
is	NULL
the	NULL
murine	NULL
PU.1	NULL
promoter	NULL
bp	NULL
-53	NULL
to	NULL
-29	NULL
,	NULL
+5	NULL
to	NULL
+24	NULL
,	NULL
containing	NULL
a	NULL
centrally	NULL
located	NULL
Sp1	NULL
binding	NULL
site	NULL
.	NULL

The	NULL
sources	NULL
of	NULL
protein	NULL
extract	NULL
,	NULL
competitor	NULL
,	NULL
and	NULL
antibody	NULL
used	NULL
are	NULL
indicated	NULL
above	NULL
the	NULL
autoradiograph	NULL
.	NULL

BJA-B	NULL
is	NULL
BJA-B	NULL
(	NULL
B	NULL
cell	NULL
)	NULL
nuclear	NULL
extract	NULL
;	NULL
U937	NULL
is	NULL
the	NULL
U937	NULL
(	NULL
myeloid	NULL
)	NULL
nuclear	NULL
extract	NULL
.	NULL

Competitors	NULL
are	NULL
wild	NULL
type	NULL
PU.1	NULL
promoter	NULL
Spl	NULL
site	NULL
oligonucleotide	NULL
(	NULL
self	NULL
)	NULL
;	NULL
the	NULL
wild	NULL
type	NULL
Sp1	NULL
oligonucleotide	NULL
from	NULL
the	NULL
CD11b	NULL
promoter	NULL
(	NULL
CD11b	NULL
)	NULL
(	NULL
42	NULL
,	NULL
72	NULL
)	NULL
;	NULL
and	NULL
a	NULL
PU.1	NULL
promoter	NULL
Spl	NULL
mutant	NULL
(	NULL
mut	NULL
)	NULL
,	NULL
containing	NULL
the	NULL
6-bp	NULL
mutation	NULL
in	NULL
the	NULL
Sp1	NULL
site	NULL
indicated	NULL
above	NULL
the	NULL
figure	NULL
.	NULL

In	NULL
lanes	NULL
6	NULL
and	NULL
12	NULL
,	NULL
an	NULL
antiserum	NULL
raised	NULL
against	NULL
bacterially	NULL
expressed	NULL
Spl	NULL
(	NULL
«	NULL
Sp1	NULL
)	NULL
was	NULL
used	NULL
to	NULL
specifically	NULL
abolish	NULL
the	NULL
Sp1	NULL
complex	NULL
(	NULL
42	NULL
)	NULL
;	NULL
in	NULL
lanes	NULL
7	NULL
and	NULL
13	NULL
,	NULL
preimmune	NULL
serum	NULL
(	NULL
pre	NULL
)	NULL
was	NULL
added	NULL
as	NULL
a	NULL
control	NULL
.	NULL

The	NULL
Sp1	NULL
complex	NULL
is	NULL
marked	NULL
on	NULL
the	NULL
right	NULL
;	NULL
the	NULL
asterisk	NULL
(	NULL
*	NULL
)	NULL
refers	NULL
to	NULL
a	NULL
complex	NULL
which	NULL
may	NULL
contain	NULL
a	NULL
breakdown	NULL
product	NULL
of	NULL
Spl	NULL
which	NULL
does	NULL
not	NULL
react	NULL
with	NULL
the	NULL
antisera	NULL
(	NULL
42	NULL
)	NULL
,	NULL
and	NULL
the	NULL
location	NULL
of	NULL
the	NULL
free	NULL
probe	NULL
is	NULL
indicated	NULL
as	NULL
well	NULL
.	NULL

610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
15748	NULL
N	NULL
B	NULL
U	NULL
H	NULL
+102	NULL
+32	NULL
JPU.1	NULL
26	NULL
-	NULL
®	NULL
]	NULL
Sp1	NULL
-51	NULL
-	NULL
]	NULL
0ct	NULL
-76	NULL
--	NULL
lyf	NULL
-*	NULL
C	NULL
a	NULL
#	NULL
in	NULL
we	NULL
1	NULL
2	NULL
3	NULL
4	NULL
Fic	NULL
.	NULL

3	NULL
.	NULL

In	NULL
vivo	NULL
footprinting	NULL
of	NULL
the	NULL
PU.1	NULL
promoter	NULL
.	NULL

In	NULL
vivo	NULL
footprinting	NULL
was	NULL
used	NULL
to	NULL
visualize	NULL
protein-DNA	NULL
interactions	NULL
on	NULL
the	NULL
PU	NULL
.	NULL
]	NULL

promoter	NULL
in	NULL
different	NULL
cell	NULL
lines	NULL
.	NULL

For	NULL
in	NULL
vivo	NULL
methylation	NULL
in	NULL
cell	NULL
lines	NULL
,	NULL
10°	NULL
BJA-B	NULL
(	NULL
B	NULL
;	NULL
lane	NULL
2	NULL
)	NULL
,	NULL
U937	NULL
(	NULL
U	NULL
;	NULL
lane	NULL
3	NULL
)	NULL
,	NULL
or	NULL
Helia	NULL
(	NULL
H	NULL
;	NULL
lane	NULL
4	NULL
)	NULL
cells	NULL
were	NULL
exposed	NULL
to	NULL
0.5	NULL
%	NULL
(	NULL
v/v	NULL
)	NULL
dimethyl	NULL
sulfate	NULL
(	NULL
Sigma	NULL
)	NULL
for	NULL
2	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
and	NULL
DNA	NULL
extracted	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
45	NULL
)	NULL
.	NULL

In	NULL
vivo	NULL
footprinting	NULL
was	NULL
visualized	NULL
using	NULL
the	NULL
ligation-mediated-PCR	NULL
procedure	NULL
(	NULL
42	NULL
,	NULL
46	NULL
)	NULL
.	NULL

In	NULL
lane	NULL
1	NULL
,	NULL
deproteinized	NULL
genomic	NULL
DNA	NULL
(	NULL
N	NULL
)	NULL
was	NULL
used	NULL
.	NULL

Positions	NULL
of	NULL
methylated	NULL
bands	NULL
,	NULL
determined	NULL
using	NULL
chemical	NULL
sequence	NULL
standards	NULL
,	NULL
is	NULL
shown	NULL
on	NULL
the	NULL
left	NULL
,	NULL
with	NULL
the	NULL
numbers	NULL
referring	NULL
to	NULL
the	NULL
human	NULL
PU	NULL
.	NULL
]	NULL

genomic	NULL
sequence	NULL
(	NULL
9	NULL
)	NULL
.	NULL

The	NULL
locations	NULL
of	NULL
core	NULL
binding	NULL
sites	NULL
for	NULL
PU.1	NULL
,	NULL
Sp1	NULL
,	NULL
and	NULL
octamer	NULL
are	NULL
shown	NULL
on	NULL
the	NULL
right	NULL
.	NULL

B	NULL
cells	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
deletion	NULL
of	NULL
a	NULL
small	NULL
region	NULL
including	NULL
this	NULL
octamer	NULL
binding	NULL
site	NULL
results	NULL
in	NULL
a	NULL
large	NULL
decrease	NULL
of	NULL
promotor	NULL
function	NULL
in	NULL
B	NULL
cell	NULL
lines	NULL
in	NULL
transient	NULL
transfection	NULL
assays	NULL
,	NULL
suggesting	NULL
that	NULL
the	NULL
octamer	NULL
site	NULL
is	NULL
important	NULL
for	NULL
PU.1	NULL
promoter	NULL
function	NULL
in	NULL
B	NULL
cells	NULL
.	NULL

In	NULL
order	NULL
to	NULL
determine	NULL
the	NULL
effects	NULL
of	NULL
specific	NULL
mutations	NULL
in	NULL
the	NULL
context	NULL
of	NULL
the	NULL
entire	NULL
promoter	NULL
,	NULL
a	NULL
6-bp	NULL
mutation	NULL
in	NULL
the	NULL
octamer	NULL
site	NULL
was	NULL
introduced	NULL
into	NULL
the	NULL
PU.1	NULL
-334	NULL
promoter/luciferase	NULL
construct	NULL
.	NULL

This	NULL
mutation	NULL
abolished	NULL
binding	NULL
by	NULL
both	NULL
Oct-1	NULL
and	NULL
Oct-2	NULL
as	NULL
determined	NULL
by	NULL
gel	NULL
shift	NULL
competition	NULL
experiments	NULL
(	NULL
Fig	NULL
.	NULL

24	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
in	NULL
order	NULL
to	NULL
compare	NULL
the	NULL
relative	NULL
contribution	NULL
of	NULL
the	NULL
octamer	NULL
,	NULL
Sp1	NULL
,	NULL
and	NULL
PU.1	NULL
sites	NULL
to	NULL
B	NULL
cell	NULL
activity	NULL
of	NULL
the	NULL
PU.1	NULL
promoter	NULL
,	NULL
similar	NULL
mutations	NULL
were	NULL
introduced	NULL
into	NULL
the	NULL
PU.1	NULL
and	NULL
Spl	NULL
sites	NULL
.	NULL

In	NULL
BJA-B	NULL
nuclear	NULL
extracts	NULL
,	NULL
Oct-1	NULL
and	NULL
Oct-2	NULL
both	NULL
specifically	NULL
and	NULL
strongly	NULL
bind	NULL
to	NULL
the	NULL
octamer	NULL
site	NULL
at	NULL
bp	NULL
-55	NULL
(	NULL
Fig	NULL
.	NULL

24	NULL
)	NULL
.	NULL

In	NULL
vitro	NULL
synthesized	NULL
PU.1	NULL
and	NULL
Spi-B	NULL
bind	NULL
to	NULL
the	NULL
PU.1	NULL
site	NULL
at	NULL
bp	NULL
+20	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
,	NULL
and	NULL
purified	NULL
Sp1	NULL
specifically	NULL
binds	NULL
to	NULL
a	NULL
site	NULL
at	NULL
bp	NULL
-40	NULL
(	NULL
Fig	NULL
.	NULL

2C	NULL
)	NULL
.	NULL

We	NULL
created	NULL
specific	NULL
mutations	NULL
in	NULL
each	NULL
of	NULL
these	NULL
sites	NULL
which	NULL
abolished	NULL
DNA	NULL
binding	NULL
of	NULL
each	NULL
factor	NULL
,	NULL
and	NULL
these	NULL
mutations	NULL
were	NULL
introduced	NULL
singly	NULL
or	NULL
in	NULL
combination	NULL
into	NULL
the	NULL
-334	NULL
murine	NULL
PU	NULL
.	NULL

1	NULL
promoter	NULL
.	NULL

Transient	NULL
transfections	NULL
were	NULL
performed	NULL
with	NULL
these	NULL
mutants	NULL
in	NULL
BJA-B	NULL
and	NULL
Hela	NULL
cell	NULL
lines	NULL
and	NULL
compared	NULL
to	NULL
the	NULL
wild	NULL
type	NULL
promoter	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
compared	NULL
to	NULL
the	NULL
wild	NULL
PU.1	NULL
Regulation	NULL
by	NULL
Octamer	NULL
Factors	NULL
and	NULL
Coactivators	NULL
RLU	NULL
per	NULL
ng	NULL
hGH/mi	NULL
@	NULL
Oct	NULL
E	NULL
LUC	NULL
mPU-334	NULL
S	NULL
&	NULL
H	NULL
$	NULL
--	NULL
Oct	NULL
mut	NULL
--	NULL
--	NULL
-	NULL
@	NULL
8-§-t=	NULL
Spi	NULL
mut	NULL
——®-8-|3—:1	NULL
Oct	NULL
&	NULL
Spl1	NULL
t	NULL
Fic	NULL
.	NULL

4	NULL
.	NULL

Mutation	NULL
of	NULL
the	NULL
octamer	NULL
site	NULL
significantly	NULL
reduces	NULL
PU.1	NULL
promoter	NULL
activity	NULL
in	NULL
B	NULL
cells	NULL
.	NULL

Specific	NULL
mutations	NULL
were	NULL
introduced	NULL
into	NULL
the	NULL
-334	NULL
to	NULL
+147	NULL
murine	NULL
promoter	NULL
at	NULL
the	NULL
octamer	NULL
site	NULL
(	NULL
mutating	NULL
bp	NULL
-56	NULL
to	NULL
-51	NULL
)	NULL
;	NULL
the	NULL
Sp1	NULL
site	NULL
(	NULL
bp	NULL
-48	NULL
to	NULL
-88	NULL
)	NULL
;	NULL
or	NULL
the	NULL
PU.1	NULL
(	NULL
bp	NULL
+17	NULL
to	NULL
+21	NULL
)	NULL
;	NULL
or	NULL
both	NULL
octamer	NULL
and	NULL
Sp1	NULL
sites	NULL
as	NULL
described	NULL
under	NULL
``	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL
``	NULL

Each	NULL
mutation	NULL
abolished	NULL
specific	NULL
binding	NULL
at	NULL
that	NULL
site	NULL
by	NULL
octamer	NULL
,	NULL
Sp1	NULL
,	NULL
or	NULL
PU.1	NULL
,	NULL
respectively	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
(	NULL
9	NULL
)	NULL
.	NULL

The	NULL
left	NULL
panel	NULL
is	NULL
a	NULL
schematic	NULL
representation	NULL
of	NULL
the	NULL
wild	NULL
type	NULL
(	NULL
mPU-334	NULL
)	NULL
and	NULL
mutant	NULL
murine	NULL
promoter	NULL
constructs	NULL
,	NULL
as	NULL
well	NULL
as	NULL
the	NULL
promoterless	NULL
luciferase	NULL
reporter	NULL
plasmid	NULL
pXP2	NULL
.	NULL

The	NULL
right	NULL
panel	NULL
shows	NULL
the	NULL
activity	NULL
observed	NULL
when	NULL
20	NULL
ug	NULL
of	NULL
these	NULL
constructs	NULL
were	NULL
transfected	NULL
into	NULL
the	NULL
BJA-B	NULL
(	NULL
black	NULL
bars	NULL
)	NULL
and	NULL
Helia	NULL
(	NULL
white	NULL
bars	NULL
)	NULL
cell	NULL
lines	NULL
.	NULL

Transfection	NULL
efficiency	NULL
was	NULL
corrected	NULL
by	NULL
cotransfecting	NULL
1	NULL
ug	NULL
of	NULL
CMV-hGH	NULL
.	NULL

Data	NULL
represent	NULL
the	NULL
mean	NULL
and	NULL
the	NULL
standard	NULL
error	NULL
of	NULL
the	NULL
mean	NULL
for	NULL
three	NULL
independent	NULL
experiments	NULL
.	NULL

type	NULL
PU.1	NULL
promoter	NULL
,	NULL
mutation	NULL
of	NULL
the	NULL
octamer	NULL
site	NULL
led	NULL
to	NULL
a	NULL
decrease	NULL
in	NULL
luciferase	NULL
activity	NULL
to	NULL
30	NULL
%	NULL
of	NULL
wild	NULL
type	NULL
in	NULL
BJA-B	NULL
cells	NULL
.	NULL

The	NULL
Spl	NULL
mutation	NULL
decreased	NULL
activity	NULL
to	NULL
64	NULL
%	NULL
and	NULL
PU.1	NULL
mutation	NULL
to	NULL
36	NULL
%	NULL
of	NULL
wild	NULL
type	NULL
activity	NULL
in	NULL
BJA-B	NULL
cells	NULL
.	NULL

The	NULL
construct	NULL
harboring	NULL
mutations	NULL
in	NULL
both	NULL
the	NULL
octamer	NULL
and	NULL
Spl	NULL
sites	NULL
yielded	NULL
a	NULL
loss	NULL
of	NULL
activity	NULL
similar	NULL
to	NULL
that	NULL
of	NULL
the	NULL
single	NULL
octamer	NULL
site	NULL
mutation	NULL
.	NULL

Similar	NULL
results	NULL
were	NULL
observed	NULL
in	NULL
the	NULL
murine	NULL
B	NULL
cell	NULL
line	NULL
K46	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

In	NULL
the	NULL
epithelial	NULL
cell	NULL
line	NULL
Hela	NULL
,	NULL
none	NULL
of	NULL
the	NULL
mutants	NULL
caused	NULL
a	NULL
significant	NULL
decrease	NULL
of	NULL
wild	NULL
type	NULL
luciferase	NULL
activity	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
in	NULL
the	NULL
myeloid	NULL
cell	NULL
line	NULL
U937	NULL
,	NULL
the	NULL
PU.1	NULL
mutant	NULL
,	NULL
rather	NULL
than	NULL
the	NULL
octamer	NULL
mutant	NULL
,	NULL
led	NULL
to	NULL
the	NULL
most	NULL
dramatic	NULL
decrease	NULL
(	NULL
9	NULL
)	NULL
.	NULL

Sp1	NULL
Can	NULL
Transactivate	NULL
the	NULL
PU.1	NULL
Promoter-In	NULL
gel	NULL
shift	NULL
experiments	NULL
,	NULL
Sp1	NULL
bound	NULL
to	NULL
a	NULL
site	NULL
at	NULL
bp	NULL
-40	NULL
of	NULL
the	NULL
PU	NULL
.	NULL

1	NULL
promoter	NULL
,	NULL
and	NULL
mutation	NULL
of	NULL
this	NULL
site	NULL
led	NULL
to	NULL
a	NULL
36	NULL
%	NULL
decrease	NULL
in	NULL
luciferase	NULL
activity	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

To	NULL
demonstrate	NULL
that	NULL
Sp1	NULL
can	NULL
transactivate	NULL
the	NULL
PU.1	NULL
promoter	NULL
,	NULL
we	NULL
cotransfected	NULL
PU.1	NULL
promoter	NULL
constructs	NULL
with	NULL
a	NULL
Sp1	NULL
expression	NULL
vector	NULL
(	NULL
pPac§p1	NULL
)	NULL
into	NULL
Drosophila	NULL
Schneider	NULL
(	NULL
82	NULL
)	NULL
cells	NULL
,	NULL
which	NULL
,	NULL
unlike	NULL
most	NULL
mammalian	NULL
cells	NULL
,	NULL
lack	NULL
endogenous	NULL
Spl	NULL
.	NULL

When	NULL
the	NULL
wild	NULL
type	NULL
mPU-334/luc	NULL
construct	NULL
was	NULL
cotransfected	NULL
with	NULL
the	NULL
pPac§p1	NULL
expression	NULL
vector	NULL
,	NULL
luciferase	NULL
activity	NULL
increased	NULL
35-fold	NULL
,	NULL
compared	NULL
to	NULL
a	NULL
9-fold	NULL
transactivation	NULL
if	NULL
the	NULL
Sp1	NULL
site	NULL
was	NULL
mutated	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

These	NULL
results	NULL
indicate	NULL
that	NULL
Sp1	NULL
can	NULL
bind	NULL
to	NULL
and	NULL
activate	NULL
the	NULL
PU.1	NULL
promoter	NULL
.	NULL

The	NULL
lesser	NULL
increase	NULL
of	NULL
activity	NULL
using	NULL
a	NULL
construct	NULL
with	NULL
a	NULL
mutation	NULL
in	NULL
the	NULL
Sp1	NULL
binding	NULL
site	NULL
is	NULL
frequently	NULL
observed	NULL
with	NULL
other	NULL
Sp1	NULL
dependent	NULL
promoters	NULL
(	NULL
60	NULL
)	NULL
and	NULL
may	NULL
reflect	NULL
transactivation	NULL
mediated	NULL
by	NULL
undetectably	NULL
weak	NULL
binding	NULL
of	NULL
Spl	NULL
to	NULL
the	NULL
mutant	NULL
site	NULL
;	NULL
by	NULL
a	NULL
mechanism	NULL
which	NULL
does	NULL
not	NULL
involve	NULL
DNA	NULL
binding	NULL
,	NULL
as	NULL
has	NULL
been	NULL
observed	NULL
with	NULL
myb	NULL
(	NULL
61	NULL
)	NULL
;	NULL
or	NULL
by	NULL
binding	NULL
of	NULL
Sp1	NULL
to	NULL
another	NULL
location	NULL
in	NULL
the	NULL
promoter	NULL
.	NULL

In	NULL
any	NULL
case	NULL
,	NULL
these	NULL
results	NULL
show	NULL
that	NULL
most	NULL
of	NULL
the	NULL
observed	NULL
Sp1	NULL
transactivation	NULL
is	NULL
mediated	NULL
through	NULL
specific	NULL
binding	NULL
to	NULL
the	NULL
site	NULL
at	NULL
bp	NULL
-40	NULL
.	NULL

Oct-2	NULL
Is	NULL
Expressed	NULL
at	NULL
Low	NULL
or	NULL
Undetectable	NULL
Levels	NULL
in	NULL
Myeloid	NULL
Cells-In	NULL
myeloid	NULL
cells	NULL
,	NULL
PU	NULL
.	NULL

1	NULL
itself	NULL
is	NULL
the	NULL
most	NULL
significant	NULL
factor	NULL
for	NULL
PU.1	NULL
promoter	NULL
function	NULL
(	NULL
9	NULL
)	NULL
,	NULL
but	NULL
the	NULL
octamer	NULL
site	NULL
is	NULL
most	NULL
important	NULL
in	NULL
B	NULL
cells	NULL
(	NULL
Figs	NULL
.	NULL

1B	NULL
and	NULL
4	NULL
)	NULL
.	NULL

In	NULL
order	NULL
to	NULL
understand	NULL
this	NULL
difference	NULL
,	NULL
we	NULL
investigated	NULL
the	NULL
pattern	NULL
of	NULL
expression	NULL
of	NULL
factors	NULL
interacting	NULL
with	NULL
the	NULL
octamer	NULL
site	NULL
.	NULL

Oct-2	NULL
,	NULL
unlike	NULL
Oct-1	NULL
,	NULL
is	NULL
expressed	NULL
primarily	NULL
in	NULL
B	NULL
cells	NULL
,	NULL
but	NULL
its	NULL
expression	NULL
pattern	NULL
in	NULL
myeloid	NULL
cells	NULL
has	NULL
not	NULL
been	NULL
extensively	NULL
described	NULL
(	NULL
22	NULL
,	NULL
57	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
in	NULL
order	NULL
to	NULL
understand	NULL
why	NULL
the	NULL
octamer	NULL
site	NULL
was	NULL
so	NULL
610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
PU.1	NULL
Regulation	NULL
by	NULL
Octamer	NULL
Factors	NULL
and	NULL
Coactivators	NULL
40.0	NULL
30.0	NULL
20.0	NULL
Fold	NULL
induction	NULL
mpy-334	NULL
.	NULL

(	NULL
Sp1	NULL
mut	NULL
)	NULL
luciferase	NULL
6	NULL
luciferase	NULL
Fic	NULL
.	NULL

5	NULL
.	NULL

Spl	NULL
stimulates	NULL
transcription	NULL
of	NULL
the	NULL
PU.1	NULL
promoter	NULL
via	NULL
the	NULL
-40-bp	NULL
site	NULL
in	NULL
transactivation	NULL
assays	NULL
.	NULL

Drosophila	NULL
Schneider	NULL
S2	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
the	NULL
wild	NULL
type	NULL
-334	NULL
PU	NULL
.	NULL

1	NULL
promoter	NULL
and	NULL
Spl	NULL
(	NULL
-48	NULL
to	NULL
-38	NULL
)	NULL
mutant	NULL
luciferase	NULL
reporter	NULL
constructs	NULL
with	NULL
and	NULL
without	NULL
the	NULL
pPacSp1	NULL
Sp1	NULL
expression	NULL
construct	NULL
.	NULL

The	NULL
data	NULL
are	NULL
presented	NULL
as	NULL
luciferase	NULL
activity	NULL
measured	NULL
with	NULL
expression	NULL
construct	NULL
divided	NULL
by	NULL
that	NULL
without	NULL
exogenous	NULL
Spl	NULL
.	NULL

Luciferase	NULL
activity	NULL
was	NULL
measured	NULL
48	NULL
h	NULL
after	NULL
transfection	NULL
.	NULL

The	NULL
data	NULL
represent	NULL
the	NULL
mean	NULL
and	NULL
standard	NULL
error	NULL
of	NULL
three	NULL
experiments	NULL
.	NULL

critical	NULL
in	NULL
B	NULL
cells	NULL
,	NULL
we	NULL
used	NULL
EMSA	NULL
to	NULL
determine	NULL
Oct-2	NULL
expression	NULL
in	NULL
myeloid	NULL
cell	NULL
lines	NULL
.	NULL

A	NULL
51-bp	NULL
oligomer	NULL
derived	NULL
from	NULL
the	NULL
immunoglobulin	NULL
heavy	NULL
chain	NULL
enhancer	NULL
(	NULL
51	NULL
)	NULL
was	NULL
used	NULL
as	NULL
a	NULL
probe	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

6A	NULL
,	NULL
Oct-1	NULL
complexes	NULL
are	NULL
found	NULL
at	NULL
high	NULL
levels	NULL
in	NULL
nuclear	NULL
extracts	NULL
of	NULL
all	NULL
cell	NULL
lines	NULL
tested	NULL
(	NULL
Fig	NULL
.	NULL

6A	NULL
,	NULL
lanes	NULL
2-17	NULL
)	NULL
.	NULL

Oct-2	NULL
complexes	NULL
were	NULL
present	NULL
at	NULL
high	NULL
levels	NULL
in	NULL
BJA-B	NULL
nuclear	NULL
extracts	NULL
only	NULL
,	NULL
with	NULL
trace	NULL
amounts	NULL
in	NULL
THP-1	NULL
,	NULL
KG-1a	NULL
,	NULL
and	NULL
M1	NULL
myeloid	NULL
lines	NULL
.	NULL

No	NULL
Oct-2	NULL
complexes	NULL
were	NULL
observed	NULL
in	NULL
Mono	NULL
Mac	NULL
6	NULL
or	NULL
U937	NULL
myeloid	NULL
lines	NULL
,	NULL
the	NULL
T	NULL
lymphoblastic	NULL
line	NULL
RPMI-8402	NULL
,	NULL
or	NULL
in	NULL
HeLa	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

6A	NULL
)	NULL
.	NULL

An	NULL
anti-Oct-2	NULL
antibody	NULL
reacted	NULL
with	NULL
the	NULL
Oct-2	NULL
complexes	NULL
but	NULL
not	NULL
the	NULL
Oct-1	NULL
complexes	NULL
(	NULL
Fig	NULL
.	NULL

6A	NULL
,	NULL
lanes	NULL
3	NULL
,	NULL
7	NULL
,	NULL
15	NULL
,	NULL
and	NULL
17	NULL
)	NULL
.	NULL

These	NULL
results	NULL
indicate	NULL
that	NULL
Oct-2	NULL
is	NULL
expressed	NULL
at	NULL
trace	NULL
or	NULL
undetectable	NULL
levels	NULL
in	NULL
myeloid	NULL
cells	NULL
.	NULL

The	NULL
Octamer	NULL
Coactivator	NULL
Bob1/OBF-1/OCA-B	NULL
Is	NULL
Not	NULL
Expressed	NULL
in	NULL
Myeloid	NULL
Cells-In	NULL
order	NULL
to	NULL
further	NULL
determine	NULL
the	NULL
mechanism	NULL
of	NULL
why	NULL
the	NULL
octamer	NULL
site	NULL
was	NULL
relatively	NULL
more	NULL
important	NULL
for	NULL
PU.1	NULL
promoter	NULL
function	NULL
in	NULL
B	NULL
cells	NULL
versus	NULL
myeloid	NULL
cells	NULL
,	NULL
we	NULL
examined	NULL
the	NULL
expression	NULL
and	NULL
function	NULL
of	NULL
the	NULL
Oct-1/Oct-2	NULL
coactivator	NULL
protein	NULL
,	NULL
Bob1l	NULL
or	NULL
OBF-1	NULL
.	NULL

This	NULL
protein	NULL
,	NULL
which	NULL
does	NULL
not	NULL
bind	NULL
to	NULL
DNA	NULL
directly	NULL
,	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
increase	NULL
the	NULL
ability	NULL
of	NULL
octamer	NULL
proteins	NULL
to	NULL
activate	NULL
octamer	NULL
dependent	NULL
promoters	NULL
(	NULL
33	NULL
,	NULL
34	NULL
)	NULL
.	NULL

The	NULL
octamer	NULL
coactivator	NULL
has	NULL
been	NULL
reported	NULL
to	NULL
be	NULL
expressed	NULL
exclusively	NULL
in	NULL
cells	NULL
of	NULL
B	NULL
cell	NULL
origin	NULL
,	NULL
but	NULL
not	NULL
in	NULL
non-B	NULL
cells	NULL
such	NULL
as	NULL
T	NULL
cell	NULL
lines	NULL
or	NULL
Hela	NULL
cells	NULL
(	NULL
33	NULL
,	NULL
34	NULL
)	NULL
.	NULL

In	NULL
order	NULL
to	NULL
determine	NULL
whether	NULL
the	NULL
coactivator	NULL
is	NULL
expressed	NULL
in	NULL
myeloid	NULL
cells	NULL
,	NULL
we	NULL
performed	NULL
Northern	NULL
blot	NULL
analysis	NULL
using	NULL
a	NULL
human	NULL
Bob1l	NULL
cDNA	NULL
probe	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

6B	NULL
,	NULL
the	NULL
Bob1	NULL
probe	NULL
hybridizes	NULL
to	NULL
a	NULL
3.2-kb	NULL
mRNA	NULL
species	NULL
in	NULL
human	NULL
BJA-B	NULL
cells	NULL
and	NULL
slightly	NULL
smaller	NULL
species	NULL
in	NULL
murine	NULL
K46	NULL
,	NULL
A20	NULL
,	NULL
and	NULL
Sp2	NULL
B	NULL
cell	NULL
lines	NULL
,	NULL
and	NULL
not	NULL
in	NULL
Hela	NULL
or	NULL
Jurkat	NULL
T	NULL
cells	NULL
,	NULL
consistent	NULL
with	NULL
previously	NULL
published	NULL
results	NULL
(	NULL
33	NULL
,	NULL
34	NULL
)	NULL
.	NULL

We	NULL
observed	NULL
no	NULL
hybridization	NULL
to	NULL
the	NULL
multipotential	NULL
line	NULL
LyD9	NULL
,	NULL
human	NULL
promyelocytic/promonocytic	NULL
lines	NULL
U937	NULL
and	NULL
HL-60	NULL
,	NULL
the	NULL
human	NULL
monocytic	NULL
line	NULL
Mono	NULL
Mac	NULL
6	NULL
,	NULL
or	NULL
to	NULL
primary	NULL
murine	NULL
peritoneal	NULL
macrophages	NULL
,	NULL
indicating	NULL
that	NULL
Bob1/OBF-1/0CA-B	NULL
is	NULL
not	NULL
expressed	NULL
in	NULL
myeloid	NULL
precursors	NULL
or	NULL
mature	NULL
macrophages	NULL
.	NULL

Octamer	NULL
Coactivator	NULL
Mediates	NULL
Oct-1/Oct-2	NULL
Transactivation	NULL
of	NULL
the	NULL
PU.1	NULL
Promoter-We	NULL
next	NULL
asked	NULL
the	NULL
question	NULL
of	NULL
whether	NULL
the	NULL
Oct-1/O0ct-2	NULL
coactivator	NULL
could	NULL
augment	NULL
the	NULL
ability	NULL
of	NULL
octamer	NULL
proteins	NULL
to	NULL
activate	NULL
the	NULL
PU.1	NULL
promoter	NULL
.	NULL

For	NULL
these	NULL
experiments	NULL
,	NULL
wild	NULL
type	NULL
mPU-334	NULL
and	NULL
octamer	NULL
mutant	NULL
PU	NULL
.	NULL

1	NULL
promoter	NULL
luciferase	NULL
constructs	NULL
were	NULL
transfected	NULL
along	NULL
with	NULL
combinations	NULL
of	NULL
Oct-1	NULL
,	NULL
Oct-2	NULL
,	NULL
and	NULL
Bob1l/OBF-1	NULL
expression	NULL
constructs	NULL
into	NULL
HeLa	NULL
cells	NULL
,	NULL
which	NULL
contain	NULL
significant	NULL
endogenous	NULL
levels	NULL
of	NULL
Oct-1	NULL
but	NULL
not	NULL
Oct-2	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

7A	NULL
,	NULL
transfection	NULL
of	NULL
the	NULL
PU.1	NULL
promoter	NULL
into	NULL
Hela	NULL
cells	NULL
gave	NULL
low	NULL
but	NULL
detectable	NULL
reporter	NULL
15749	NULL
A	NULL
IgH	NULL
enhancer	NULL
octamer	NULL
probe	NULL
I	NULL
I	NULL
§	NULL
8	NULL
mo	NULL
§	NULL
~	NULL
8	NULL
,	NULL
7	NULL
€	NULL
]	NULL
1	NULL
a	NULL
t	NULL
E	NULL
~-=o	NULL
E0	NULL
&	NULL
@	NULL
5	NULL
G	NULL
z	NULL
mo	NULL
s	NULL
BoR	NULL
5	NULL
B	NULL
S	NULL
&	NULL
roa	NULL
r	NULL
ra	NULL
r	NULL
a	NULL
mora	NULL
aOct-2	NULL
Ab	NULL
-	NULL
-	NULL
+	NULL
-	NULL
nok	NULL
c	NULL
&	NULL
cog	NULL
-o	NULL
40	NULL
>	NULL
4	NULL
-+	NULL
+	NULL
Oct-2	NULL
supershift	NULL
Oct-1	NULL
Oct-2	NULL
-	NULL
»	NULL
p-MhM-ﬁ-	NULL
ine	NULL
free	NULL
probe-1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
10	NULL
111213	NULL
14151617	NULL
B	NULL
g	NULL
3	NULL
ses	NULL
aP	NULL
as	NULL
@	NULL
5§ggmm55=3=	NULL
=§§E	NULL
;	NULL
.	NULL

;	NULL
E'=g°	NULL
&	NULL
s	NULL
2	NULL
4	NULL
5	NULL
I	NULL
gagﬁeégeégg	NULL
#	NULL
324	NULL
|	NULL
2g	NULL
|	NULL
#	NULL
2	NULL
HOL	NULL
#	NULL
1	NULL
-	NULL
288	NULL
hBob-1	NULL
-	NULL
,	NULL
4	NULL
--	NULL
‘	NULL
q-	NULL
Stl	NULL
is	NULL
-	NULL
188	NULL
ton	NULL
-	NULL
nene	NULL
en	NULL
nen	NULL
=	NULL
nes	NULL
=	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
1011	NULL
Fig	NULL
.	NULL

6	NULL
.	NULL

A	NULL
,	NULL
Oct-2	NULL
is	NULL
expressed	NULL
at	NULL
trace	NULL
or	NULL
undetectable	NULL
levels	NULL
in	NULL
myeloid	NULL
cells	NULL
.	NULL

The	NULL
probe	NULL
used	NULL
in	NULL
the	NULL
gel	NULL
shift	NULL
is	NULL
the	NULL
IgH	NULL
enhancer	NULL
fragment	NULL
,	NULL
containing	NULL
a	NULL
centrally	NULL
located	NULL
octamer	NULL
site	NULL
as	NULL
described	NULL
under	NULL
``	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL
``	NULL

The	NULL
source	NULL
of	NULL
protein	NULL
extract	NULL
,	NULL
and	NULL
the	NULL
presence	NULL
(	NULL
+	NULL
)	NULL
or	NULL
absence	NULL
(	NULL
-	NULL
)	NULL
of	NULL
a	NULL
specific	NULL
Oct-2	NULL
antibody	NULL
added	NULL
to	NULL
the	NULL
binding	NULL
reaction	NULL
are	NULL
indicated	NULL
above	NULL
the	NULL
autoradiograph	NULL
.	NULL

Lane	NULL
1	NULL
represents	NULL
free	NULL
probe	NULL
.	NULL

Sources	NULL
of	NULL
nuclear	NULL
extracts	NULL
the	NULL
human	NULL
cell	NULL
lines	NULL
BJA-B	NULL
(	NULL
B	NULL
cell	NULL
)	NULL
;	NULL
Mono-Mac6	NULL
(	NULL
monocytic	NULL
)	NULL
THP-1	NULL
(	NULL
monocytic	NULL
)	NULL
;	NULL
Hela	NULL
(	NULL
epithelial	NULL
carcinoma	NULL
)	NULL
;	NULL
U937	NULL
(	NULL
monocytic	NULL
)	NULL
;	NULL
RPMI	NULL
8402	NULL
(	NULL
CD34*	NULL
T	NULL
lymphoblastic	NULL
)	NULL
;	NULL
KG-1a	NULL
(	NULL
early	NULL
myeloid	NULL
)	NULL
;	NULL
and	NULL
the	NULL
murine	NULL
M1	NULL
myeloid	NULL
line	NULL
.	NULL

The	NULL
symbols	NULL
Oct-1	NULL
and	NULL
Oct-2	NULL
on	NULL
the	NULL
Zeft	NULL
refer	NULL
to	NULL
the	NULL
locations	NULL
of	NULL
the	NULL
respective	NULL
complexes	NULL
,	NULL
and	NULL
Oct-2	NULL
supershift	NULL
to	NULL
the	NULL
complex	NULL
observed	NULL
when	NULL
Oct-2	NULL
antiserum	NULL
is	NULL
added	NULL
to	NULL
the	NULL
reaction	NULL
.	NULL

A	NULL
faint	NULL
band	NULL
corresponding	NULL
to	NULL
the	NULL
Oct-2	NULL
supershift	NULL
can	NULL
be	NULL
observed	NULL
in	NULL
lanes	NULL
7	NULL
,	NULL
15	NULL
,	NULL
and	NULL
17	NULL
on	NULL
long	NULL
exposures	NULL
of	NULL
the	NULL
autoradiograph	NULL
.	NULL

The	NULL
location	NULL
of	NULL
the	NULL
free	NULL
probe	NULL
is	NULL
indicated	NULL
as	NULL
well	NULL
.	NULL

B	NULL
,	NULL
the	NULL
octamer	NULL
coactivator	NULL
Bob1/OBF-1	NULL
is	NULL
expressed	NULL
specifically	NULL
in	NULL
B	NULL
cell	NULL
lines	NULL
and	NULL
not	NULL
in	NULL
myeloid	NULL
cells	NULL
.	NULL

Comparative	NULL
expression	NULL
of	NULL
mRNA	NULL
in	NULL
human	NULL
epithelial	NULL
,	NULL
myeloid	NULL
,	NULL
T	NULL
and	NULL
B	NULL
cell	NULL
lines	NULL
,	NULL
and	NULL
murine	NULL
B	NULL
cell	NULL
lines	NULL
and	NULL
macrophages	NULL
is	NULL
shown	NULL
.	NULL

Each	NULL
lane	NULL
contained	NULL
10	NULL
ug	NULL
of	NULL
total	NULL
RNA	NULL
.	NULL

The	NULL
blot	NULL
was	NULL
probed	NULL
with	NULL
a	NULL
human	NULL
cDNA	NULL
clone	NULL
encompassing	NULL
the	NULL
Bobl	NULL
coding	NULL
region	NULL
(	NULL
83	NULL
,	NULL
34	NULL
)	NULL
,	NULL
and	NULL
autoradiography	NULL
was	NULL
performed	NULL
for	NULL
4	NULL
days	NULL
with	NULL
an	NULL
intensifying	NULL
screen	NULL
.	NULL

Shown	NULL
on	NULL
the	NULL
lef	NULL
?	NULL

is	NULL
the	NULL
location	NULL
of	NULL
the	NULL
human	NULL
Bobl/OBF-1	NULL
mRNA	NULL
;	NULL
the	NULL
asterisk	NULL
(	NULL
*	NULL
)	NULL
denotes	NULL
the	NULL
position	NULL
of	NULL
a	NULL
slightly	NULL
faster	NULL
migrating	NULL
species	NULL
observed	NULL
in	NULL
murine	NULL
cells	NULL
.	NULL

On	NULL
the	NULL
right	NULL
is	NULL
shown	NULL
the	NULL
position	NULL
of	NULL
the	NULL
28	NULL
and	NULL
18	NULL
S	NULL
ribosomal	NULL
bands	NULL
.	NULL

The	NULL
bottom	NULL
panel	NULL
shows	NULL
hybridization	NULL
of	NULL
the	NULL
same	NULL
blot	NULL
to	NULL
an	NULL
18	NULL
S	NULL
oligonucleotide	NULL
,	NULL
which	NULL
was	NULL
used	NULL
to	NULL
demonstrate	NULL
the	NULL
amount	NULL
of	NULL
RNA	NULL
in	NULL
each	NULL
lane	NULL
.	NULL

gene	NULL
activity	NULL
,	NULL
and	NULL
this	NULL
activity	NULL
was	NULL
decreased	NULL
50	NULL
%	NULL
by	NULL
introduction	NULL
of	NULL
a	NULL
mutation	NULL
in	NULL
the	NULL
octamer	NULL
site	NULL
.	NULL

The	NULL
residual	NULL
activity	NULL
possibly	NULL
reflects	NULL
the	NULL
fact	NULL
that	NULL
Hela	NULL
cells	NULL
contain	NULL
significant	NULL
610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
15750	NULL
A	NULL
Hela	NULL
@	NULL
oc	NULL
Zepl	NULL
Oru	NULL
:	NULL
mPU-334	NULL
a	NULL
E	NULL
LUC	NULL
Oct	NULL
mut	NULL
e	NULL
Z6	NULL
Fold	NULL
induction	NULL
0	NULL
2	NULL
4	NULL
6	NULL
8	NULL
+Oct-1	NULL
§§	NULL
mPU334	NULL
+Oct-2	NULL
]	NULL
Oct	NULL
mut	NULL
+Oct-1+Bob1	NULL
-*	NULL
+Oct-2+Bob1	NULL
-f	NULL
``	NULL
B	NULL
U937	NULL
fe	NULL
Fold	NULL
induction	NULL
4	NULL
PU-334	NULL
1	NULL
+Oct-1	NULL
1.8	NULL
+Oct-2	NULL
2.5	NULL
+Bob1	NULL
1.4	NULL
+Oct-1+Bob1	NULL
2.6	NULL
+Oct-2+Bobl	NULL
57	NULL
Fig	NULL
.	NULL

7	NULL
.	NULL

A	NULL
,	NULL
octamer	NULL
coactivator	NULL
augments	NULL
transactivation	NULL
of	NULL
the	NULL
PU.1	NULL
promoter	NULL
in	NULL
HeLa	NULL
cells	NULL
.	NULL

The	NULL
left	NULL
panel	NULL
is	NULL
a	NULL
schematic	NULL
representation	NULL
of	NULL
the	NULL
murine	NULL
PU	NULL
.	NULL

1	NULL
promoter-luciferase	NULL
constructs	NULL
,	NULL
showing	NULL
the	NULL
wild	NULL
type	NULL
and	NULL
octamer	NULL
mutant	NULL
promoters	NULL
.	NULL

The	NULL
right	NULL
panel	NULL
shows	NULL
the	NULL
fold	NULL
change	NULL
observed	NULL
when	NULL
10	NULL
ug	NULL
of	NULL
PU	NULL
.	NULL

1	NULL
promoter	NULL
constructs	NULL
with	NULL
2	NULL
ug	NULL
of	NULL
an	NULL
Oct-1	NULL
or	NULL
Oct-2	NULL
expression	NULL
vector	NULL
with	NULL
or	NULL
without	NULL
2	NULL
ug	NULL
of	NULL
the	NULL
octamer	NULL
coactivator	NULL
Bobl	NULL
expression	NULL
vector	NULL
were	NULL
transfected	NULL
into	NULL
Hela	NULL
cells	NULL
by	NULL
Ca	NULL
,	NULL
(	NULL
PO	NULL
,	NULL
)	NULL
,	NULL
coprecipitation	NULL
(	NULL
42	NULL
)	NULL
.	NULL

Luciferase	NULL
assays	NULL
were	NULL
performed	NULL
48	NULL
h	NULL
after	NULL
transfection	NULL
.	NULL

Transfection	NULL
efficiency	NULL
was	NULL
normalized	NULL
by	NULL
cotransfecting	NULL
0.2	NULL
ug	NULL
of	NULL
CMV-hGH	NULL
.	NULL

Data	NULL
represent	NULL
the	NULL
mean	NULL
and	NULL
the	NULL
standard	NULL
error	NULL
of	NULL
the	NULL
mean	NULL
for	NULL
three	NULL
independent	NULL
experiments	NULL
.	NULL

B	NULL
,	NULL
octamer	NULL
coactivator	NULL
can	NULL
also	NULL
augment	NULL
octamer-mediated	NULL
transactivation	NULL
of	NULL
the	NULL
PU	NULL
.	NULL

1	NULL
promoter	NULL
in	NULL
myeloid	NULL
cells	NULL
.	NULL

The	NULL
figure	NULL
represents	NULL
the	NULL
same	NULL
experiment	NULL
as	NULL
described	NULL
in	NULL
A	NULL
,	NULL
except	NULL
that	NULL
only	NULL
wild	NULL
type	NULL
promoter	NULL
constructs	NULL
were	NULL
transfected	NULL
by	NULL
electroporation	NULL
into	NULL
myeloid	NULL
U937	NULL
cells	NULL
.	NULL

To	NULL
the	NULL
right	NULL
of	NULL
each	NULL
bar	NULL
is	NULL
shown	NULL
the	NULL
fold	NULL
induction	NULL
,	NULL
representing	NULL
the	NULL
increase	NULL
in	NULL
luciferase	NULL
activity	NULL
with	NULL
expression	NULL
constructs	NULL
over	NULL
that	NULL
of	NULL
the	NULL
promoter	NULL
only	NULL
.	NULL

Luciferase	NULL
assays	NULL
were	NULL
performed	NULL
24	NULL
h	NULL
after	NULL
transfection	NULL
(	NULL
483	NULL
)	NULL
,	NULL
and	NULL
transfection	NULL
efficiency	NULL
was	NULL
normalized	NULL
by	NULL
cotransfecting	NULL
0.2	NULL
ug	NULL
of	NULL
CMV-hGH	NULL
.	NULL

Data	NULL
represent	NULL
the	NULL
mean	NULL
and	NULL
the	NULL
standard	NULL
error	NULL
of	NULL
the	NULL
mean	NULL
for	NULL
three	NULL
independent	NULL
experiments	NULL
.	NULL

levels	NULL
of	NULL
both	NULL
Oct-1	NULL
and	NULL
Sp1	NULL
,	NULL
two	NULL
activators	NULL
of	NULL
PU.1	NULL
promoter	NULL
activity	NULL
.	NULL

Introduction	NULL
of	NULL
the	NULL
Oct-1	NULL
expression	NULL
vector	NULL
did	NULL
not	NULL
augment	NULL
wild	NULL
type	NULL
promoter	NULL
activity	NULL
,	NULL
but	NULL
addition	NULL
of	NULL
Oct-2	NULL
increased	NULL
promoter	NULL
activity	NULL
2.4-fold	NULL
,	NULL
as	NULL
did	NULL
transfection	NULL
of	NULL
Bobl	NULL
alone	NULL
,	NULL
presumably	NULL
through	NULL
its	NULL
augmentation	NULL
of	NULL
Oct-1	NULL
activity	NULL
.	NULL

Cotransfection	NULL
of	NULL
both	NULL
Oct-2	NULL
and	NULL
Bob1l	NULL
led	NULL
to	NULL
a	NULL
dramatic	NULL
increase	NULL
in	NULL
wild	NULL
type	NULL
activity	NULL
,	NULL
which	NULL
was	NULL
not	NULL
observed	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
a	NULL
mutation	NULL
in	NULL
the	NULL
octamer	NULL
site	NULL
of	NULL
the	NULL
promoter	NULL
(	NULL
Fig	NULL
.	NULL

7A	NULL
)	NULL
.	NULL

These	NULL
results	NULL
indicate	NULL
that	NULL
Bob1	NULL
can	NULL
significantly	NULL
stimulate	NULL
PU.1	NULL
promoter	NULL
activity	NULL
,	NULL
particularly	NULL
in	NULL
concert	NULL
with	NULL
Oct-2	NULL
.	NULL

Cotransfection	NULL
of	NULL
Oct-1	NULL
and	NULL
Bobl	NULL
did	NULL
not	NULL
increase	NULL
promoter	NULL
activity	NULL
greater	NULL
than	NULL
that	NULL
of	NULL
Bob1l	NULL
alone	NULL
,	NULL
perhaps	NULL
due	NULL
to	NULL
the	NULL
significant	NULL
endogenous	NULL
levels	NULL
of	NULL
Oct-1	NULL
in	NULL
Hela	NULL
cells	NULL
.	NULL

Similar	NULL
experiments	NULL
were	NULL
performed	NULL
in	NULL
the	NULL
promonocytic	NULL
U937	NULL
cell	NULL
line	NULL
,	NULL
which	NULL
expresses	NULL
neither	NULL
Oct-2	NULL
or	NULL
Bob1	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

7B	NULL
,	NULL
transient	NULL
expression	NULL
of	NULL
the	NULL
PU.1	NULL
promoter/luciferase	NULL
construct	NULL
with	NULL
an	NULL
expression	NULL
vector	NULL
for	NULL
Oct-2	NULL
led	NULL
to	NULL
a	NULL
2.5-fold	NULL
increase	NULL
of	NULL
PU-334	NULL
activity	NULL
,	NULL
higher	NULL
than	NULL
that	NULL
observed	NULL
with	NULL
Oct-1	NULL
or	NULL
Bob1	NULL
alone	NULL
.	NULL

Cotransfection	NULL
of	NULL
Bob1	NULL
with	NULL
either	NULL
Oct-1	NULL
or	NULL
Oct-2	NULL
expression	NULL
vectors	NULL
with	NULL
the	NULL
PU-334	NULL
construct	NULL
showed	NULL
a	NULL
further	NULL
increase	NULL
of	NULL
promoter	NULL
function	NULL
.	NULL

Cotransfection	NULL
of	NULL
Bob1l	NULL
and	NULL
Oct-2	NULL
increased	NULL
the	NULL
PU-334	NULL
promoter	NULL
activity	NULL
5.7-fold	NULL
,	NULL
over	NULL
twice	NULL
the	NULL
transactivation	NULL
observed	NULL
with	NULL
Bob1	NULL
and	NULL
Oct-1	NULL
.	NULL

PU.1	NULL
Regulation	NULL
by	NULL
Octamer	NULL
Factors	NULL
and	NULL
Coactivators	NULL
TaBur	NULL
I	NULL
Relative	NULL
contribution	NULL
of	NULL
octamer	NULL
,	NULL
Sp1	NULL
,	NULL
and	NULL
PU.1	NULL
sites	NULL
to	NULL
PU.1	NULL
promoter	NULL
activity	NULL
in	NULL
myeloid	NULL
and	NULL
B	NULL
cells	NULL
The	NULL
activity	NULL
of	NULL
the	NULL
wild	NULL
type	NULL
and	NULL
mutant	NULL
constructs	NULL
transfected	NULL
into	NULL
either	NULL
U937	NULL
myeloid	NULL
cells	NULL
or	NULL
BJA-B	NULL
cells	NULL
.	NULL

The	NULL
numbers	NULL
indicate	NULL
percentage	NULL
of	NULL
wild	NULL
type	NULL
activity	NULL
,	NULL
averaged	NULL
over	NULL
at	NULL
least	NULL
three	NULL
independent	NULL
transfections	NULL
with	NULL
at	NULL
least	NULL
three	NULL
different	NULL
DNA	NULL
preparations	NULL
for	NULL
each	NULL
construct	NULL
.	NULL

The	NULL
mutants	NULL
are	NULL
described	NULL
under	NULL
``	NULL
Materials	NULL
and	NULL
Methods	NULL
``	NULL
and	NULL
depicted	NULL
in	NULL
Fig	NULL
.	NULL

4	NULL
.	NULL

The	NULL
wild	NULL
type	NULL
murine	NULL
PU.1	NULL
promoter	NULL
is	NULL
five	NULL
times	NULL
more	NULL
active	NULL
in	NULL
BJA-B	NULL
cells	NULL
than	NULL
in	NULL
myeloid	NULL
U937	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
,	NULL
hatched	NULL
bar	NULL
)	NULL
.	NULL

Construct	NULL
U937	NULL
BJA-B	NULL
%	NULL
mPU-334	NULL
wild	NULL
type	NULL
100	NULL
100	NULL
mPU-334	NULL
Oct	NULL
mut	NULL
52	NULL
29.9	NULL
mPU-334	NULL
Sp1	NULL
mut	NULL
62	NULL
64.3	NULL
mPU-334	NULL
Oct	NULL
&	NULL
Sp1	NULL
48	NULL
26.7	NULL
mPU-334	NULL
PU1	NULL
mut	NULL
2.4	NULL
35.7	NULL
pXP2	NULL
1.6	NULL
2.8	NULL
DISCUSSION	NULL
Previous	NULL
studies	NULL
of	NULL
PU.1	NULL
expression	NULL
(	NULL
8	NULL
,	NULL
50	NULL
,	NULL
62-65	NULL
)	NULL
and	NULL
the	NULL
PU.1	NULL
promoter	NULL
(	NULL
9	NULL
)	NULL
indicated	NULL
that	NULL
the	NULL
PU	NULL
.	NULL

1	NULL
promoter	NULL
shows	NULL
cell	NULL
type	NULL
specificity	NULL
in	NULL
myeloid	NULL
cells	NULL
which	NULL
express	NULL
PU.1	NULL
,	NULL
but	NULL
not	NULL
in	NULL
T	NULL
cells	NULL
nor	NULL
in	NULL
nonhematopoietic	NULL
cells	NULL
,	NULL
and	NULL
that	NULL
in	NULL
myeloid	NULL
cells	NULL
PU.1	NULL
autoregulates	NULL
its	NULL
own	NULL
promoter	NULL
by	NULL
a	NULL
positive	NULL
feedback	NULL
loop	NULL
through	NULL
a	NULL
PU.1	NULL
DNA	NULL
binding	NULL
site	NULL
at	NULL
bp	NULL
+20	NULL
of	NULL
the	NULL
5'-untranslated	NULL
region	NULL
.	NULL

In	NULL
this	NULL
report	NULL
,	NULL
we	NULL
studied	NULL
PU.1	NULL
promoter	NULL
function	NULL
in	NULL
B	NULL
cells	NULL
,	NULL
and	NULL
specifically	NULL
how	NULL
its	NULL
regulation	NULL
might	NULL
differ	NULL
from	NULL
that	NULL
observed	NULL
in	NULL
myeloid	NULL
cells	NULL
.	NULL

DNA	NULL
binding	NULL
and	NULL
transfection	NULL
analysis	NULL
of	NULL
deletions	NULL
,	NULL
mutations	NULL
,	NULL
in	NULL
vivo	NULL
footprint-ing	NULL
,	NULL
and	NULL
cotransactivation	NULL
analysis	NULL
all	NULL
indicate	NULL
that	NULL
the	NULL
octamer	NULL
binding	NULL
site	NULL
at	NULL
bp	NULL
-55	NULL
plays	NULL
an	NULL
important	NULL
role	NULL
in	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
PU.1	NULL
gene	NULL
in	NULL
B	NULL
cells	NULL
.	NULL

We	NULL
considered	NULL
how	NULL
B	NULL
cell-type	NULL
specificity	NULL
is	NULL
mediated	NULL
by	NULL
the	NULL
octamer	NULL
site	NULL
,	NULL
since	NULL
Oct-1	NULL
is	NULL
expressed	NULL
ubiquitously	NULL
(	NULL
22	NULL
)	NULL
.	NULL

One	NULL
potential	NULL
mechanism	NULL
which	NULL
could	NULL
explain	NULL
octamer	NULL
mediation	NULL
of	NULL
B	NULL
cell	NULL
type	NULL
specific	NULL
regulation	NULL
is	NULL
that	NULL
a	NULL
special	NULL
cofactor	NULL
expressed	NULL
only	NULL
in	NULL
B	NULL
cells	NULL
augments	NULL
the	NULL
function	NULL
of	NULL
Oct-1	NULL
or	NULL
Oct-2	NULL
.	NULL

Our	NULL
data	NULL
support	NULL
a	NULL
model	NULL
in	NULL
which	NULL
a	NULL
B	NULL
cell	NULL
specific	NULL
octamer	NULL
coactivator	NULL
augments	NULL
the	NULL
ability	NULL
of	NULL
octamer	NULL
proteins	NULL
to	NULL
stimulate	NULL
the	NULL
PU.1	NULL
promoter	NULL
,	NULL
and	NULL
this	NULL
occurs	NULL
specifically	NULL
in	NULL
B	NULL
cells	NULL
because	NULL
the	NULL
octamer	NULL
coactivator	NULL
Bob1/OBF-1/0CA-B	NULL
is	NULL
highly	NULL
expressed	NULL
in	NULL
B	NULL
cells	NULL
and	NULL
expressed	NULL
at	NULL
very	NULL
low	NULL
or	NULL
undetectable	NULL
levels	NULL
in	NULL
myeloid	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

6B	NULL
)	NULL
.	NULL

In	NULL
B	NULL
cells	NULL
,	NULL
the	NULL
octamer	NULL
coactivator	NULL
may	NULL
augment	NULL
the	NULL
physical	NULL
interaction	NULL
between	NULL
Oct-1	NULL
or	NULL
Oct-2	NULL
and	NULL
the	NULL
TATAA	NULL
binding	NULL
protein	NULL
,	NULL
TBP	NULL
(	NULL
66	NULL
)	NULL
.	NULL

In	NULL
myeloid	NULL
cells	NULL
,	NULL
which	NULL
express	NULL
Oct-1	NULL
but	NULL
very	NULL
little	NULL
or	NULL
no	NULL
Oct-2	NULL
(	NULL
Fig	NULL
.	NULL

6A	NULL
)	NULL
and	NULL
no	NULL
octamer	NULL
coactivator	NULL
,	NULL
the	NULL
TBP	NULL
binding	NULL
function	NULL
mediated	NULL
by	NULL
Oct-1/0ct-2	NULL
and	NULL
Bob1/OBF-1	NULL
in	NULL
B	NULL
cells	NULL
may	NULL
be	NULL
substituted	NULL
by	NULL
binding	NULL
of	NULL
PU.1	NULL
,	NULL
since	NULL
PU.1	NULL
can	NULL
also	NULL
bind	NULL
to	NULL
TBP	NULL
in	NULL
vitro	NULL
(	NULL
67	NULL
,	NULL
68	NULL
)	NULL
.	NULL

Although	NULL
many	NULL
cells	NULL
,	NULL
including	NULL
myeloid	NULL
cells	NULL
,	NULL
express	NULL
Oct-1	NULL
,	NULL
Oct-2	NULL
is	NULL
more	NULL
restricted	NULL
to	NULL
B	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

6A	NULL
)	NULL
.	NULL

We	NULL
also	NULL
showed	NULL
that	NULL
the	NULL
octamer	NULL
coactivator	NULL
is	NULL
expressed	NULL
in	NULL
B	NULL
and	NULL
not	NULL
myeloid	NULL
cell	NULL
lines	NULL
(	NULL
Fig	NULL
.	NULL

6B	NULL
)	NULL
.	NULL

In	NULL
the	NULL
case	NULL
of	NULL
the	NULL
PU	NULL
.	NULL

1	NULL
promoter	NULL
,	NULL
expression	NULL
of	NULL
Oct-2	NULL
alone	NULL
increases	NULL
activation	NULL
of	NULL
the	NULL
PU.1	NULL
promoter	NULL
in	NULL
HeLa	NULL
cells	NULL
and	NULL
U937	NULL
cells	NULL
to	NULL
a	NULL
degree	NULL
greater	NULL
than	NULL
that	NULL
of	NULL
Oct-1	NULL
,	NULL
and	NULL
this	NULL
increase	NULL
is	NULL
augmented	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
the	NULL
coactivator	NULL
Bob1	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
)	NULL
.	NULL

These	NULL
results	NULL
indicate	NULL
that	NULL
Oct-1	NULL
can	NULL
by	NULL
itself	NULL
activate	NULL
the	NULL
PU	NULL
.	NULL

1	NULL
promoter	NULL
,	NULL
but	NULL
that	NULL
this	NULL
activation	NULL
is	NULL
weaker	NULL
than	NULL
that	NULL
mediated	NULL
by	NULL
Oct-2	NULL
,	NULL
whose	NULL
effect	NULL
is	NULL
further	NULL
augmented	NULL
by	NULL
B	NULL
cell-specific	NULL
expression	NULL
of	NULL
the	NULL
octamer	NULL
coactivator	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
we	NULL
observed	NULL
no	NULL
decrease	NULL
of	NULL
luciferase	NULL
activity	NULL
when	NULL
the	NULL
PU	NULL
.	NULL

1	NULL
promoter	NULL
was	NULL
transfected	NULL
into	NULL
Oct-2	NULL
knockout	NULL
B	NULL
cell	NULL
lines	NULL
(	NULL
30	NULL
)	NULL
,	NULL
compared	NULL
to	NULL
that	NULL
observed	NULL
in	NULL
matched	NULL
heterozy-gote	NULL
(	NULL
Oct-2+/-	NULL
)	NULL
lines	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

These	NULL
findings	NULL
imply	NULL
610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
PU.1	NULL
Regulation	NULL
by	NULL
Octamer	NULL
Factors	NULL
and	NULL
Coactivators	NULL
In	NULL
B	NULL
lymphocytes	NULL
:	NULL
In	NULL
macrophages	NULL
:	NULL
®	NULL
&	NULL
Note	NULL
:	NULL
GTF	NULL
-general	NULL
transcriptional	NULL
factors	NULL
Fic	NULL
.	NULL

8	NULL
.	NULL

Model	NULL
for	NULL
the	NULL
differential	NULL
activation	NULL
of	NULL
the	NULL
PU.1	NULL
promoter	NULL
in	NULL
B	NULL
lymphocytes	NULL
and	NULL
myeloid	NULL
cells	NULL
.	NULL

We	NULL
propose	NULL
that	NULL
,	NULL
in	NULL
B	NULL
cells	NULL
,	NULL
the	NULL
major	NULL
activation	NULL
of	NULL
the	NULL
general	NULL
transcription	NULL
factors	NULL
(	NULL
GTF	NULL
)	NULL
,	NULL
including	NULL
RNA	NULL
polymerase	NULL
II	NULL
and	NULL
associated	NULL
general	NULL
factors	NULL
,	NULL
is	NULL
via	NULL
the	NULL
octamer	NULL
site	NULL
binding	NULL
Oct-1	NULL
or	NULL
Oct-2	NULL
,	NULL
with	NULL
postulated	NULL
interactions	NULL
of	NULL
the	NULL
octamer	NULL
coactivator	NULL
Bob1	NULL
(	NULL
identical	NULL
to	NULL
OBF-1	NULL
and	NULL
OCA-B	NULL
)	NULL
between	NULL
octamer	NULL
binding	NULL
proteins	NULL
and	NULL
the	NULL
GTF	NULL
.	NULL

PU.1	NULL
and	NULL
Sp1	NULL
may	NULL
play	NULL
lesser	NULL
roles	NULL
in	NULL
activating	NULL
the	NULL
promoter	NULL
.	NULL

In	NULL
myeloid	NULL
cells	NULL
,	NULL
due	NULL
to	NULL
lack	NULL
of	NULL
Oct-2	NULL
and	NULL
Bob1	NULL
,	NULL
the	NULL
PU.1	NULL
site	NULL
may	NULL
play	NULL
a	NULL
more	NULL
significant	NULL
relative	NULL
role	NULL
.	NULL

Our	NULL
data	NULL
support	NULL
a	NULL
model	NULL
whereby	NULL
the	NULL
effects	NULL
of	NULL
the	NULL
octamer	NULL
and	NULL
PU.1	NULL
sites	NULL
in	NULL
the	NULL
two	NULL
different	NULL
cell	NULL
types	NULL
are	NULL
additive	NULL
,	NULL
so	NULL
that	NULL
the	NULL
increased	NULL
activity	NULL
of	NULL
the	NULL
promoter	NULL
in	NULL
B	NULL
cells	NULL
can	NULL
be	NULL
attributed	NULL
to	NULL
presence	NULL
of	NULL
Oct-2	NULL
and	NULL
Bob1	NULL
(	NULL
see	NULL
Figs	NULL
.	NULL

1B	NULL
and	NULL
7B	NULL
)	NULL
.	NULL

that	NULL
B	NULL
cell-specific	NULL
expression	NULL
of	NULL
Oct-2	NULL
is	NULL
by	NULL
itself	NULL
not	NULL
essential	NULL
for	NULL
PU.1	NULL
promoter	NULL
function	NULL
and	NULL
,	NULL
depending	NULL
on	NULL
the	NULL
cell	NULL
type	NULL
;	NULL
,	NULL
Oct-1	NULL
and/or	NULL
Oct-2	NULL
can	NULL
support	NULL
PU.1	NULL
expression	NULL
.	NULL

The	NULL
differences	NULL
in	NULL
the	NULL
abilities	NULL
of	NULL
Oct-1	NULL
and/or	NULL
Oct-2	NULL
to	NULL
activate	NULL
the	NULL
PU	NULL
.	NULL

1	NULL
promoter	NULL
reflect	NULL
differences	NULL
in	NULL
expression	NULL
of	NULL
octamer	NULL
proteins	NULL
,	NULL
octamer	NULL
coactivators	NULL
,	NULL
and	NULL
other	NULL
transcription	NULL
factors	NULL
(	NULL
Spl	NULL
,	NULL
PU.1	NULL
)	NULL
which	NULL
interact	NULL
on	NULL
the	NULL
PU.1	NULL
promoter	NULL
regions	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
differences	NULL
in	NULL
modifications	NULL
of	NULL
these	NULL
proteins	NULL
,	NULL
such	NULL
as	NULL
phosphorylation	NULL
of	NULL
Oct-1	NULL
and	NULL
Oct-2	NULL
during	NULL
the	NULL
cell	NULL
cycle	NULL
(	NULL
44	NULL
,	NULL
69	NULL
)	NULL
,	NULL
may	NULL
also	NULL
play	NULL
an	NULL
important	NULL
role	NULL
.	NULL

Our	NULL
transactivation	NULL
studies	NULL
in	NULL
Schneider	NULL
cells	NULL
implied	NULL
that	NULL
the	NULL
Sp1	NULL
site	NULL
at	NULL
bp	NULL
-40	NULL
of	NULL
the	NULL
PU	NULL
.	NULL

1	NULL
promoter	NULL
is	NULL
involved	NULL
in	NULL
PU.1	NULL
regulation	NULL
.	NULL

In	NULL
vitro	NULL
gel	NULL
shift	NULL
assays	NULL
also	NULL
demonstrated	NULL
that	NULL
Sp1	NULL
from	NULL
nuclear	NULL
extracts	NULL
from	NULL
BJA-B	NULL
and	NULL
U937	NULL
cells	NULL
can	NULL
specifically	NULL
form	NULL
a	NULL
complex	NULL
with	NULL
an	NULL
Sp1	NULL
site	NULL
oligonucleotide	NULL
from	NULL
the	NULL
PU.1	NULL
promoter	NULL
.	NULL

Since	NULL
the	NULL
Sp1	NULL
and	NULL
octamer	NULL
sites	NULL
are	NULL
very	NULL
close	NULL
to	NULL
one	NULL
another	NULL
in	NULL
the	NULL
PU.1	NULL
promoter	NULL
,	NULL
the	NULL
octamer	NULL
proteins	NULL
binding	NULL
at	NULL
bp	NULL
-55	NULL
may	NULL
interact	NULL
with	NULL
Sp1	NULL
,	NULL
which	NULL
binds	NULL
to	NULL
an	NULL
adjacent	NULL
site	NULL
at	NULL
bp	NULL
-40	NULL
.	NULL

This	NULL
idea	NULL
is	NULL
supported	NULL
by	NULL
our	NULL
data	NULL
showing	NULL
that	NULL
if	NULL
the	NULL
octamer	NULL
site	NULL
has	NULL
been	NULL
deleted	NULL
,	NULL
further	NULL
deletion	NULL
of	NULL
the	NULL
Sp1	NULL
site	NULL
does	NULL
not	NULL
lead	NULL
to	NULL
further	NULL
loss	NULL
of	NULL
activity	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
,	NULL
compare	NULL
-48	NULL
to	NULL
-39	NULL
deletion	NULL
)	NULL
.	NULL

However	NULL
,	NULL
mutation	NULL
of	NULL
the	NULL
Sp1	NULL
site	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
an	NULL
intact	NULL
octamer	NULL
site	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
Sp1	NULL
mut	NULL
)	NULL
leads	NULL
to	NULL
a	NULL
significant	NULL
loss	NULL
in	NULL
promoter	NULL
activity	NULL
.	NULL

Cooperative	NULL
interactions	NULL
between	NULL
Oct-1	NULL
and	NULL
Spl	NULL
have	NULL
been	NULL
described	NULL
in	NULL
other	NULL
RNA	NULL
polymerase	NULL
II	NULL
promoters	NULL
(	NULL
70	NULL
)	NULL
.	NULL

Cooperation	NULL
between	NULL
adjacent	NULL
octamer	NULL
and	NULL
Spl	NULL
sites	NULL
could	NULL
perhaps	NULL
explain	NULL
the	NULL
functional	NULL
importance	NULL
of	NULL
the	NULL
octamer	NULL
site	NULL
in	NULL
myeloid	NULL
cells	NULL
(	NULL
9	NULL
)	NULL
,	NULL
in	NULL
which	NULL
the	NULL
octamer	NULL
coactivator	NULL
is	NULL
not	NULL
expressed	NULL
.	NULL

15751	NULL
In	NULL
the	NULL
case	NULL
of	NULL
the	NULL
PU.1	NULL
promoter	NULL
,	NULL
we	NULL
were	NULL
not	NULL
able	NULL
to	NULL
observe	NULL
a	NULL
tertiary	NULL
complex	NULL
with	NULL
Spl	NULL
and	NULL
Oct-1	NULL
,	NULL
even	NULL
when	NULL
large	NULL
amounts	NULL
of	NULL
recombinant	NULL
proteins	NULL
were	NULL
added	NULL
to	NULL
the	NULL
binding	NULL
reaction	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

PU.1	NULL
is	NULL
also	NULL
likely	NULL
to	NULL
be	NULL
involved	NULL
in	NULL
activation	NULL
of	NULL
the	NULL
PU.1	NULL
promoter	NULL
in	NULL
B	NULL
cells	NULL
.	NULL

Mutation	NULL
of	NULL
the	NULL
PU.1	NULL
site	NULL
in	NULL
the	NULL
PU.1	NULL
promoter	NULL
reduced	NULL
promoter	NULL
activity	NULL
to	NULL
36	NULL
%	NULL
of	NULL
wild	NULL
type	NULL
,	NULL
close	NULL
to	NULL
the	NULL
magnitude	NULL
of	NULL
that	NULL
observed	NULL
with	NULL
mutations	NULL
of	NULL
the	NULL
octamer	NULL
site	NULL
,	NULL
but	NULL
significantly	NULL
less	NULL
than	NULL
that	NULL
observed	NULL
in	NULL
myeloid	NULL
cells	NULL
.	NULL

We	NULL
sought	NULL
but	NULL
did	NULL
not	NULL
find	NULL
evidence	NULL
of	NULL
any	NULL
physical	NULL
interactions	NULL
between	NULL
PU.1	NULL
and	NULL
either	NULL
Oct-1	NULL
or	NULL
Oct-2	NULL
in	NULL
vitro	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Interestingly	NULL
,	NULL
it	NULL
has	NULL
been	NULL
previously	NULL
shown	NULL
that	NULL
Oct-1	NULL
,	NULL
Oct-2	NULL
,	NULL
and	NULL
Ets-1	NULL
itself	NULL
can	NULL
positively	NULL
regulate	NULL
the	NULL
Ets-1	NULL
promoter	NULL
(	NULL
71	NULL
)	NULL
in	NULL
a	NULL
manner	NULL
that	NULL
is	NULL
similar	NULL
to	NULL
that	NULL
which	NULL
we	NULL
have	NULL
now	NULL
described	NULL
for	NULL
the	NULL
regulation	NULL
of	NULL
the	NULL
related	NULL
family	NULL
member	NULL
PU.1	NULL
.	NULL

In	NULL
summary	NULL
,	NULL
our	NULL
studies	NULL
have	NULL
suggested	NULL
an	NULL
explanation	NULL
of	NULL
some	NULL
of	NULL
the	NULL
mechanisms	NULL
underlying	NULL
the	NULL
differences	NULL
in	NULL
activity	NULL
of	NULL
the	NULL
PU	NULL
.	NULL

1	NULL
promoter	NULL
in	NULL
myeloid	NULL
versus	NULL
B	NULL
cells	NULL
(	NULL
Table	NULL
I	NULL
and	NULL
Fig	NULL
.	NULL

8	NULL
)	NULL
.	NULL

In	NULL
B	NULL
cells	NULL
,	NULL
the	NULL
presence	NULL
of	NULL
both	NULL
Oct-1	NULL
and	NULL
Oct-2	NULL
and	NULL
the	NULL
octamer	NULL
coactivator	NULL
Bob1/OBF-1/0CA-B	NULL
may	NULL
mediate	NULL
activation	NULL
of	NULL
the	NULL
promoter	NULL
,	NULL
presumably	NULL
by	NULL
interactions	NULL
with	NULL
general	NULL
transcription	NULL
factors	NULL
.	NULL

Conversely	NULL
,	NULL
in	NULL
myeloid	NULL
cells	NULL
,	NULL
which	NULL
express	NULL
Oct-1	NULL
but	NULL
either	NULL
trace	NULL
amounts	NULL
or	NULL
no	NULL
Oct-2	NULL
and	NULL
no	NULL
Bobl	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
,	NULL
the	NULL
octamer	NULL
site	NULL
is	NULL
not	NULL
as	NULL
significant	NULL
for	NULL
promoter	NULL
activity	NULL
as	NULL
is	NULL
the	NULL
PU.1	NULL
site	NULL
.	NULL

Overall	NULL
,	NULL
the	NULL
PU	NULL
.	NULL

1	NULL
promoter	NULL
appears	NULL
to	NULL
be	NULL
approximately	NULL
5	NULL
fold	NULL
stronger	NULL
in	NULL
the	NULL
B	NULL
cell	NULL
lines	NULL
tested	NULL
than	NULL
in	NULL
myeloid	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
.	NULL

Our	NULL
transactivation	NULL
studies	NULL
suggest	NULL
that	NULL
this	NULL
5	NULL
fold	NULL
difference	NULL
might	NULL
be	NULL
largely	NULL
accounted	NULL
for	NULL
by	NULL
the	NULL
action	NULL
of	NULL
Oct-2	NULL
and/or	NULL
Bobl/OBF-1	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
)	NULL
.	NULL

The	NULL
actual	NULL
role	NULL
of	NULL
the	NULL
OBF-1/Bob1	NULL
coactivator	NULL
in	NULL
PU.1	NULL
expression	NULL
in	NULL
B	NULL
cells	NULL
may	NULL
eventually	NULL
be	NULL
determined	NULL
by	NULL
investigating	NULL
PU.1	NULL
expression	NULL
in	NULL
OBF-1/Bob1	NULL
``	NULL
knockout	NULL
``	NULL
mice	NULL
.	NULL

Finally	NULL
,	NULL
an	NULL
important	NULL
question	NULL
not	NULL
yet	NULL
addressed	NULL
by	NULL
these	NULL
and	NULL
our	NULL
previous	NULL
studies	NULL
(	NULL
9	NULL
)	NULL
is	NULL
how	NULL
PU.1	NULL
is	NULL
activated	NULL
in	NULL
early	NULL
multiprogenitor	NULL
cells	NULL
(	NULL
7	NULL
,	NULL
50	NULL
)	NULL
,	NULL
and	NULL
this	NULL
shall	NULL
be	NULL
the	NULL
focus	NULL
of	NULL
future	NULL
studies	NULL
of	NULL
PU	NULL
.	NULL

1	NULL
gene	NULL
regulation	NULL
.	NULL

Acknowledgments-We	NULL
thank	NULL
Richard	NULL
Maki	NULL
and	NULL
Deborah	NULL
Galson	NULL
for	NULL
providing	NULL
murine	NULL
PU	NULL
.	NULL

1	NULL
cDNAs	NULL
;	NULL
Laurel	NULL
Eckhardt	NULL
for	NULL
the	NULL
consensus	NULL
octamer	NULL
probe	NULL
;	NULL
Richard	NULL
Maki	NULL
for	NULL
PU.1	NULL
antisera	NULL
and	NULL
Stephen	NULL
Jackson	NULL
for	NULL
Spl	NULL
antisera	NULL
;	NULL
Masafumi	NULL
Tanaka	NULL
for	NULL
octamer	NULL
expression	NULL
vectors	NULL
;	NULL
Matthias	NULL
Gstaiger	NULL
and	NULL
Walter	NULL
Schaffner	NULL
for	NULL
Bobl	NULL
plasmids	NULL
;	NULL
Patrick	NULL
Matthias	NULL
for	NULL
OBF-1	NULL
plasmids	NULL
;	NULL
Bob	NULL
Tjian	NULL
for	NULL
the	NULL
Spl	NULL
expression	NULL
vector	NULL
;	NULL
Lynn	NULL
Corcoran	NULL
and	NULL
David	NULL
Baltimore	NULL
for	NULL
Oct-2	NULL
knockout	NULL
cell	NULL
B	NULL
lines	NULL
;	NULL
H.W	NULL
.	NULL

Lims	NULL
Ziegler-Heitbrock	NULL
for	NULL
Mono	NULL
Mac	NULL
6	NULL
cells	NULL
;	NULL
Ronald	NULL
Palacios	NULL
for	NULL
LyD9	NULL
cells	NULL
;	NULL
Suzan	NULL
Dziennis	NULL
for	NULL
assistance	NULL
with	NULL
isolation	NULL
of	NULL
murine	NULL
tissues	NULL
and	NULL
Donald	NULL
Yergeau	NULL
for	NULL
help	NULL
with	NULL
preparation	NULL
of	NULL
RNA	NULL
samples	NULL
;	NULL
and	NULL
Martha	NULL
Petrovick	NULL
,	NULL
Timothy	NULL
Burn	NULL
,	NULL
Anne	NULL
Satterthwaite	NULL
,	NULL
Steven	NULL
Ackerman	NULL
,	NULL
Kristina	NULL
Rhoades	NULL
,	NULL
and	NULL
Laura	NULL
Smith	NULL
for	NULL
many	NULL
helpful	NULL
discussions	NULL
,	NULL
and	NULL
Mary	NULL
Singleton	NULL
for	NULL
assistance	NULL
with	NULL
preparation	NULL
of	NULL
the	NULL
manuscript	NULL
.	NULL

We	NULL
also	NULL
thank	NULL
Thomas	NULL
Wirth	NULL
for	NULL
sharing	NULL
similar	NULL
unpublished	NULL
data	NULL
on	NULL
octamer	NULL
binding	NULL
to	NULL
the	NULL
PU.1	NULL
promoter	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Moreau-Gachelin	NULL
,	NULL
F.	NULL
,	NULL
Tavitian	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Tambourin	NULL
,	NULL
P.	NULL
(	NULL
1988	NULL
)	NULL
Nature	NULL
381	NULL
,	NULL
277-280	NULL
2	NULL
.	NULL

Paul	NULL
,	NULL
R.	NULL
,	NULL
Schuetze	NULL
,	NULL
S.	NULL
,	NULL
Kozak	NULL
,	NULL
S.	NULL
L.	NULL
,	NULL
Kozak	NULL
,	NULL
C.	NULL
A.	NULL
,	NULL
and	NULL
Kabat	NULL
,	NULL
D.	NULL
(	NULL
1991	NULL
)	NULL
J.	NULL
Virol	NULL
.	NULL

65	NULL
,	NULL
464-467	NULL
3	NULL
.	NULL

Klemsz	NULL
,	NULL
M.	NULL
J.	NULL
,	NULL
McKercher	NULL
,	NULL
S.	NULL
R.	NULL
,	NULL
Celada	NULL
,	NULL
A.	NULL
,	NULL
Van	NULL
Beveren	NULL
,	NULL
C.	NULL
,	NULL
and	NULL
Maki	NULL
,	NULL
R.	NULL
A	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Cell	NULL
61	NULL
,	NULL
113-124	NULL
4	NULL
.	NULL

Moreau-Gachelin	NULL
,	NULL
F.	NULL
(	NULL
1994	NULL
)	NULL
Biochim	NULL
.	NULL

Biophys	NULL
.	NULL

Acta	NULL
1198	NULL
,	NULL
149-163	NULL
5	NULL
.	NULL

Schuetze	NULL
,	NULL
S.	NULL
,	NULL
Stenberg	NULL
,	NULL
P.	NULL
E.	NULL
,	NULL
and	NULL
Kabat	NULL
,	NULL
D.	NULL
(	NULL
1998	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

18	NULL
,	NULL
5670-5678	NULL
6	NULL
.	NULL

Delgado	NULL
,	NULL
M.	NULL
D.	NULL
,	NULL
Hallier	NULL
,	NULL
M.	NULL
,	NULL
Meneceur	NULL
,	NULL
P.	NULL
,	NULL
Tavitian	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Moreau-Gachelin	NULL
,	NULL
F.	NULL
(	NULL
1994	NULL
)	NULL
Oncogene	NULL
9	NULL
,	NULL
1723-1727	NULL
7	NULL
.	NULL

Voso	NULL
,	NULL
M.	NULL
T.	NULL
,	NULL
Burn	NULL
,	NULL
T.	NULL
C.	NULL
,	NULL
Wulf	NULL
,	NULL
G.	NULL
,	NULL
Lim	NULL
,	NULL
B.	NULL
,	NULL
Leone	NULL
,	NULL
G.	NULL
,	NULL
and	NULL
Tenen	NULL
,	NULL
D.	NULL
G.	NULL
(	NULL
1994	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

91	NULL
,	NULL
17982-17936	NULL
8	NULL
.	NULL

Scott	NULL
,	NULL
E.	NULL
W.	NULL
,	NULL
Simon	NULL
,	NULL
M.	NULL
C.	NULL
,	NULL
Anastai	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Singh	NULL
,	NULL
H.	NULL
(	NULL
1994	NULL
)	NULL
Science	NULL
265	NULL
,	NULL
1573-1577	NULL
9	NULL
.	NULL

Chen	NULL
,	NULL
H.	NULL
M.	NULL
,	NULL
Ray-Gallet	NULL
,	NULL
D.	NULL
,	NULL
Zhang	NULL
,	NULL
P.	NULL
,	NULL
Hetherington	NULL
,	NULL
C.	NULL
J.	NULL
,	NULL
Gonzalez	NULL
,	NULL
D.	NULL
A.	NULL
,	NULL
Zhang	NULL
,	NULL
D.-E.	NULL
,	NULL
Moreau-Gachelin	NULL
,	NULL
F.	NULL
,	NULL
and	NULL
Tenen	NULL
,	NULL
D.	NULL
G.	NULL
(	NULL
1995	NULL
)	NULL
Oncogene	NULL
11	NULL
,	NULL
1549-1560	NULL
10	NULL
.	NULL

Zhang	NULL
,	NULL
D.-E.	NULL
,	NULL
Hohaus	NULL
,	NULL
S.	NULL
,	NULL
Voso	NULL
,	NULL
M.	NULL
T.	NULL
,	NULL
Chen	NULL
,	NULL
H.	NULL
M.	NULL
,	NULL
Smith	NULL
,	NULL
L.	NULL
T.	NULL
,	NULL
Hetherington	NULL
,	NULL
C.	NULL
J.	NULL
,	NULL
and	NULL
Tenen	NULL
,	NULL
D.	NULL
G.	NULL
(	NULL
1996	NULL
)	NULL
Curr	NULL
.	NULL

Top	NULL
.	NULL

Microbiol	NULL
.	NULL

Immunol	NULL
.	NULL

211	NULL
,	NULL
137-147	NULL
610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
15752	NULL
11	NULL
12	NULL
.	NULL

13	NULL
.	NULL

14	NULL
.	NULL

15	NULL
.	NULL

16	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

24	NULL
.	NULL

25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

40	NULL
.	NULL

41.	NULL
.	NULL

Omori	NULL
,	NULL
S.	NULL
A.	NULL
,	NULL
and	NULL
Wall	NULL
,	NULL
R.	NULL
(	NULL
1993	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.A.	NULL
90	NULL
,	NULL
11723-11727	NULL
Pongubala	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
Nagulapalli	NULL
,	NULL
S.	NULL
,	NULL
Klemsz	NULL
,	NULL
M.	NULL
J.	NULL
,	NULL
McKercher	NULL
,	NULL
S.	NULL
R.	NULL
,	NULL
Maki	NULL
,	NULL
R.	NULL
A.	NULL
,	NULL
and	NULL
Atchison	NULL
,	NULL
M.	NULL
L.	NULL
(	NULL
1992	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

12	NULL
,	NULL
368-378	NULL
Nelsen	NULL
,	NULL
B.	NULL
,	NULL
Tian	NULL
,	NULL
G.	NULL
,	NULL
Erman	NULL
,	NULL
B.	NULL
,	NULL
Gregoire	NULL
,	NULL
J.	NULL
,	NULL
Maki	NULL
,	NULL
R.	NULL
,	NULL
Graves	NULL
,	NULL
B.	NULL
,	NULL
and	NULL
Sen	NULL
,	NULL
R.	NULL
(	NULL
1993	NULL
)	NULL
Science	NULL
261	NULL
,	NULL
82-86	NULL
Eisenbeis	NULL
,	NULL
C.	NULL
F.	NULL
,	NULL
Singh	NULL
,	NULL
H.	NULL
,	NULL
and	NULL
Storb	NULL
,	NULL
U	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

18	NULL
,	NULL
6452-6461	NULL
Shin	NULL
,	NULL
M.	NULL
K.	NULL
,	NULL
and	NULL
Koshland	NULL
,	NULL
M.	NULL
E.	NULL
(	NULL
1993	NULL
)	NULL
Genes	NULL
Dev	NULL
.	NULL

7	NULL
,	NULL
2006-2015	NULL
Laux	NULL
,	NULL
G.	NULL
,	NULL
Adam	NULL
,	NULL
B.	NULL
,	NULL
Strobl	NULL
,	NULL
L.	NULL
J.	NULL
,	NULL
and	NULL
Moreau-Gachelin	NULL
,	NULL
F.	NULL
(	NULL
1994	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

18	NULL
,	NULL
5624-5632	NULL
Johannsen	NULL
,	NULL
E.	NULL
,	NULL
Koh	NULL
,	NULL
E.	NULL
,	NULL
Mosialos	NULL
,	NULL
G.	NULL
,	NULL
Tong	NULL
,	NULL
X.	NULL
,	NULL
Kieff	NULL
,	NULL
E.	NULL
,	NULL
and	NULL
Grossman	NULL
,	NULL
S.	NULL
R.	NULL
(	NULL
1995	NULL
)	NULL
J.	NULL
Virol	NULL
.	NULL

69	NULL
,	NULL
253-262	NULL
Schwarzenbach	NULL
,	NULL
H.	NULL
,	NULL
Newell	NULL
,	NULL
J.	NULL
W.	NULL
,	NULL
and	NULL
Matthias	NULL
,	NULL
P.	NULL
(	NULL
1995	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270	NULL
,	NULL
898-907	NULL
Staudt	NULL
,	NULL
L.	NULL
M.	NULL
,	NULL
and	NULL
Lenardo	NULL
,	NULL
M.	NULL
J	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

9	NULL
,	NULL
373-898	NULL
Eckhardt	NULL
,	NULL
L.	NULL
A	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
FASEB	NULL
J	NULL
.	NULL

6	NULL
,	NULL
2553-2560	NULL
Herr	NULL
,	NULL
W.	NULL
,	NULL
Sturm	NULL
,	NULL
R.	NULL
A.	NULL
,	NULL
Clere	NULL
,	NULL
R.	NULL
G.	NULL
,	NULL
Corcoran	NULL
,	NULL
L.	NULL
M.	NULL
,	NULL
Baltimore	NULL
,	NULL
D.	NULL
,	NULL
Sharp	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
Ingraham	NULL
,	NULL
H.	NULL
A.	NULL
,	NULL
Rosenfeld	NULL
,	NULL
M.	NULL
G.	NULL
,	NULL
Finney	NULL
,	NULL
M.	NULL
,	NULL
Ruvkun	NULL
,	NULL
G.	NULL
,	NULL
et	NULL
al	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
Genes	NULL
Dev	NULL
.	NULL

2	NULL
,	NULL
1513-1516	NULL
Sturm	NULL
,	NULL
R.	NULL
A.	NULL
,	NULL
Das	NULL
,	NULL
G.	NULL
,	NULL
and	NULL
Herr	NULL
,	NULL
W.	NULL
(	NULL
1988	NULL
)	NULL
Genes	NULL
Dev	NULL
.	NULL

2	NULL
,	NULL
1582-1599	NULL
Muller	NULL
,	NULL
M.	NULL
M.	NULL
,	NULL
Ruppert	NULL
,	NULL
S.	NULL
,	NULL
Schaffner	NULL
,	NULL
W.	NULL
,	NULL
and	NULL
Matthias	NULL
,	NULL
P.	NULL
(	NULL
1988	NULL
)	NULL
Nature	NULL
836	NULL
,	NULL
544-551	NULL
Staudt	NULL
,	NULL
L.	NULL
M.	NULL
,	NULL
Clerc	NULL
,	NULL
R.	NULL
G.	NULL
,	NULL
Singh	NULL
,	NULL
H.	NULL
,	NULL
LeBowitz	NULL
,	NULL
J.	NULL
H.	NULL
,	NULL
Sharp	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
and	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1988	NULL
)	NULL
Science	NULL
241	NULL
,	NULL
577-580	NULL
Scheidereit	NULL
,	NULL
C.	NULL
,	NULL
Cromlish	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
Gerster	NULL
,	NULL
T.	NULL
,	NULL
Kawakami	NULL
,	NULL
K.	NULL
,	NULL
Balmaceda	NULL
,	NULL
C.	NULL
G.	NULL
,	NULL
Currie	NULL
,	NULL
R.	NULL
A.	NULL
,	NULL
and	NULL
Roeder	NULL
,	NULL
R.	NULL
G.	NULL
(	NULL
1988	NULL
)	NULL
Nature	NULL
886	NULL
,	NULL
551-557	NULL
Cockerill	NULL
,	NULL
P.	NULL
N.	NULL
,	NULL
and	NULL
Klinken	NULL
,	NULL
S.	NULL
P.	NULL
(	NULL
1990	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

10	NULL
,	NULL
1293-1296	NULL
Scholer	NULL
,	NULL
H.	NULL
R.	NULL
,	NULL
Hatzopoulos	NULL
,	NULL
A.	NULL
K.	NULL
,	NULL
Balling	NULL
,	NULL
R.	NULL
,	NULL
Suzuki	NULL
,	NULL
N.	NULL
,	NULL
and	NULL
Gruss	NULL
,	NULL
P.	NULL
(	NULL
1989	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

8	NULL
,	NULL
2543-2550	NULL
Radomska	NULL
,	NULL
H.	NULL
S.	NULL
,	NULL
Shen	NULL
,	NULL
C.	NULL
P.	NULL
,	NULL
Kadesch	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Eckhardt	NULL
,	NULL
L.	NULL
A	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Immunity	NULL
1	NULL
,	NULL
628-634	NULL
Junker	NULL
,	NULL
S.	NULL
,	NULL
Pedersen	NULL
,	NULL
S.	NULL
,	NULL
Schreiber	NULL
,	NULL
E.	NULL
,	NULL
and	NULL
Matthias	NULL
,	NULL
P.	NULL
(	NULL
1990	NULL
)	NULL
Cell	NULL
61	NULL
,	NULL
467-474	NULL
Corcoran	NULL
,	NULL
L.	NULL
M.	NULL
,	NULL
Karvelas	NULL
,	NULL
M.	NULL
,	NULL
Nossal	NULL
,	NULL
G.	NULL
J.	NULL
V.	NULL
,	NULL
Ye	NULL
,	NULL
Z.	NULL
S.	NULL
,	NULL
Jacks	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1993	NULL
)	NULL
Genes	NULL
Dev	NULL
.	NULL

7	NULL
,	NULL
570-582	NULL
Luo	NULL
,	NULL
Y.	NULL
,	NULL
Fujii	NULL
,	NULL
H.	NULL
,	NULL
Gerster	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Roeder	NULL
,	NULL
R.	NULL
G.	NULL
(	NULL
1992	NULL
)	NULL
Cell	NULL
71	NULL
,	NULL
231-241	NULL
Pfisterer	NULL
,	NULL
P.	NULL
,	NULL
Annweiler	NULL
,	NULL
A.	NULL
,	NULL
Ullmer	NULL
,	NULL
C.	NULL
,	NULL
Corcoran	NULL
,	NULL
L.	NULL
M.	NULL
,	NULL
and	NULL
Wirth	NULL
,	NULL
T.	NULL
(	NULL
1994	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

18	NULL
,	NULL
1654-1663	NULL
Gstaiger	NULL
,	NULL
M.	NULL
,	NULL
Knoepfel	NULL
,	NULL
L.	NULL
,	NULL
Georgiev	NULL
,	NULL
O.	NULL
,	NULL
Schaffner	NULL
,	NULL
W.	NULL
,	NULL
and	NULL
Hovens	NULL
,	NULL
C.	NULL
M.	NULL
(	NULL
1995	NULL
)	NULL
Nature	NULL
878	NULL
,	NULL
360-362	NULL
Strubin	NULL
,	NULL
M.	NULL
,	NULL
Newell	NULL
,	NULL
J.	NULL
W.	NULL
,	NULL
and	NULL
Matthias	NULL
,	NULL
P.	NULL
(	NULL
1995	NULL
)	NULL
Cell	NULL
80	NULL
,	NULL
497-506	NULL
Luo	NULL
,	NULL
Y.	NULL
and	NULL
Roeder	NULL
,	NULL
R.	NULL
G.	NULL
(	NULL
1995	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

15	NULL
,	NULL
4115-4124	NULL
Huang	NULL
,	NULL
C.	NULL
C.	NULL
,	NULL
Hou	NULL
,	NULL
Y.	NULL
,	NULL
Woods	NULL
,	NULL
L.	NULL
K.	NULL
,	NULL
Moore	NULL
,	NULL
G.	NULL
E.	NULL
,	NULL
and	NULL
Minowada	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1974	NULL
)	NULL
J.	NULL
Natl	NULL
.	NULL

Cancer	NULL
Inst	NULL
.	NULL

58	NULL
,	NULL
655-660	NULL
Klein	NULL
,	NULL
G.	NULL
,	NULL
Lindahl	NULL
,	NULL
T.	NULL
,	NULL
Jondal	NULL
,	NULL
M.	NULL
,	NULL
Leibold	NULL
,	NULL
W.	NULL
,	NULL
Menezes	NULL
,	NULL
J.	NULL
,	NULL
Nilsson	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
Sundstrom	NULL
,	NULL
C.	NULL
(	NULL
1974	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

71	NULL
,	NULL
8283-3286	NULL
Kim	NULL
,	NULL
K.	NULL
J.	NULL
,	NULL
Kanellopoulos-Langevin	NULL
,	NULL
C.	NULL
,	NULL
Merwin	NULL
,	NULL
R.	NULL
M.	NULL
,	NULL
Sachs	NULL
,	NULL
D.	NULL
H.	NULL
,	NULL
and	NULL
Asofsky	NULL
,	NULL
R.	NULL
(	NULL
1979	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

122	NULL
,	NULL
549-554	NULL
Ziegler-Heitbrock	NULL
,	NULL
H.	NULL
W.	NULL
,	NULL
Thiel	NULL
,	NULL
E.	NULL
,	NULL
Futterer	NULL
,	NULL
A.	NULL
,	NULL
Herzog	NULL
,	NULL
V.	NULL
,	NULL
Wirtz	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Riethmuller	NULL
,	NULL
G.	NULL
(	NULL
1988	NULL
)	NULL
Int	NULL
.	NULL

J	NULL
.	NULL

Cancer	NULL
41	NULL
,	NULL
456-461	NULL
Palacios	NULL
,	NULL
R.	NULL
,	NULL
Karasuyama	NULL
,	NULL
H.	NULL
,	NULL
and	NULL
Rolink	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1987	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

6	NULL
,	NULL
3687-3693	NULL
Zaret	NULL
,	NULL
K.	NULL
S.	NULL
,	NULL
Liu	NULL
,	NULL
J.	NULL
K.	NULL
,	NULL
and	NULL
DiPersio	NULL
,	NULL
C.	NULL
M.	NULL
(	NULL
1990	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

87	NULL
,	NULL
5469-5473	NULL
42	NULL
.	NULL

43	NULL
.	NULL

44	NULL
.	NULL

45	NULL
.	NULL

46	NULL
.	NULL

47	NULL
.	NULL

48	NULL
.	NULL

49	NULL
.	NULL

50	NULL
.	NULL

51	NULL
.	NULL

52	NULL
.	NULL

53	NULL
.	NULL

54	NULL
.	NULL

55	NULL
.	NULL

56	NULL
.	NULL

57	NULL
.	NULL

58	NULL
.	NULL

59	NULL
.	NULL

60	NULL
.	NULL

61	NULL
.	NULL

62	NULL
.	NULL

63	NULL
.	NULL

64	NULL
.	NULL

65	NULL
.	NULL

66	NULL
.	NULL

67	NULL
.	NULL

68	NULL
.	NULL

69	NULL
.	NULL

70	NULL
.	NULL

TL	NULL
72	NULL
.	NULL

PU.1	NULL
Regulation	NULL
by	NULL
Octamer	NULL
Factors	NULL
and	NULL
Coactivators	NULL
Chen	NULL
,	NULL
H.	NULL
M.	NULL
,	NULL
Pahl	NULL
,	NULL
H.	NULL
L.	NULL
,	NULL
Scheibe	NULL
,	NULL
R.	NULL
J.	NULL
,	NULL
Zhang	NULL
,	NULL
D.	NULL
E.	NULL
,	NULL
and	NULL
Tenen	NULL
,	NULL
D.	NULL
G.	NULL
(	NULL
1993	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

268	NULL
,	NULL
8230-8239	NULL
Pahl	NULL
,	NULL
H.	NULL
L.	NULL
,	NULL
Burn	NULL
,	NULL
T.	NULL
C.	NULL
,	NULL
and	NULL
Tenen	NULL
,	NULL
D.	NULL
G.	NULL
(	NULL
1991	NULL
)	NULL
Exp	NULL
.	NULL

Hematol	NULL
.	NULL

19	NULL
,	NULL
1038-1041	NULL
Tanaka	NULL
,	NULL
M.	NULL
and	NULL
Herr	NULL
,	NULL
W.	NULL
(	NULL
1990	NULL
)	NULL
Cell	NULL
60	NULL
,	NULL
375-386	NULL
Tsai	NULL
,	NULL
8	NULL
.	NULL

F.	NULL
,	NULL
Strauss	NULL
,	NULL
E.	NULL
,	NULL
and	NULL
Orkin	NULL
,	NULL
S.	NULL
H.	NULL
(	NULL
1991	NULL
)	NULL
Genes	NULL
Dev	NULL
.	NULL

5	NULL
,	NULL
919-981	NULL
Mueller	NULL
,	NULL
P.	NULL
R.	NULL
,	NULL
and	NULL
Wold	NULL
,	NULL
B	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
Science	NULL
246	NULL
,	NULL
780-786	NULL
Dignam	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
Lebovitz	NULL
,	NULL
R.	NULL
M.	NULL
,	NULL
and	NULL
Roeder	NULL
,	NULL
R.	NULL
G.	NULL
(	NULL
1983	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

11	NULL
,	NULL
1475-1489	NULL
Nuchprayoon	NULL
,	NULL
I.	NULL
,	NULL
Meyers	NULL
,	NULL
S.	NULL
,	NULL
Scott	NULL
,	NULL
L.	NULL
M.	NULL
,	NULL
Suzow	NULL
,	NULL
J.	NULL
,	NULL
Hiebert	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
Friedman	NULL
,	NULL
A.	NULL
D.	NULL
(	NULL
1994	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

14	NULL
,	NULL
5558-5568	NULL
Zhang	NULL
,	NULL
D.	NULL
E.	NULL
,	NULL
Fujioka	NULL
,	NULL
K.	NULL
L.	NULL
,	NULL
Hetherington	NULL
,	NULL
C.	NULL
J.	NULL
,	NULL
Shapiro	NULL
,	NULL
L.	NULL
H.	NULL
,	NULL
Chen	NULL
,	NULL
H.	NULL
M.	NULL
,	NULL
Look	NULL
,	NULL
A.	NULL
T.	NULL
,	NULL
and	NULL
Tenen	NULL
,	NULL
D.	NULL
G.	NULL
(	NULL
1994	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

14	NULL
,	NULL
8085-8095	NULL
Chen	NULL
,	NULL
H.	NULL
M.	NULL
,	NULL
Zhang	NULL
,	NULL
P.	NULL
,	NULL
Voso	NULL
,	NULL
M.	NULL
T.	NULL
,	NULL
Hohaus	NULL
,	NULL
S.	NULL
,	NULL
Gonzalez	NULL
,	NULL
D.	NULL
A.	NULL
,	NULL
Glass	NULL
,	NULL
C.	NULL
K.	NULL
,	NULL
Zhang	NULL
,	NULL
D.	NULL
E.	NULL
,	NULL
and	NULL
Tenen	NULL
,	NULL
D.	NULL
G.	NULL
(	NULL
1995	NULL
)	NULL
Blood	NULL
85	NULL
,	NULL
2918-2928	NULL
Yu	NULL
,	NULL
H.	NULL
,	NULL
Porton	NULL
,	NULL
B.	NULL
,	NULL
Shen	NULL
,	NULL
L.	NULL
Y.	NULL
,	NULL
and	NULL
Eckhardt	NULL
,	NULL
L.	NULL
A	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
Cell	NULL
58	NULL
,	NULL
441-448	NULL
Kadonaga	NULL
,	NULL
J.	NULL
T.	NULL
,	NULL
Carner	NULL
,	NULL
K.	NULL
R.	NULL
,	NULL
Masiarz	NULL
,	NULL
F.	NULL
R.	NULL
,	NULL
and	NULL
Tjian	NULL
,	NULL
R.	NULL
(	NULL
1987	NULL
)	NULL
Cell	NULL
51	NULL
,	NULL
1079-1090	NULL
Chirgwin	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
Przybyla	NULL
,	NULL
A.	NULL
E.	NULL
,	NULL
MacDonald	NULL
,	NULL
R.	NULL
J.	NULL
,	NULL
and	NULL
Rutter	NULL
,	NULL
W.	NULL
J	NULL
.	NULL

(	NULL
1979	NULL
)	NULL
Biochemistry	NULL
18	NULL
,	NULL
5294-5299	NULL
Torezynski	NULL
,	NULL
R.	NULL
M.	NULL
,	NULL
Fuke	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Bollon	NULL
,	NULL
A.	NULL
P.	NULL
(	NULL
1985	NULL
)	NULL
DNA	NULL
(	NULL
N	NULL
.	NULL

Y	NULL
.	NULL
)	NULL

4	NULL
,	NULL
283-291	NULL
Feinberg	NULL
,	NULL
A.	NULL
P.	NULL
,	NULL
and	NULL
Vogelstein	NULL
,	NULL
B	NULL
.	NULL

(	NULL
1983	NULL
)	NULL
Anal	NULL
.	NULL

Biochem	NULL
.	NULL

182	NULL
,	NULL
6-13	NULL
Rosenberg	NULL
,	NULL
H.	NULL
F.	NULL
,	NULL
Ackerman	NULL
,	NULL
S.	NULL
J.	NULL
,	NULL
and	NULL
Tenen	NULL
,	NULL
D.	NULL
G.	NULL
(	NULL
1990	NULL
)	NULL
BioTechniques	NULL
8	NULL
,	NULL
384	NULL
Staudt	NULL
,	NULL
L.	NULL
M.	NULL
,	NULL
Singh	NULL
,	NULL
H.	NULL
,	NULL
Sen	NULL
,	NULL
R.	NULL
,	NULL
Wirth	NULL
,	NULL
T.	NULL
,	NULL
Sharp	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
and	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1986	NULL
)	NULL
Nature	NULL
828	NULL
,	NULL
640-643	NULL
Wirth	NULL
,	NULL
T.	NULL
,	NULL
Staudt	NULL
,	NULL
L.	NULL
,	NULL
and	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1987	NULL
)	NULL
Nature	NULL
829	NULL
,	NULL
174-178	NULL
Ray-Gallet	NULL
,	NULL
D.	NULL
,	NULL
Mao	NULL
,	NULL
C.	NULL
,	NULL
Tavitian	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Moreau-Gachelin	NULL
,	NULL
F.	NULL
(	NULL
1995	NULL
)	NULL
Oncogene	NULL
11	NULL
,	NULL
303-313	NULL
Zhang	NULL
,	NULL
D.	NULL
E.	NULL
,	NULL
Hetherington	NULL
,	NULL
C.	NULL
J.	NULL
,	NULL
Tan	NULL
,	NULL
S.	NULL
,	NULL
Dziennis	NULL
,	NULL
S.	NULL
E.	NULL
,	NULL
Gonzalez	NULL
,	NULL
D.	NULL
A.	NULL
,	NULL
Chen	NULL
,	NULL
H.	NULL
M.	NULL
,	NULL
and	NULL
Tenen	NULL
,	NULL
D.	NULL
G.	NULL
(	NULL
1994	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

269	NULL
,	NULL
11425-11434	NULL
Klempnauer	NULL
,	NULL
K.	NULL
H.	NULL
,	NULL
Arnold	NULL
,	NULL
H.	NULL
,	NULL
and	NULL
Biedenkapp	NULL
,	NULL
H.	NULL
(	NULL
1989	NULL
)	NULL
Genes	NULL
Dev	NULL
.	NULL

8	NULL
,	NULL
1582-1589	NULL
Moreau-Gachelin	NULL
,	NULL
F.	NULL
,	NULL
Ray	NULL
,	NULL
D.	NULL
,	NULL
Mattei	NULL
,	NULL
M.	NULL
G.	NULL
,	NULL
Tambourin	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
Tavitian	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
Oncogene	NULL
4	NULL
,	NULL
1449-1456	NULL
Ray	NULL
,	NULL
D.	NULL
,	NULL
Culine	NULL
,	NULL
S.	NULL
,	NULL
Tavitian	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Moreau-Gachelin	NULL
,	NULL
F.	NULL
(	NULL
1990	NULL
)	NULL
Oncogene	NULL
5	NULL
,	NULL
663-668	NULL
Galson	NULL
,	NULL
D.	NULL
L.	NULL
,	NULL
Hensold	NULL
,	NULL
J.	NULL
O.	NULL
,	NULL
Bishop	NULL
,	NULL
T.	NULL
R.	NULL
,	NULL
Schalling	NULL
,	NULL
M.	NULL
,	NULL
D'Andrea	NULL
,	NULL
A.	NULL
D.	NULL
,	NULL
Jones	NULL
,	NULL
C.	NULL
,	NULL
Auron	NULL
,	NULL
P.	NULL
E.	NULL
,	NULL
and	NULL
Housman	NULL
,	NULL
D.	NULL
E.	NULL
(	NULL
1993	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

18	NULL
,	NULL
2929-2941	NULL
Hromas	NULL
,	NULL
R.	NULL
,	NULL
Orazi	NULL
,	NULL
A.	NULL
,	NULL
Neiman	NULL
,	NULL
R.	NULL
S.	NULL
,	NULL
Maki	NULL
,	NULL
R.	NULL
,	NULL
Vanbeveran	NULL
,	NULL
C.	NULL
,	NULL
Moore	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Klemsz	NULL
,	NULL
M.	NULL
(	NULL
1993	NULL
)	NULL
Blood	NULL
82	NULL
,	NULL
2998-3004	NULL
Zwilling	NULL
,	NULL
S.	NULL
,	NULL
Annweiler	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Wirth	NULL
,	NULL
T.	NULL
(	NULL
1994	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

22	NULL
,	NULL
1655-1662	NULL
Hagemeier	NULL
,	NULL
C.	NULL
,	NULL
Bannister	NULL
,	NULL
A.	NULL
J.	NULL
,	NULL
Cook	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Kouzarides	NULL
,	NULL
T.	NULL
(	NULL
1993	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

90	NULL
,	NULL
1580-1584	NULL
Weintraub	NULL
,	NULL
S.	NULL
J.	NULL
,	NULL
Chow	NULL
,	NULL
K.	NULL
N.	NULL
,	NULL
Luo	NULL
,	NULL
R.	NULL
X.	NULL
,	NULL
Zhang	NULL
,	NULL
S.	NULL
H.	NULL
,	NULL
He	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
Dean	NULL
,	NULL
D.	NULL
C.	NULL
(	NULL
1995	NULL
)	NULL
Nature	NULL
875	NULL
,	NULL
812-815	NULL
Segil	NULL
,	NULL
N.	NULL
,	NULL
Roberts	NULL
,	NULL
S.	NULL
B.	NULL
,	NULL
and	NULL
Heintz	NULL
,	NULL
N.	NULL
(	NULL
1991	NULL
)	NULL
Science	NULL
254	NULL
,	NULL
1814-1816	NULL
Janson	NULL
,	NULL
L.	NULL
and	NULL
Pettersson	NULL
,	NULL
U	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

87	NULL
,	NULL
4732-4736	NULL
Chen	NULL
,	NULL
J.	NULL
H.	NULL
and	NULL
Wright	NULL
,	NULL
C.	NULL
D.	NULL
(	NULL
1993	NULL
)	NULL
Oncogene	NULL
8	NULL
,	NULL
3375-3383	NULL
Pahl	NULL
,	NULL
H.	NULL
L.	NULL
,	NULL
Scheibe	NULL
,	NULL
R.	NULL
J.	NULL
,	NULL
Zhang	NULL
,	NULL
D.	NULL
E.	NULL
,	NULL
Chen	NULL
,	NULL
H.	NULL
M.	NULL
,	NULL
Galson	NULL
,	NULL
D.	NULL
L.	NULL
,	NULL
Maki	NULL
,	NULL
R.	NULL
A.	NULL
,	NULL
and	NULL
Tenen	NULL
,	NULL
D.	NULL
G.	NULL
(	NULL
1993	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

268	NULL
,	NULL
5014-5020	NULL
610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
Octamer	NULL
Binding	NULL
Factors	NULL
and	NULL
Their	NULL
Coactivator	NULL
Can	NULL
Activate	NULL
the	NULL
Murine	NULL
PU.1	NULL
(	NULL
spi-1	NULL
)	NULL
Promoter	NULL
Hui-min	NULL
Chen	NULL
,	NULL
Pu	NULL
Zhang	NULL
,	NULL
Hanna	NULL
S.	NULL
Radomska	NULL
,	NULL
Christopher	NULL
J.	NULL
Hetherington	NULL
,	NULL
Dong-Er	NULL
Zhang	NULL
and	NULL
Daniel	NULL
G.	NULL
Tenen	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

1996	NULL
,	NULL
271:15743-15752.	NULL
doi	NULL
:	NULL
10.1074/jb0.271.26.15743	NULL
Access	NULL
the	NULL
most	NULL
updated	NULL
version	NULL
of	NULL
this	NULL
article	NULL
at	NULL
http	NULL
:	NULL
/www.jbe.org/content/271/26/15743	NULL
Alerts	NULL
:	NULL
«	NULL
When	NULL
this	NULL
article	NULL
is	NULL
cited	NULL
«	NULL
When	NULL
a	NULL
correction	NULL
for	NULL
this	NULL
article	NULL
is	NULL
posted	NULL
Click	NULL
here	NULL
to	NULL
choose	NULL
from	NULL
all	NULL
of	NULL
JBC	NULL
's	NULL
e-mail	NULL
alerts	NULL
This	NULL
article	NULL
cites	NULL
72	NULL
references	NULL
,	NULL
34	NULL
of	NULL
which	NULL
can	NULL
be	NULL
accessed	NULL
free	NULL
at	NULL
http	NULL
:	NULL
//www	NULL
610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
4q	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL

